Healthcare Distribution Alliance – Patients Move Us.
SEARCH
Site Search
Search Results For ""
Number Of Results : 1001
Pharmaceutical Distributors Provide Essential Services to Specialty Rx Supply Chain
/news/2015-12-21-rx-distributors-provide-essential-services-to-specialty-rx-supply-chain
New research published by the Center for Healthcare Supply Chain Research, HDMA’s knowledge partner, indicates that pharmaceutical distributors provide the specialty pharmaceutical supply chain essential services while efficiently aggregating and delivering thousands of lifesaving medications to a large network of providers for the treatment of critically ill patient populations with chronic or rare diseases.
/news/2015-12-21-rx-distributors-provide-essential-services-to-specialty-rx-supply-chain
New research published by the Center for Healthcare Supply Chain Research, HDMA’s knowledge partner, indicates that pharmaceutical distributors provide the specialty pharmaceutical supply chain essential services while efficiently aggregating and delivering thousands of lifesaving medications to a large network of providers for the treatment of critically ill patient populations with chronic or rare diseases.
HDA Statement on Department of Justice Opioid Efforts
/news/2018-02-27-hda-statement-on-doj-opioid-efforts
Today, Healthcare Distribution Alliance (HDA) President and CEO John M. Gray issued a statement in response to new efforts by the Department of Justice to address the opioid epidemic.
/news/2018-02-27-hda-statement-on-doj-opioid-efforts
Today, Healthcare Distribution Alliance (HDA) President and CEO John M. Gray issued a statement in response to new efforts by the Department of Justice to address the opioid epidemic.
HDMA and Hamacher Resource Group Report Explores Dialogue Between Indepdendent Pharmacists and Patients, Impact on Front-of-Store Sales
/news/2015-02-03-hdma-and-hamacher-resource-group-report
A new study commissioned by HDMA and conducted by Hamacher Resource Group (HRG), Pharmacist and Patient Conversations at Independent Pharmacy, delves into the dialogue between independent pharmacists and their customers and how those communications impact consumer purchasing decisions. The study is based on electronic and phone surveys of independent pharmacists conducted in 2014 and includes secondary research that supports these most recent findings. The report is the fifth in a series focusing on the opportunities for pharmaceutical distributors and manufacturers to support independent pharmacy.
/news/2015-02-03-hdma-and-hamacher-resource-group-report
A new study commissioned by HDMA and conducted by Hamacher Resource Group (HRG), Pharmacist and Patient Conversations at Independent Pharmacy, delves into the dialogue between independent pharmacists and their customers and how those communications impact consumer purchasing decisions. The study is based on electronic and phone surveys of independent pharmacists conducted in 2014 and includes secondary research that supports these most recent findings. The report is the fifth in a series focusing on the opportunities for pharmaceutical distributors and manufacturers to support independent pharmacy.
What The Washington Post Won’t Say About Distributors and Regulation of Controlled Substances in the Supply Chain
/news/2017-10-15-correcting-the-record
/news/2017-10-15-correcting-the-record
AAOA Launches Pharmacy Toolkit
/news/2018-09-18-aaoa-launches-pharmacy-toolkit
Allied Against Opioid Abuse (AAOA), a national initiative to help prevent prescription opioid abuse and misuse through education, has created a pharmacy toolkit (http://bit.ly/2xiNmnj) to equip pharmacists with resources to engage and educate patients about the safe use, storage and disposal of pain medicines.
/news/2018-09-18-aaoa-launches-pharmacy-toolkit
Allied Against Opioid Abuse (AAOA), a national initiative to help prevent prescription opioid abuse and misuse through education, has created a pharmacy toolkit (http://bit.ly/2xiNmnj) to equip pharmacists with resources to engage and educate patients about the safe use, storage and disposal of pain medicines.
HDA Statement on Senate Passage of Legislation to Address Opioid Abuse Epidemic
/news/2018-09-17-hda-statement-on-hr-6
Healthcare Distribution Alliance (HDA) President and CEO John M. Gray released the following statement on the Senate passage of comprehensive opioid legislation, the SUPPORT for Patients and Communities Act (H.R. 6).
/news/2018-09-17-hda-statement-on-hr-6
Healthcare Distribution Alliance (HDA) President and CEO John M. Gray released the following statement on the Senate passage of comprehensive opioid legislation, the SUPPORT for Patients and Communities Act (H.R. 6).
McKesson's Paul C. Julian Honored With 2015 Nexus Award for Lifetime Achievement
/news/2015-06-09-paul-julian-honored-with-nexus-award
The Center for Healthcare Supply Chain Research, HDMA’s non-profit research foundation, and Genentech, Inc., A Member of the Roche Group, honored Paul C. Julian, Executive Vice President and Group President for McKesson Corporation with the 2015 Nexus Award for Lifetime Achievement.
/news/2015-06-09-paul-julian-honored-with-nexus-award
The Center for Healthcare Supply Chain Research, HDMA’s non-profit research foundation, and Genentech, Inc., A Member of the Roche Group, honored Paul C. Julian, Executive Vice President and Group President for McKesson Corporation with the 2015 Nexus Award for Lifetime Achievement.
Center for Healthcare Supply Chain Research Releases Specialty Pharmaceutical Distribution: Facts, Figures and Trends
/news/2015-12-02-center-releases-specialty-trends
HDMA’s Center for Healthcare Supply Chain Research has published the latest edition of its annual benchmarking publication, Specialty Pharmaceutical Distribution: Facts, Figures and Trends (2015 Edition). The seventh edition is sponsored by CuraScript Specialty Distribution; Genentech, A Member of the Roche Group; and Pharmacy First.
/news/2015-12-02-center-releases-specialty-trends
HDMA’s Center for Healthcare Supply Chain Research has published the latest edition of its annual benchmarking publication, Specialty Pharmaceutical Distribution: Facts, Figures and Trends (2015 Edition). The seventh edition is sponsored by CuraScript Specialty Distribution; Genentech, A Member of the Roche Group; and Pharmacy First.
91.4 Percent of U.S. Pharmaceutical Sales Channeled Through HDMA-Member Distributors
/news/2015-12-16-91-percent-of-us-pharmaceutical-sales-channeled-through-hdma-member-distributors
Approximately 91 percent of pharmaceutical products — about $350 billion — came to market through HDMA-member traditional pharmaceutical distributors in 2014, according to the 86th Edition HDMA Factbook: The Facts, Figures and Trends in Healthcare (2015-2016). This represents a 1.3 percentage point increase from 2013. Meanwhile, the Factbook notes that spending on pharmaceuticals continues to rise in the U.S., reaching about $374 billion in 2014, according to IMS Health.
/news/2015-12-16-91-percent-of-us-pharmaceutical-sales-channeled-through-hdma-member-distributors
Approximately 91 percent of pharmaceutical products — about $350 billion — came to market through HDMA-member traditional pharmaceutical distributors in 2014, according to the 86th Edition HDMA Factbook: The Facts, Figures and Trends in Healthcare (2015-2016). This represents a 1.3 percentage point increase from 2013. Meanwhile, the Factbook notes that spending on pharmaceuticals continues to rise in the U.S., reaching about $374 billion in 2014, according to IMS Health.
House Legislation Encourages Collaboration, Cooperation in the Fight Against Prescription Drug Abuse
/news/2015-01-22-house-legislation-encourages-collaboration
HDMA President and CEO John M. Gray applauded the reintroduction of the Ensuring Patient Access and Effective Drug Enforcement Act of 2015, introduced on January 22 in the House of Representatives.
/news/2015-01-22-house-legislation-encourages-collaboration
HDMA President and CEO John M. Gray applauded the reintroduction of the Ensuring Patient Access and Effective Drug Enforcement Act of 2015, introduced on January 22 in the House of Representatives.
HDMA-Supported Legislation Addressing Rx Drug Abuse Passes House Subcommittee
/news/2015-02-04-hr-471-passes-house-subcommittee
HDMA President and CEO John M. Gray released a statement following the House Energy and Commerce Subcommittee on Health’s markup of the Ensuring Patient Access and Effective Drug Enforcement Act of 2015 (H.R. 471), sponsored by Reps. Tom Marino (R-Pa.), Marsha Blackburn (R-Tenn.), Peter Welch (D-Vt.) and Judy Chu (D-Calif.)
/news/2015-02-04-hr-471-passes-house-subcommittee
HDMA President and CEO John M. Gray released a statement following the House Energy and Commerce Subcommittee on Health’s markup of the Ensuring Patient Access and Effective Drug Enforcement Act of 2015 (H.R. 471), sponsored by Reps. Tom Marino (R-Pa.), Marsha Blackburn (R-Tenn.), Peter Welch (D-Vt.) and Judy Chu (D-Calif.)
H.R. 471 Approved by House Energy and Commerce Committee
/news/2015-02-12-hr-471-approved-by-house-committee
HDMA President and CEO John M. Gray issued the following statement following the House Energy and Commerce Committee’s approval of the Ensuring Patient Access and Effective Drug Enforcement Act of 2015 (H.R. 471). The legislation is sponsored by Reps. Tom Marino (R-Pa.), Marsha Blackburn (R-Tenn.), Peter Welch (D-Vt.) and Judy Chu (D-Calif).
/news/2015-02-12-hr-471-approved-by-house-committee
HDMA President and CEO John M. Gray issued the following statement following the House Energy and Commerce Committee’s approval of the Ensuring Patient Access and Effective Drug Enforcement Act of 2015 (H.R. 471). The legislation is sponsored by Reps. Tom Marino (R-Pa.), Marsha Blackburn (R-Tenn.), Peter Welch (D-Vt.) and Judy Chu (D-Calif).
Perry Fri Named Chief Operating Officer of the HDA Research Foundation
/news/2016-10-06-perry-fri-named-coo-of-the-hda-research-foundation
The HDA Research Foundation (formerly the Center for Healthcare Supply Chain Research) today announces the appointment of Perry L. Fri as its Chief Operating Officer. He assumes leadership of the Foundation, the 501(c)(3) non-profit charitable organization of the Healthcare Distribution Alliance (HDA, formerly HDMA), from Karen J. Ribler, who retired at the end of September.
/news/2016-10-06-perry-fri-named-coo-of-the-hda-research-foundation
The HDA Research Foundation (formerly the Center for Healthcare Supply Chain Research) today announces the appointment of Perry L. Fri as its Chief Operating Officer. He assumes leadership of the Foundation, the 501(c)(3) non-profit charitable organization of the Healthcare Distribution Alliance (HDA, formerly HDMA), from Karen J. Ribler, who retired at the end of September.
AmerisourceBergen Corporation Wins HDMA’s Distribution Management Award for Centralizing DSCSA Data and Serialization Requirements
/news/2016-03-08-abc-honored-with-dma
AmerisourceBergen Corporation was named the winner of HDMA’s 2016 Distribution Management Award for centralizing its data for Drug Supply Chain Security Act (DSCSA) compliance, as well as to prepare for long-term serialization requirements.
/news/2016-03-08-abc-honored-with-dma
AmerisourceBergen Corporation was named the winner of HDMA’s 2016 Distribution Management Award for centralizing its data for Drug Supply Chain Security Act (DSCSA) compliance, as well as to prepare for long-term serialization requirements.
HDA Named One of the Best Places to Work in Virginia for Seventh Year in a Row
/news/2017-01-09-hda-named-one-of-the-best-places-to-work-in-va
For the seventh consecutive year, the Healthcare Distribution Alliance (HDA) is named one of the 2017 Best Places to Work in Virginia by Virginia Business magazine and Best Companies Group.
/news/2017-01-09-hda-named-one-of-the-best-places-to-work-in-va
For the seventh consecutive year, the Healthcare Distribution Alliance (HDA) is named one of the 2017 Best Places to Work in Virginia by Virginia Business magazine and Best Companies Group.
HDMA Presents Rx Safety and Healthcare Leadership Award to Four Legislative Champions
/news/2015-02-05-hdma-presents-rx-award-to-legislative-champions
In early February, 2015, HDMA recognized four members of Congress ― Reps. Tom Marino (R-Pa.), Marsha Blackburn (R-Tenn.), Peter Welch (D-Vt.) and Judy Chu (D-Calif.) — with the Association’s Rx Safety and Healthcare Leadership Award (or Rx Award).
/news/2015-02-05-hdma-presents-rx-award-to-legislative-champions
In early February, 2015, HDMA recognized four members of Congress ― Reps. Tom Marino (R-Pa.), Marsha Blackburn (R-Tenn.), Peter Welch (D-Vt.) and Judy Chu (D-Calif.) — with the Association’s Rx Safety and Healthcare Leadership Award (or Rx Award).
HDMA Named One of the Best Places to Work in Virginia for Fifth Consecutive Year
/news/2015-01-08-hdma-named-one-of-the-best-places-to-work-for-fifth-consecutive-year
For the fifth year in a row, the Healthcare Distribution Management Association (HDMA) has been named one of the 2015 Best Places to Work in Virginia by Virginia Business magazine and Best Companies Group.
/news/2015-01-08-hdma-named-one-of-the-best-places-to-work-for-fifth-consecutive-year
For the fifth year in a row, the Healthcare Distribution Management Association (HDMA) has been named one of the 2015 Best Places to Work in Virginia by Virginia Business magazine and Best Companies Group.
HDA Statement on Proposed DEA Regulations
/news/2019-10-28-hda-statement-on-proposed-dea-regulations
In response to the Drug Enforcement Administration’s (DEA) proposed regulations related to the review and monitoring of annual production quotas, the Healthcare Distribution Alliance (HDA) released the following statement.
/news/2019-10-28-hda-statement-on-proposed-dea-regulations
In response to the Drug Enforcement Administration’s (DEA) proposed regulations related to the review and monitoring of annual production quotas, the Healthcare Distribution Alliance (HDA) released the following statement.
HDA Statement on Release of DEA ARCOS Data
/news/2019-07-16-hda-statement-on-dea-arcos-data-release
Healthcare Distribution Alliance (HDA) Senior Vice President of Communications John Parker released the following statement on the release of the Drug Enforcement Administration’s (DEA) Automation of Reports and Consolidated Orders System (ARCOS) data.
/news/2019-07-16-hda-statement-on-dea-arcos-data-release
Healthcare Distribution Alliance (HDA) Senior Vice President of Communications John Parker released the following statement on the release of the Drug Enforcement Administration’s (DEA) Automation of Reports and Consolidated Orders System (ARCOS) data.
Fact Check: Where 60 Minutes Got it Wrong
/news/2019-06-30-fact-check-where-60-minutes-got-it-wrong
60 Minutes has consistently presented misleading, inaccurate accounts of pharmaceutical distributors’ role in the opioid abuse crisis. The latest episode perpetuates a number of myths around the opioid epidemic and does a disservice to any effort to truly understand and address its root causes — notably, the shift in medical practice to treat pain more aggressively and the role of illegal drugs in most overdose deaths.
/news/2019-06-30-fact-check-where-60-minutes-got-it-wrong
60 Minutes has consistently presented misleading, inaccurate accounts of pharmaceutical distributors’ role in the opioid abuse crisis. The latest episode perpetuates a number of myths around the opioid epidemic and does a disservice to any effort to truly understand and address its root causes — notably, the shift in medical practice to treat pain more aggressively and the role of illegal drugs in most overdose deaths.
Americares Honors Endo with Power of Partnership Award
/news/2017-06-12-americares-honors-endo-with-power-of-partnership-award
Americares, in partnership with the Healthcare Distribution Alliance (HDA), has presented its annual Power of Partnership award to Endo Pharmaceuticals Inc. and Par Pharmaceutical, operating companies of Endo International plc, in recognition of their outstanding commitment to increasing access to health care around the world. Endo is among Americares most dedicated and longstanding supporters, providing pharmaceutical products for the global relief and development organization’s emergency response work and ongoing health programs.
/news/2017-06-12-americares-honors-endo-with-power-of-partnership-award
Americares, in partnership with the Healthcare Distribution Alliance (HDA), has presented its annual Power of Partnership award to Endo Pharmaceuticals Inc. and Par Pharmaceutical, operating companies of Endo International plc, in recognition of their outstanding commitment to increasing access to health care around the world. Endo is among Americares most dedicated and longstanding supporters, providing pharmaceutical products for the global relief and development organization’s emergency response work and ongoing health programs.
HDA’s John M. Gray Highlights State of the Distribution Industry in Chain Drug Review
/news/2017-06-05-gray-interview-in-chain-drug-review
Ahead of the HDA Business and Leadership Conference, President and CEO John M. Gray was interviewed by Chain Drug Review as part of the publication’s “Annual Report of Drug Wholesalers.”
/news/2017-06-05-gray-interview-in-chain-drug-review
Ahead of the HDA Business and Leadership Conference, President and CEO John M. Gray was interviewed by Chain Drug Review as part of the publication’s “Annual Report of Drug Wholesalers.”
HDA Supports PAHPA Reauthorization
/news/2019-06-04-hda-supports-pahpa-reauthorization
Following the passage of legislation to reauthorize the Pandemic and All-Hazards Preparedness and Advancing Innovation Act, Healthcare Distribution Alliance (HDA) President and CEO John M. Gray released this statement.
/news/2019-06-04-hda-supports-pahpa-reauthorization
Following the passage of legislation to reauthorize the Pandemic and All-Hazards Preparedness and Advancing Innovation Act, Healthcare Distribution Alliance (HDA) President and CEO John M. Gray released this statement.
HDMA Announces Staff Promotions
/news/2015-01-13-hdma-announces-staff-promotions
The Healthcare Distribution Management Association recently promoted four staff members.
/news/2015-01-13-hdma-announces-staff-promotions
The Healthcare Distribution Management Association recently promoted four staff members.
HDMA's Gray Highlights 2015 Distribution Industry Priorities in Chain Drug Review
/news/2015-01-05-hdmas-gray-highlights-2015-industry-priorities
HDMA President and CEO John M. Gray, along with other healthcare supply chain leaders, contributed to Chain Drug Review's annual "Pharmacy Outlook" feature, published on January 5.
/news/2015-01-05-hdmas-gray-highlights-2015-industry-priorities
HDMA President and CEO John M. Gray, along with other healthcare supply chain leaders, contributed to Chain Drug Review's annual "Pharmacy Outlook" feature, published on January 5.
HDA Statement on “Connecticut Option” Proposal
/news/2019-05-24-hda-statement-on-connecticut-option
The Healthcare Distribution Alliance (HDA) issued a statement in response to the proposed “Connecticut Option,” which imposes an assessment on the first sale of prescription opioids.
/news/2019-05-24-hda-statement-on-connecticut-option
The Healthcare Distribution Alliance (HDA) issued a statement in response to the proposed “Connecticut Option,” which imposes an assessment on the first sale of prescription opioids.
HDMA Launches New Identity as the Healthcare Distribution Alliance
/news/2016-06-13-hdma-launches-new-identity-as-hda
HDMA President and CEO John M. Gray announced that the organization has changed its name to the Healthcare Distribution Alliance (HDA), effective immediately, at the opening general session of its 2016 Business and Leadership Conference in Colorado Springs. Additionally, HDA’s non-profit charitable research foundation, the Center for Healthcare Supply Chain Research, will now be known as the HDA Research Foundation.
/news/2016-06-13-hdma-launches-new-identity-as-hda
HDMA President and CEO John M. Gray announced that the organization has changed its name to the Healthcare Distribution Alliance (HDA), effective immediately, at the opening general session of its 2016 Business and Leadership Conference in Colorado Springs. Additionally, HDA’s non-profit charitable research foundation, the Center for Healthcare Supply Chain Research, will now be known as the HDA Research Foundation.
AmeriCares Honors Fresenius Kabi USA with Power of Partnership Award
/news/2016-06-13-americares-honors-fresenius-kabi-usa
AmeriCares presented its annual Power of Partnership Award to Fresenius Kabi USA today in recognition of the company’s outstanding commitment to helping disaster survivors and improving health care access around the world.
/news/2016-06-13-americares-honors-fresenius-kabi-usa
AmeriCares presented its annual Power of Partnership Award to Fresenius Kabi USA today in recognition of the company’s outstanding commitment to helping disaster survivors and improving health care access around the world.
H. D. Smith's Henry Dale Smith, Jr., Presented With the 2016 Nexus Award for Lifetime Achievement
/news/2016-06-14-smith-presented-with-2016-nexus-award
The HDA Research Foundation (formerly the Center for Healthcare Supply Chain Research), Genentech Inc., a member of the Roche Group, and Mylan Inc., honored Henry Dale Smith, Jr., of H. D. Smith Holding Company with the 2016 Nexus Award for Lifetime Achievement. The HDA Research Foundation is the charitable research arm of the Healthcare Distribution Alliance (HDA, formerly the Healthcare Distribution Management Association).
/news/2016-06-14-smith-presented-with-2016-nexus-award
The HDA Research Foundation (formerly the Center for Healthcare Supply Chain Research), Genentech Inc., a member of the Roche Group, and Mylan Inc., honored Henry Dale Smith, Jr., of H. D. Smith Holding Company with the 2016 Nexus Award for Lifetime Achievement. The HDA Research Foundation is the charitable research arm of the Healthcare Distribution Alliance (HDA, formerly the Healthcare Distribution Management Association).
HDMA Names Ruth Miller Senior Director of Regulatory Affairs
/news/2016-04-25-ruth-miller-named-senior-director-regulatory-affairs
HDMA announced today that Ruth Miller has joined the Association’s Government Affairs team as Senior Director of Regulatory Affairs. In this new position Miller will be responsible for recommending policies and positions on federal regulatory proposals — with a primary emphasis on those related to the Drug Enforcement Administration (DEA). She also will facilitate and coordinate HDMA members' efforts to implement federal regulations.
/news/2016-04-25-ruth-miller-named-senior-director-regulatory-affairs
HDMA announced today that Ruth Miller has joined the Association’s Government Affairs team as Senior Director of Regulatory Affairs. In this new position Miller will be responsible for recommending policies and positions on federal regulatory proposals — with a primary emphasis on those related to the Drug Enforcement Administration (DEA). She also will facilitate and coordinate HDMA members' efforts to implement federal regulations.
President Obama Signs S. 483; HDMA-Championed Legislation is First Enacted Law Addressing Rx Drug Abuse in the 114th Congress
/news/2016-04-19-president-obama-signs-s-483
The HDMA-supported legislation, the Ensuring Patient Access and Effective Drug Enforcement Act (S. 483), sponsored by Senators Orrin Hatch (R-Utah) and Sheldon Whitehouse (D-R.I.), was signed into law by President Obama on April 19.
/news/2016-04-19-president-obama-signs-s-483
The HDMA-supported legislation, the Ensuring Patient Access and Effective Drug Enforcement Act (S. 483), sponsored by Senators Orrin Hatch (R-Utah) and Sheldon Whitehouse (D-R.I.), was signed into law by President Obama on April 19.
Jon Giacomin of Cardinal Health, Inc., Elected Chairman of HDA Board of Directors
/news/2016-09-26-giacomin-named-hda-chairman
The Healthcare Distribution Alliance (HDA, formerly HDMA) announced the election of Jon Giacomin, Chief Executive Officer, Pharmaceutical segment, Cardinal Health, Inc., as Chairman of the HDA Board of Directors at its Annual Board and Membership Meeting.
/news/2016-09-26-giacomin-named-hda-chairman
The Healthcare Distribution Alliance (HDA, formerly HDMA) announced the election of Jon Giacomin, Chief Executive Officer, Pharmaceutical segment, Cardinal Health, Inc., as Chairman of the HDA Board of Directors at its Annual Board and Membership Meeting.
EPA Waste Rule Examined in HDA Op-Ed for Chain Drug Review
/news/2016-08-08-epa-waste-rule-examined-in-hda-op-ed-for-chain-drug-review
An op-ed written for Chain Drug Review by HDA’s Senior Vice President of Regulatory Affairs, Anita Ducca, examines the implications of the EPA’s proposed rule on managing pharmaceutical waste.
/news/2016-08-08-epa-waste-rule-examined-in-hda-op-ed-for-chain-drug-review
An op-ed written for Chain Drug Review by HDA’s Senior Vice President of Regulatory Affairs, Anita Ducca, examines the implications of the EPA’s proposed rule on managing pharmaceutical waste.
HDA Saleable Returns Pilot Study Identifies Two Recommendations to Meet 2019 DSCSA Requirements
/news/2016-11-10-hda-pilot-results-revealed
The Healthcare Distribution Alliance (HDA, formerly HDMA) presented the results of its Pilot Study for Saleable Returns, which recommended two scenarios that would help pharmaceutical manufacturers and distributors comply with requirements set forth by the Drug Supply Chain Security Act (DSCSA). The recommendations were presented this morning at HDA’s Traceability Seminar in Washington, D.C.
/news/2016-11-10-hda-pilot-results-revealed
The Healthcare Distribution Alliance (HDA, formerly HDMA) presented the results of its Pilot Study for Saleable Returns, which recommended two scenarios that would help pharmaceutical manufacturers and distributors comply with requirements set forth by the Drug Supply Chain Security Act (DSCSA). The recommendations were presented this morning at HDA’s Traceability Seminar in Washington, D.C.
Nearly 94 Percent of U.S. Rx Sales Pass Through Pharmaceutical Distributors
/news/2016-12-6-annual-factbook-release
Nearly 94 percent (about $407 billion) of total pharmaceuticals sales in the U.S. were channeled through HDA-member pharmaceutical distributors in 2015, according to a new report by the HDA Research Foundation (formerly The Center for Supply Chain Research). The Foundation, the 501(c)(3) of the Healthcare Distribution Alliance, released the new findings in its 87th Edition HDA Factbook: The Facts, Figures and Trends in Healthcare (2016-2017).
/news/2016-12-6-annual-factbook-release
Nearly 94 percent (about $407 billion) of total pharmaceuticals sales in the U.S. were channeled through HDA-member pharmaceutical distributors in 2015, according to a new report by the HDA Research Foundation (formerly The Center for Supply Chain Research). The Foundation, the 501(c)(3) of the Healthcare Distribution Alliance, released the new findings in its 87th Edition HDA Factbook: The Facts, Figures and Trends in Healthcare (2016-2017).
HDA Announces Partnership With ValueCentric
/news/2016-12-19-hda-announces-partnership-with-valuecentric
The Healthcare Distribution Alliance (HDA) announced a new, long-term partnership with ValueCentric, LLC, to create a GTIN Repository Service designed to help ensure the efficient introduction of a GTIN coding system and ease its adoption across the pharmaceutical supply chain.
/news/2016-12-19-hda-announces-partnership-with-valuecentric
The Healthcare Distribution Alliance (HDA) announced a new, long-term partnership with ValueCentric, LLC, to create a GTIN Repository Service designed to help ensure the efficient introduction of a GTIN coding system and ease its adoption across the pharmaceutical supply chain.
Cardinal Health Wins HDMA’s Distribution Management Award for Innovative Pharmacy Restocking Solutions
/news/2015-03-10-cardinal-health-wins-hdma-dma
Cardinal Health was named the winner of HDMA’s 2015 Distribution Management Award for EZ Cart and EZ Tote, two solutions that streamline the restocking process for their pharmacy customers. The award was presented on March 10 at the 2015 Distribution Management Conference and Expo in Orlando, Fla., and selected by distributor and manufacturer members of the Association’s Industry Relations Council.
/news/2015-03-10-cardinal-health-wins-hdma-dma
Cardinal Health was named the winner of HDMA’s 2015 Distribution Management Award for EZ Cart and EZ Tote, two solutions that streamline the restocking process for their pharmacy customers. The award was presented on March 10 at the 2015 Distribution Management Conference and Expo in Orlando, Fla., and selected by distributor and manufacturer members of the Association’s Industry Relations Council.
HDMA Recognizes Former Purdue Pharma Executive Stephen Seid With Distribution Management Award for Industry Leadership
/news/2015-03-10-hdma-recognizes-seid-with-dma-for-leadership
HDMA honored former Purdue Pharma L.P. executive Stephen Seid with the 2015 Distribution Management Award for Industry Leadership on March 10, 2015.
/news/2015-03-10-hdma-recognizes-seid-with-dma-for-leadership
HDMA honored former Purdue Pharma L.P. executive Stephen Seid with the 2015 Distribution Management Award for Industry Leadership on March 10, 2015.
Georgia Attorney General Carr Announces Winners of HDA-Supported Rx Drug Abuse Awareness Video Contest
/news/2017-02-06-ag-carr-announces-winners-of-rx-drug-abuse-awareness-video-contest
Today, Attorney General Chris Carr announced at Dunwoody High School in Dunwoody, Ga., the winners of the “We’re Not Gonna Take It” video contest aimed at preventing prescription drug abuse among teens. The winning video was produced by Dunwoody High School student Peter Vuong. The runner-up was produced by Northview High School students Vivek Ramchandani and Chris Wei. The people’s choice award winner was produced by Martha Ellen Stilwell School of the Arts student Niara Thompson.
/news/2017-02-06-ag-carr-announces-winners-of-rx-drug-abuse-awareness-video-contest
Today, Attorney General Chris Carr announced at Dunwoody High School in Dunwoody, Ga., the winners of the “We’re Not Gonna Take It” video contest aimed at preventing prescription drug abuse among teens. The winning video was produced by Dunwoody High School student Peter Vuong. The runner-up was produced by Northview High School students Vivek Ramchandani and Chris Wei. The people’s choice award winner was produced by Martha Ellen Stilwell School of the Arts student Niara Thompson.
TraceLink Will Dismiss Litigation Claims Against Healthcare Distribution Alliance (HDA)
/news/2018-02-05-tracelink-dismisses-litigation-claims-against-hda
TraceLink Inc., and the Healthcare Distribution Alliance (HDA) today announced that TraceLink will dismiss litigation claims that it asserted against HDA, which stated that HDA participated in conspiracies to unreasonably restrain trade and to monopolize.
/news/2018-02-05-tracelink-dismisses-litigation-claims-against-hda
TraceLink Inc., and the Healthcare Distribution Alliance (HDA) today announced that TraceLink will dismiss litigation claims that it asserted against HDA, which stated that HDA participated in conspiracies to unreasonably restrain trade and to monopolize.
The Rest of the Story: Facts About Pharmaceutical Distributors and the Opioid Crisis
/news/facts-about-rx-distributors-and-the-opioid-crisis
As the country continues to face a serious problem with opioid addiction, elected officials, the media and the public continue to discuss and debate the cause and possible solutions to this problem. Unfortunately, these conversations often include a narrow, distorted view of the prescription drug supply chain and, in many cases, overstate pharmaceutical wholesale distributors’ role in this serious public health issue. Many stakeholders in the supply chain — including physicians, pharmacists, manufacturers, distributors, federal and state regulators, law enforcement, and others — share responsibility for opioid abuse and misuse in our country. It is important to understand the role each stakeholder plays as we work to end the current opioid epidemic.
/news/facts-about-rx-distributors-and-the-opioid-crisis
As the country continues to face a serious problem with opioid addiction, elected officials, the media and the public continue to discuss and debate the cause and possible solutions to this problem. Unfortunately, these conversations often include a narrow, distorted view of the prescription drug supply chain and, in many cases, overstate pharmaceutical wholesale distributors’ role in this serious public health issue. Many stakeholders in the supply chain — including physicians, pharmacists, manufacturers, distributors, federal and state regulators, law enforcement, and others — share responsibility for opioid abuse and misuse in our country. It is important to understand the role each stakeholder plays as we work to end the current opioid epidemic.
Giacomin, Smith Reelected to Lead HDA Board of Directors
/news/2017-09-26-giacomin-smith-reelected-to-lead-hda-board-of-directors
The Healthcare Distribution Alliance (HDA) announced Jon Giacomin, Chief Executive Officer, Pharmaceutical segment, Cardinal Health, will serve a second term as Chairman of the HDA Board of Directors. Mr. Giacomin’s reelection was announced at the HDA Annual Board and Membership Meeting. Henry Dale Smith, Jr., Chairman and CEO, H. D. Smith Holding Company, also was reelected to serve as Vice Chairman.
/news/2017-09-26-giacomin-smith-reelected-to-lead-hda-board-of-directors
The Healthcare Distribution Alliance (HDA) announced Jon Giacomin, Chief Executive Officer, Pharmaceutical segment, Cardinal Health, will serve a second term as Chairman of the HDA Board of Directors. Mr. Giacomin’s reelection was announced at the HDA Annual Board and Membership Meeting. Henry Dale Smith, Jr., Chairman and CEO, H. D. Smith Holding Company, also was reelected to serve as Vice Chairman.
HDA Honors Manufacturer Members with DIANA Awards
/news/2017-06-13-hda-honors-manufacturer-members-with-diana-awards
The Healthcare Distribution Alliance (HDA) recognized pharmaceutical manufacturers for their commitment to innovation and collaboration in the supply chain through the presentation of the annual Distribution Industry Awards for Notable Achievements in Healthcare (DIANA). Awards were presented as part of HDA’s 2017 Business and Leadership Conference in Phoenix, Ariz.
/news/2017-06-13-hda-honors-manufacturer-members-with-diana-awards
The Healthcare Distribution Alliance (HDA) recognized pharmaceutical manufacturers for their commitment to innovation and collaboration in the supply chain through the presentation of the annual Distribution Industry Awards for Notable Achievements in Healthcare (DIANA). Awards were presented as part of HDA’s 2017 Business and Leadership Conference in Phoenix, Ariz.
Cardinal Health Wins HDA's Distribution Management Award for Ergonomic Upright Refrigerated Unit
/news/2017-03-07-cardinal-health-honored-with-dma
Cardinal Health is the winner of HDA’s 2017 Distribution Management Award for its ergonomically friendly and timesaving upright refrigerated unit. Recognized annually, the award was presented today at the 2017 Distribution Management Conference and Expo in Palm Desert, California.
/news/2017-03-07-cardinal-health-honored-with-dma
Cardinal Health is the winner of HDA’s 2017 Distribution Management Award for its ergonomically friendly and timesaving upright refrigerated unit. Recognized annually, the award was presented today at the 2017 Distribution Management Conference and Expo in Palm Desert, California.
HDA Honors Elsevier’s Kay Morgan with 2017 Distribution Management Award for Industry Leadership
/news/2017-03-07-kay-morgan-wins-dma-for-industry-leadership
Kay Morgan of Elsevier Clinical Solutions is the 2017 recipient of the Healthcare Distribution Alliance’s (HDA) Distribution Management Award (DMA) for Industry Leadership.The award was presented at the HDA Distribution Management Conference in Palm Desert, Calif.
/news/2017-03-07-kay-morgan-wins-dma-for-industry-leadership
Kay Morgan of Elsevier Clinical Solutions is the 2017 recipient of the Healthcare Distribution Alliance’s (HDA) Distribution Management Award (DMA) for Industry Leadership.The award was presented at the HDA Distribution Management Conference in Palm Desert, Calif.
HDA Adds Two Staff Members to State Government Affairs Team
/news/2016-10-19-hda-adds-two-staff-members-to-state-government-affairs-team
The Healthcare Distribution Alliance (HDA, formerly HDMA) today announces the hiring of two new members to its State Government Affairs team.
/news/2016-10-19-hda-adds-two-staff-members-to-state-government-affairs-team
The Healthcare Distribution Alliance (HDA, formerly HDMA) today announces the hiring of two new members to its State Government Affairs team.
HDA Statement on Enhanced Information Sharing Between DEA and Attorneys General
/news/2018-04-18-hda-statement-on-enhanced-information-sharing-between-dea-and-attorneys-general
Healthcare Distribution Alliance (HDA) President and CEO John M. Gray welcomed Attorney General Jeff Sessions’ announcement yesterday of a prescription drug information-sharing agreement between the Drug Enforcement Administration (DEA) and the attorneys general of 46 states, the District of Columbia and Puerto Rico. Through this agreement, the DEA will share information from its Automation of Reports and Consolidated Orders System (ARCOS), with states providing the Agency additional information, “often from prescription drug monitoring programs (PDMPs).”
/news/2018-04-18-hda-statement-on-enhanced-information-sharing-between-dea-and-attorneys-general
Healthcare Distribution Alliance (HDA) President and CEO John M. Gray welcomed Attorney General Jeff Sessions’ announcement yesterday of a prescription drug information-sharing agreement between the Drug Enforcement Administration (DEA) and the attorneys general of 46 states, the District of Columbia and Puerto Rico. Through this agreement, the DEA will share information from its Automation of Reports and Consolidated Orders System (ARCOS), with states providing the Agency additional information, “often from prescription drug monitoring programs (PDMPs).”
HDA to Launch "Origin" Product Data Source in July
/news/2017-04-26-hda-to-launch-origin-product-data-source-in-july
The Healthcare Distribution Alliance (HDA), in collaboration with ValueCentric, LLC, will provide an update on the development of its GTIN repository service, “Origin: HDA’s Product Data Source,” through a complimentary webinar to be held on Friday, April 28 from 11:00–12:00 (Eastern).
/news/2017-04-26-hda-to-launch-origin-product-data-source-in-july
The Healthcare Distribution Alliance (HDA), in collaboration with ValueCentric, LLC, will provide an update on the development of its GTIN repository service, “Origin: HDA’s Product Data Source,” through a complimentary webinar to be held on Friday, April 28 from 11:00–12:00 (Eastern).
HDA Announces Appointments to Executive Committee, Foundation Board of Directors
/news/2017-02-23-hda-announces-executive-committee-board-appointments
/news/2017-02-23-hda-announces-executive-committee-board-appointments
Hospitals Accounted for Nearly One-Third of Specialty Distributor Sales in 2015
/news/2016-12-21-foundation-releases-specialty-pharmaceutical-distribution
Sales to hospitals by specialty distributors significantly increased in 2015, according to new research by the HDA Research Foundation. As noted in Specialty Pharmaceutical Distribution: Facts, Figures and Trends (2016 Edition), there was a seven percentage point increase in sales from specialty distributors to hospitals, climbing to 30 percent in 2015. Meanwhile, sales to independent physician-owned/-operated clinics continued to decrease from previous edition; these clinics captured 49 percent of specialty distributors’ sales.
/news/2016-12-21-foundation-releases-specialty-pharmaceutical-distribution
Sales to hospitals by specialty distributors significantly increased in 2015, according to new research by the HDA Research Foundation. As noted in Specialty Pharmaceutical Distribution: Facts, Figures and Trends (2016 Edition), there was a seven percentage point increase in sales from specialty distributors to hospitals, climbing to 30 percent in 2015. Meanwhile, sales to independent physician-owned/-operated clinics continued to decrease from previous edition; these clinics captured 49 percent of specialty distributors’ sales.
HDMA Observes National Medicine Abuse Awareness Month
/news/2015-10-08-hdma-supports-anti-drug-abuse-efforts
HDMA, the national association representing primary pharmaceutical distributors, is supporting efforts to educate the public about the dangers abusing prescription and over-the-counter medicines during National Medicine Abuse Awareness Month (NMAAM).
/news/2015-10-08-hdma-supports-anti-drug-abuse-efforts
HDMA, the national association representing primary pharmaceutical distributors, is supporting efforts to educate the public about the dangers abusing prescription and over-the-counter medicines during National Medicine Abuse Awareness Month (NMAAM).
HDMA Mourns the Passing of Henry Dale Smith, Sr., Founder and CEO Emeritus of H. D. Smith
/news/2015-09-21-hdma-mourns-henry-dale-smith-sr
HDMA mourns the loss of Henry Dale Smith, Sr., Founder and Chairman Emeritus of H. D. Smith, who passed away this weekend at the age of 87.
/news/2015-09-21-hdma-mourns-henry-dale-smith-sr
HDMA mourns the loss of Henry Dale Smith, Sr., Founder and Chairman Emeritus of H. D. Smith, who passed away this weekend at the age of 87.
Rx Drug Abuse Legislation to Enhance Collaboration Between Regulators, Supply Chain Passed by House of Representatives
/news/2015-04-21-hr-471-passes-house-of-representatives
HDMA President and CEO John M. Gray hailed the April 21 passage of the Ensuring Patient Access and Effective Drug Enforcement Act of 2015 (H.R. 471) by the U.S. House of Representatives. H.R. 471 is sponsored by Reps. Tom Marino (R-Pa.), Marsha Blackburn (R-Tenn.), Peter Welch (D-Vt.) and Judy Chu (D-Calif.)
/news/2015-04-21-hr-471-passes-house-of-representatives
HDMA President and CEO John M. Gray hailed the April 21 passage of the Ensuring Patient Access and Effective Drug Enforcement Act of 2015 (H.R. 471) by the U.S. House of Representatives. H.R. 471 is sponsored by Reps. Tom Marino (R-Pa.), Marsha Blackburn (R-Tenn.), Peter Welch (D-Vt.) and Judy Chu (D-Calif.)
HDMA Supports Senate Legislation to Enhance Collaborative Efforts in the Fight Against Rx Drug Abuse
/news/2015-02-12-hdma-supports-senate-legislation
HDMA President and CEO John M. Gray released a statement in support of the Ensuring Patient Access and Effective Drug Enforcement Act of 2015, introduced today by Senators Orrin Hatch (R-Utah) and Sheldon Whitehouse (D-R.I.) The legislation is a companion to the House legislation (H.R. 471) sponsored by Reps. Tom Marino (R-Pa.), Marsha Blackburn (R-Tenn.), Peter Welch (D-Vt.) and Judy Chu (D-Calif.)
/news/2015-02-12-hdma-supports-senate-legislation
HDMA President and CEO John M. Gray released a statement in support of the Ensuring Patient Access and Effective Drug Enforcement Act of 2015, introduced today by Senators Orrin Hatch (R-Utah) and Sheldon Whitehouse (D-R.I.) The legislation is a companion to the House legislation (H.R. 471) sponsored by Reps. Tom Marino (R-Pa.), Marsha Blackburn (R-Tenn.), Peter Welch (D-Vt.) and Judy Chu (D-Calif.)
AmeriCares Honors Bristol-Myers Squibb with Power of Partnership Award
/news/2015-06-08-americares-honors-bristol-myers-squibb
AmeriCares, in partnership with the Healthcare Distribution Management Association (HDMA), has presented its annual Power of Partnership Award to Bristol-Myers Squibb in recognition of its outstanding commitment to increasing access to medicine, health worker safety and improving the wellbeing of children worldwide. Bristol-Myers Squibb and the Bristol-Myers Squibb Foundation are among AmeriCares most consistent supporters, providing both pharmaceutical products and financial support for the aid organization’s emergency response work and ongoing health programs in under-resourced communities.
/news/2015-06-08-americares-honors-bristol-myers-squibb
AmeriCares, in partnership with the Healthcare Distribution Management Association (HDMA), has presented its annual Power of Partnership Award to Bristol-Myers Squibb in recognition of its outstanding commitment to increasing access to medicine, health worker safety and improving the wellbeing of children worldwide. Bristol-Myers Squibb and the Bristol-Myers Squibb Foundation are among AmeriCares most consistent supporters, providing both pharmaceutical products and financial support for the aid organization’s emergency response work and ongoing health programs in under-resourced communities.
HDMA Announces Gary Riddle as New Vice President of State Government Affairs, Elevates Kristen Freitas to Vice President, Federal Government Affairs
/news/2015-05-28-gary-riddle-named-vp-of-state-government-affairs-freitas-elevated
HDMA announced on May 28, 2015, that Gary Riddle has joined the Association as Vice President of State Government Affairs, and that it has promoted Kristen Freitas from Senior Director to Vice President of Federal Government Affairs.
/news/2015-05-28-gary-riddle-named-vp-of-state-government-affairs-freitas-elevated
HDMA announced on May 28, 2015, that Gary Riddle has joined the Association as Vice President of State Government Affairs, and that it has promoted Kristen Freitas from Senior Director to Vice President of Federal Government Affairs.
HDA Research Foundation Report Analyzes Reverse Distribution of Pharmaceutical Products
/news/2018-08-06-hda-research-foundation-report-analyzes-reverse-distribution
A new report published by the HDA Research Foundation entitled The Role of Reverse Distribution provides insights into the reverse distribution of pharmaceutical products. The Foundation estimates that this channel accounts for 3.5 to 4 percent of all pharmaceutical sales — more than 120 million product units — and exceeds $13 billion in product value.
/news/2018-08-06-hda-research-foundation-report-analyzes-reverse-distribution
A new report published by the HDA Research Foundation entitled The Role of Reverse Distribution provides insights into the reverse distribution of pharmaceutical products. The Foundation estimates that this channel accounts for 3.5 to 4 percent of all pharmaceutical sales — more than 120 million product units — and exceeds $13 billion in product value.
HDMA Presents 2015 DIANA Awards
/news/2015-06-09-diana-awards-presented
At HDMA’s 2015 Business and Leadership Conference in San Antonio, the Association recognized pharmaceutical and consumer product manufacturers with its annual Distribution Industry Awards for Notable Achievements in Healthcare (or DIANA awards).
/news/2015-06-09-diana-awards-presented
At HDMA’s 2015 Business and Leadership Conference in San Antonio, the Association recognized pharmaceutical and consumer product manufacturers with its annual Distribution Industry Awards for Notable Achievements in Healthcare (or DIANA awards).
HDA Statement on Rhode Island Opioid Fee
/news/2019-06-15-hda-statement-on-rhode-island-opioid-fee
The Healthcare Distribution Alliance (HDA) issued the following statement in response to the Rhode Island Legislature’s inclusion of a $5 million fee on prescription opioids in the state budget.
/news/2019-06-15-hda-statement-on-rhode-island-opioid-fee
The Healthcare Distribution Alliance (HDA) issued the following statement in response to the Rhode Island Legislature’s inclusion of a $5 million fee on prescription opioids in the state budget.
HDMA to Host Second International Pharmaceutical Distribution Conference in Brussels
/news/2015-05-12-hdma-hosting-second-ipdc
HDMA, GIRP (the European Association of Pharmaceutical Full-line Wholesalers) and IFPW are collaborating to convene the second annual International Pharmaceutical Distribution Conference (IPDC) in Brussels, Belgium, on November 12–13 at the Steigenberger Wiltcher's hotel.
/news/2015-05-12-hdma-hosting-second-ipdc
HDMA, GIRP (the European Association of Pharmaceutical Full-line Wholesalers) and IFPW are collaborating to convene the second annual International Pharmaceutical Distribution Conference (IPDC) in Brussels, Belgium, on November 12–13 at the Steigenberger Wiltcher's hotel.
HDA Statement on Minnesota Senate Passage of HF 400
/news/2019-05-21-hda-statement-on-minnesota-passage-of-hf-400
The Healthcare Distribution Alliance (HDA) issued a statement in response to the Minnesota Senate’s passage of HF 400, which imposes annual fees on prescription opioid manufacturers and distributors.
/news/2019-05-21-hda-statement-on-minnesota-passage-of-hf-400
The Healthcare Distribution Alliance (HDA) issued a statement in response to the Minnesota Senate’s passage of HF 400, which imposes annual fees on prescription opioid manufacturers and distributors.
HDA Statement on Energy and Commerce Committee Report
/news/2018-12-19-hda-statement-on-energy-and-commerce-committee-report
On the release of the Energy and Commerce Committee’s review of opioid distribution in West Virginia, the Healthcare Distribution Alliance (HDA) released the following statement.
/news/2018-12-19-hda-statement-on-energy-and-commerce-committee-report
On the release of the Energy and Commerce Committee’s review of opioid distribution in West Virginia, the Healthcare Distribution Alliance (HDA) released the following statement.
HDA Statement on New York Opioid Stewardship Act Ruling
/news/2018-12-19-hda-statement-on-ny-osa-ruling
Following U.S. District Court Judge Katherine Polk Failla’s ruling today that New York’s Opioid Stewardship Act is unconstitutional, the Healthcare Distribution Alliance (HDA) issued the following statement.
/news/2018-12-19-hda-statement-on-ny-osa-ruling
Following U.S. District Court Judge Katherine Polk Failla’s ruling today that New York’s Opioid Stewardship Act is unconstitutional, the Healthcare Distribution Alliance (HDA) issued the following statement.
AAOA Celebrates First Year
/news/2019-02-13-aaoa-celebrates-first-year
This month marks one year since the launch of Allied Against Opioid Abuse (AAOA), a national initiative to help address the nation’s prescription opioid abuse epidemic through education and awareness. In its first year, AAOA built a network of national and local partnerships, expanding its membership to include 16 national partners and more than 50 state and local partners.
/news/2019-02-13-aaoa-celebrates-first-year
This month marks one year since the launch of Allied Against Opioid Abuse (AAOA), a national initiative to help address the nation’s prescription opioid abuse epidemic through education and awareness. In its first year, AAOA built a network of national and local partnerships, expanding its membership to include 16 national partners and more than 50 state and local partners.
HDA Statement on Enhanced DEA ARCOS Data Monitoring
/news/2019-02-27-hda-statement-on-enhanced-dea-arcos-data-monitoring
Healthcare Distribution Alliance (HDA) President and CEO John M. Gray issued a statement in response to the Drug Enforcement Administration’s (DEA) announcement of an enhanced data tool to support additional information sharing with pharmaceutical distributors and manufacturers.
/news/2019-02-27-hda-statement-on-enhanced-dea-arcos-data-monitoring
Healthcare Distribution Alliance (HDA) President and CEO John M. Gray issued a statement in response to the Drug Enforcement Administration’s (DEA) announcement of an enhanced data tool to support additional information sharing with pharmaceutical distributors and manufacturers.
HDA Statement in Response to 60 Minutes
/news/2018-12-18-hda-statement-in-response-to-60-minutes
“The latest episode of 60 Minutes perpetuates a number of myths around the opioid epidemic and does a disservice to any effort to truly understand and address its root causes — notably, the shift in medical practice to treat pain more aggressively and the role of illegal drugs in most overdose deaths.
/news/2018-12-18-hda-statement-in-response-to-60-minutes
“The latest episode of 60 Minutes perpetuates a number of myths around the opioid epidemic and does a disservice to any effort to truly understand and address its root causes — notably, the shift in medical practice to treat pain more aggressively and the role of illegal drugs in most overdose deaths.
HDA Statement on Inspector General's DEA Report
/news/2019-10-01-hda-statement-on-inspector-general-dea-report
In response to the release of the U.S. Department of Justice Office of the Inspector General's Review of the Drug Enforcement Administration’s (DEA) Regulatory and Enforcement Efforts to Control the Diversion of Opioids, John Parker, Senior Vice President of Communications with the Healthcare Distribution Alliance (HDA) released the following statement.
/news/2019-10-01-hda-statement-on-inspector-general-dea-report
In response to the release of the U.S. Department of Justice Office of the Inspector General's Review of the Drug Enforcement Administration’s (DEA) Regulatory and Enforcement Efforts to Control the Diversion of Opioids, John Parker, Senior Vice President of Communications with the Healthcare Distribution Alliance (HDA) released the following statement.
Key Excerpts from IG Review of the DEA's Efforts to Control the Diversion of Opioids
/news/2019-10-01-excerpts-from-doj-oig-report
The following are excerpts from the recent report by the Office of the Inspector General, U.S. Department of Justice on the Drug Enforcement Administration’s (DEA) regulatory and enforcement efforts to control the diversion of opioids.
/news/2019-10-01-excerpts-from-doj-oig-report
The following are excerpts from the recent report by the Office of the Inspector General, U.S. Department of Justice on the Drug Enforcement Administration’s (DEA) regulatory and enforcement efforts to control the diversion of opioids.
HDA Statement on Senate Judiciary Committee Hearing on Mitigating the Opioid Crisis
/news/2019-12-17-statement-on-senate-judiciary-committee-hearing-on-mitigating-opioid-crisis
The Healthcare Distribution Alliance (HDA) released the following statement following the organization’s testimony before the Senate Judiciary Committee on “Tackling the Opioid Crisis: A Whole-of-Government Approach.”
/news/2019-12-17-statement-on-senate-judiciary-committee-hearing-on-mitigating-opioid-crisis
The Healthcare Distribution Alliance (HDA) released the following statement following the organization’s testimony before the Senate Judiciary Committee on “Tackling the Opioid Crisis: A Whole-of-Government Approach.”
John M. Gray Announces Retirement From HDA
/news/2019-06-03-gray-announces-retirement-from-hda
John M. Gray, President and CEO of the Healthcare Distribution Alliance (HDA), today announced his retirement from the organization. Mr. Gray will remain in his position until May 2, 2020.
/news/2019-06-03-gray-announces-retirement-from-hda
John M. Gray, President and CEO of the Healthcare Distribution Alliance (HDA), today announced his retirement from the organization. Mr. Gray will remain in his position until May 2, 2020.
HDA Statement on the Ensuring Patient Access and Effective Drug Enforcement Act
/news/2019-09-13-hda-statement-on-the-epaedea
/news/2019-09-13-hda-statement-on-the-epaedea
What the ARCOS Data Won’t Tell You
/news/2019-07-24-fact-check-arcos-data
Any discussion about ARCOS data must take into account the overall evolution of the prescription opioid epidemic and the complexity of the pharmaceutical supply chain.
/news/2019-07-24-fact-check-arcos-data
Any discussion about ARCOS data must take into account the overall evolution of the prescription opioid epidemic and the complexity of the pharmaceutical supply chain.
Drew and Mauch Reelected to Lead HDA Board of Directors
/news/2019-10-21-drew-and-mauch-reelected
The Healthcare Distribution Alliance (HDA) announced that Greg Drew, RPh, President of Value Drug Company, and Robert Mauch, PhD, PharmD, EVP and Group President of AmerisourceBergen Corporation, were recently elected to second terms as Chairman and Vice Chairman of the HDA Board of Directors.
/news/2019-10-21-drew-and-mauch-reelected
The Healthcare Distribution Alliance (HDA) announced that Greg Drew, RPh, President of Value Drug Company, and Robert Mauch, PhD, PharmD, EVP and Group President of AmerisourceBergen Corporation, were recently elected to second terms as Chairman and Vice Chairman of the HDA Board of Directors.
Important Context About the Ensuring Patient Access and Effective Drug Enforcement Act
/news/2019-09-12-important-context-about-epaedea
The fundamental premise of recent media coverage — that the passage of the Ensuring Patient Access and Effective Drug Enforcement Act of 2016 (EPAEDEA) weakened the Drug Enforcement Administration’s (DEA) enforcement authority during the opioid crisis — is factually incorrect.
/news/2019-09-12-important-context-about-epaedea
The fundamental premise of recent media coverage — that the passage of the Ensuring Patient Access and Effective Drug Enforcement Act of 2016 (EPAEDEA) weakened the Drug Enforcement Administration’s (DEA) enforcement authority during the opioid crisis — is factually incorrect.
Coalition of Public Health Organizations and Supply Chain Partners Launch Educational Initiative to Reduce Opioid Abuse and Misuse
/news/2018-02-06-coalition-launches-educational-initiative-to-reduce-opioid-abuse-and-misuse
Today, leading partners across healthcare, public health and the pharmaceutical supply chain joined together to launch Allied Against Opioid Abuse (AAOA), a national education and awareness initiative to help combat the nation’s opioid abuse epidemic.
/news/2018-02-06-coalition-launches-educational-initiative-to-reduce-opioid-abuse-and-misuse
Today, leading partners across healthcare, public health and the pharmaceutical supply chain joined together to launch Allied Against Opioid Abuse (AAOA), a national education and awareness initiative to help combat the nation’s opioid abuse epidemic.
HDA Calls for “Universal” Suspicious Orders Database to Enhance Efforts Against Diversion, Misuse
/news/2018-02-22-hda-calls-for-universal-suspicious-orders-database-against-diversion-misuse
In a letter to the Drug Enforcement Administration (DEA) Acting Administrator Robert Patterson, Healthcare Distribution Alliance (HDA) President and CEO John M. Gray called for a “universal” database to support enhanced monitoring of suspicious orders of controlled substances, including controlled opioid drugs. While the DEA has indicated that it currently is developing a suspicious orders database for its own use, HDA’s latest letter calls for the agency to share this data, and DEA’s advanced analytical tools, with state regulators and state/local law enforcement officials to improve information sharing and coordination.
/news/2018-02-22-hda-calls-for-universal-suspicious-orders-database-against-diversion-misuse
In a letter to the Drug Enforcement Administration (DEA) Acting Administrator Robert Patterson, Healthcare Distribution Alliance (HDA) President and CEO John M. Gray called for a “universal” database to support enhanced monitoring of suspicious orders of controlled substances, including controlled opioid drugs. While the DEA has indicated that it currently is developing a suspicious orders database for its own use, HDA’s latest letter calls for the agency to share this data, and DEA’s advanced analytical tools, with state regulators and state/local law enforcement officials to improve information sharing and coordination.
Smith Drug Company Receives Distribution Management Award for Implementation of Cloud-Based Predictive Inventory Management System
/news/2018-03-06-smith-drug-company-receives-dma-for-cloud-based-predictive-ims
Smith Drug Company, Div. J M Smith Corporation, has received the Healthcare Distribution Alliance’s (HDA) 2018 Distribution Management Award (DMA) for their implementation of a cloud-based predictive inventory management system (IMS). The award was presented at HDA’s Distribution Management Conference and Expo in Austin, Texas.
/news/2018-03-06-smith-drug-company-receives-dma-for-cloud-based-predictive-ims
Smith Drug Company, Div. J M Smith Corporation, has received the Healthcare Distribution Alliance’s (HDA) 2018 Distribution Management Award (DMA) for their implementation of a cloud-based predictive inventory management system (IMS). The award was presented at HDA’s Distribution Management Conference and Expo in Austin, Texas.
HDA Statement to 60 Minutes
/news/2018-12-14-hda-statement-to-60-minutes
“While HDA cannot speak to the specifics of the litigation, it defies common sense to single out distributors for the opioid crisis. As logistics experts, distributors do not manufacture, promote or prescribe opioids, influence clinical decision-making or in any way drive demand for the product. Distributors deliver medicines prescribed by a licensed physician and ordered by a licensed pharmacy.
/news/2018-12-14-hda-statement-to-60-minutes
“While HDA cannot speak to the specifics of the litigation, it defies common sense to single out distributors for the opioid crisis. As logistics experts, distributors do not manufacture, promote or prescribe opioids, influence clinical decision-making or in any way drive demand for the product. Distributors deliver medicines prescribed by a licensed physician and ordered by a licensed pharmacy.
HDA Research Foundation Specialty Pharmaceutical Analysis Highlights Distributor Efficiencies Amid Evolving Market Dynamics
/news/2018-12-18-hda-research-foundation-releases-specialty-pharmaceutical-analysis
/news/2018-12-18-hda-research-foundation-releases-specialty-pharmaceutical-analysis
/news/2015-02-02-physicians-offices-and-clinics-are-largest-specialty-rx-customer
Physician’s offices and independently owned and operated physician clinics remain the largest customer base for specialty pharmaceutical distributors, at 63 percent of their sales value, according to the 2014 Specialty Pharmaceutical Distribution: Facts, Figures and Trends, published by HDMA’s Center for Healthcare Supply Chain Research.
HDA Presents Distribution Management Award for Industry Leadership
/news/2019-03-12-hda-presents-dma-for-industry-leadership
The Healthcare Distribution Alliance (HDA) recognized Scott Mooney of McKesson Corporation with the 2019 Distribution Management Award for Industry Leadership. The award, which honors an individual for their extraordinary contributions to the healthcare distribution industry, was presented today at HDA’s Distribution Management Conference in Palm Desert, Calif.
/news/2019-03-12-hda-presents-dma-for-industry-leadership
The Healthcare Distribution Alliance (HDA) recognized Scott Mooney of McKesson Corporation with the 2019 Distribution Management Award for Industry Leadership. The award, which honors an individual for their extraordinary contributions to the healthcare distribution industry, was presented today at HDA’s Distribution Management Conference in Palm Desert, Calif.
HDA Initiative to Highlight Value Distributors Provide to the Healthcare System
/news/2019-05-16-hda-initiative-to-highlight-value-distributors-provide-to-healthcare
Today, the Healthcare Distribution Alliance (HDA) announced the launch of a new initiative highlighting pharmaceutical distributors’ critical role in the safe, reliable and efficient delivery of medical products to hundreds of thousands of pharmacies, hospitals and other healthcare providers nationwide. The initiative focuses on the work distributors undertake every day, even during the most challenging times, in collaboration with partners across the pharmaceutical supply chain.
/news/2019-05-16-hda-initiative-to-highlight-value-distributors-provide-to-healthcare
Today, the Healthcare Distribution Alliance (HDA) announced the launch of a new initiative highlighting pharmaceutical distributors’ critical role in the safe, reliable and efficient delivery of medical products to hundreds of thousands of pharmacies, hospitals and other healthcare providers nationwide. The initiative focuses on the work distributors undertake every day, even during the most challenging times, in collaboration with partners across the pharmaceutical supply chain.
Suspicious Order Reporting and Prescription Opioid Medications
/news/2019-05-22-suspicious-order-reporting
As the logistics experts of the pharmaceutical supply chain, distributors have developed advanced security and monitoring systems to make sure that the medications they handle and transport are authentic and legitimate; secured throughout delivery to avoid tampering or diversion; and received by licensed pharmacies and healthcare providers across the country.
/news/2019-05-22-suspicious-order-reporting
As the logistics experts of the pharmaceutical supply chain, distributors have developed advanced security and monitoring systems to make sure that the medications they handle and transport are authentic and legitimate; secured throughout delivery to avoid tampering or diversion; and received by licensed pharmacies and healthcare providers across the country.
HDA Statement on President Trump's Announcement on the Opioid Crisis
/news/2017-10-26-statement-on-president-announcement-on-opioid-crisis
Following President Trump’s announcement on the response to the opioid epidemic, Healthcare Distribution Alliance (HDA) President and CEO John M. Gray issued the following statement.
/news/2017-10-26-statement-on-president-announcement-on-opioid-crisis
Following President Trump’s announcement on the response to the opioid epidemic, Healthcare Distribution Alliance (HDA) President and CEO John M. Gray issued the following statement.
HDA "Origin" Repository Officially Launches
/news/2017-07-31-hda-origin-officially-launches
The Healthcare Distribution Alliance (HDA), in collaboration with ValueCentric, LLC, today announce the official launch of Origin: HDA’s Product Data Source. Origin is a high-powered, central data repository hosting verified Global Trade Item Number (GTIN) information. The service enables the secure, accurate and efficient exchange of pharmaceutical product master data between manufacturers and their supply chain partners to help comply with the Drug Supply Chain Security Act (DSCSA).
/news/2017-07-31-hda-origin-officially-launches
The Healthcare Distribution Alliance (HDA), in collaboration with ValueCentric, LLC, today announce the official launch of Origin: HDA’s Product Data Source. Origin is a high-powered, central data repository hosting verified Global Trade Item Number (GTIN) information. The service enables the secure, accurate and efficient exchange of pharmaceutical product master data between manufacturers and their supply chain partners to help comply with the Drug Supply Chain Security Act (DSCSA).
HDA Statement on Attorneys General Opioid Investigations
/news/2017-09-18-hda-statement-on-attorneys-general-opioid-investigations
Following today’s announcement on investigations regarding the opioid epidemic, John M. Gray, President and CEO of the Healthcare Distribution Alliance (HDA), released the following statement.
/news/2017-09-18-hda-statement-on-attorneys-general-opioid-investigations
Following today’s announcement on investigations regarding the opioid epidemic, John M. Gray, President and CEO of the Healthcare Distribution Alliance (HDA), released the following statement.
HDA Statement on New Report from President's Commission on Combating Drug Addiction and the Opioid Crisis
/news/2017-11-01-hda-statement-on-commission-report
Following the new report released by the President’s Commission on Combating Drug Addiction and the Opioid Crisis, Healthcare Distribution Alliance (HDA) President and CEO John M. Gray released the following statement.
/news/2017-11-01-hda-statement-on-commission-report
Following the new report released by the President’s Commission on Combating Drug Addiction and the Opioid Crisis, Healthcare Distribution Alliance (HDA) President and CEO John M. Gray released the following statement.
HDA Statement on 60 Minutes/Washington Post Coverage on Distributors, Opioid Epidemic
/news/2017-10-13-hda-statement-on-60-minutes-washington-post-coverage-on-distributors-opioid-epidemic
HDA President and CEO John M. Gray released a statement in response to 60 Minutes/Washington Post coverage on the opioid epidemic.
/news/2017-10-13-hda-statement-on-60-minutes-washington-post-coverage-on-distributors-opioid-epidemic
HDA President and CEO John M. Gray released a statement in response to 60 Minutes/Washington Post coverage on the opioid epidemic.
Nearly 96 Percent of All U.S. Pharmaceutical Sales Went to Market Through HDA-Member Traditional Primary Distributors
/news/2017-12-05-hda-foundation-releases-annual-factbook
The total number of U.S. pharmaceutical sales that went to market through pharmaceutical distributors increased to nearly 95.7 percent in 2016 (nearly two percentage points over the previous year) according to a new report published by the HDA Research Foundation. The Foundation released this new statistic in its 88th Edition HDA Factbook: The Facts, Figures and Trends in Healthcare (2017-2018).
/news/2017-12-05-hda-foundation-releases-annual-factbook
The total number of U.S. pharmaceutical sales that went to market through pharmaceutical distributors increased to nearly 95.7 percent in 2016 (nearly two percentage points over the previous year) according to a new report published by the HDA Research Foundation. The Foundation released this new statistic in its 88th Edition HDA Factbook: The Facts, Figures and Trends in Healthcare (2017-2018).
HDA Statement in Opposition of New York State Opioid Tax
/news/2018-03-30-hda-statement-in-opposition-of-new-york-state-opioid-tax
HDA President and CEO John M. Gray released the following statement after the passage of the 2019 New York State budget.
/news/2018-03-30-hda-statement-in-opposition-of-new-york-state-opioid-tax
HDA President and CEO John M. Gray released the following statement after the passage of the 2019 New York State budget.
HDMA Comments on Release of Medicaid AMP Final Rule
/news/2016-01-28-amp-statement
HDMA President and CEO John M. Gray issued a statement on the Centers for Medicare & Medicaid Services’ (CMS) final rule implementing Affordable Care Act changes to Medicaid rebates, the Average Manufacturer Price (AMP) and Federal Upper Limits under the Medicaid Covered Outpatient Drug Program. The rule, referred to as the “AMP rule,” will go into effect on April 1, 2016, with state Medicaid agencies receiving an additional year to adapt their respective programs to the regulation.
/news/2016-01-28-amp-statement
HDMA President and CEO John M. Gray issued a statement on the Centers for Medicare & Medicaid Services’ (CMS) final rule implementing Affordable Care Act changes to Medicaid rebates, the Average Manufacturer Price (AMP) and Federal Upper Limits under the Medicaid Covered Outpatient Drug Program. The rule, referred to as the “AMP rule,” will go into effect on April 1, 2016, with state Medicaid agencies receiving an additional year to adapt their respective programs to the regulation.
HDA Statement on Review of Annual Production Quotas for Opioids
/news/2018-03-02-hda-statement-on-review-of-annual-production-quotas-for-opioids
HDA President and CEO John M. Gray released the following statement in response to Attorney General Jeff Sessions' recent memo regarding opioid production quotas.
/news/2018-03-02-hda-statement-on-review-of-annual-production-quotas-for-opioids
HDA President and CEO John M. Gray released the following statement in response to Attorney General Jeff Sessions' recent memo regarding opioid production quotas.
HDMA-Supported Legislation to Enhance Efforts to Mitigate Rx Drug Abuse Clears Senate Judiciary Committee
/news/2016-02-11-legislation-clears-senate-judiciary
The Ensuring Patient Access and Effective Drug Enforcement Act of 2015 (S. 483), sponsored by Senators Orrin Hatch (R-Utah) and Sheldon Whitehouse (D-R.I.) was approved following a markup by the Senate Judiciary Committee. The bill is the companion to H.R. 471, sponsored by Reps. Tom Marino (R-Pa.), Marsha Blackburn (R-Tenn.), Peter Welch (D-Vt.) and Judy Chu (D-Calif.), which was passed by the House of Representatives in April 2015.
/news/2016-02-11-legislation-clears-senate-judiciary
The Ensuring Patient Access and Effective Drug Enforcement Act of 2015 (S. 483), sponsored by Senators Orrin Hatch (R-Utah) and Sheldon Whitehouse (D-R.I.) was approved following a markup by the Senate Judiciary Committee. The bill is the companion to H.R. 471, sponsored by Reps. Tom Marino (R-Pa.), Marsha Blackburn (R-Tenn.), Peter Welch (D-Vt.) and Judy Chu (D-Calif.), which was passed by the House of Representatives in April 2015.
HDMA Op-Ed: Collaboration Vital to Further Progress on Key Supply Chain Issues
/news/2016-02-08-hdma-oped-in-pharmaceutical-commerce
Collaboration will continue to be the key to a healthy supply chain in 2016, writes HDMA President and CEO John M. Gray in a new opinion piece published in the January/February issue of Pharmaceutical Commerce magazine. In particular, Gray writes that, “Collaboration has been most evident in the way the supply chain has tackled two of our industry’s toughest issues — traceability and prescription drug abuse.”
/news/2016-02-08-hdma-oped-in-pharmaceutical-commerce
Collaboration will continue to be the key to a healthy supply chain in 2016, writes HDMA President and CEO John M. Gray in a new opinion piece published in the January/February issue of Pharmaceutical Commerce magazine. In particular, Gray writes that, “Collaboration has been most evident in the way the supply chain has tackled two of our industry’s toughest issues — traceability and prescription drug abuse.”
HDMA and Georgia AG Olens Announce Winners of Rx Drug Abuse Awareness Video Contest
/news/2015-12-08-olens-announces-winners-of-rx-drug-abuse-awareness-contest
Attorney General Sam Olens announced at Duluth High School in Duluth, Ga., the winners of the “We’re Not Gonna Take It” video contest aimed at preventing prescription drug abuse among teens.
/news/2015-12-08-olens-announces-winners-of-rx-drug-abuse-awareness-contest
Attorney General Sam Olens announced at Duluth High School in Duluth, Ga., the winners of the “We’re Not Gonna Take It” video contest aimed at preventing prescription drug abuse among teens.
HDA Recognizes Dianne Pfahl of Cardinal Health with Distribution Management Award for Industry Leadership
/news/2018-03-06-hda-recognizes-dianne-pfahl-with-dma-for-leadership
The Healthcare Distribution Alliance (HDA) has honored Dianne Pfahl, Vice President, Strategic Sourcing National Brands, Cardinal Health, Inc., with the 2018 Distribution Management Award (DMA) for Industry Leadership. The award was presented at HDA’s Distribution Management Conference and Expo in Austin, Texas.
/news/2018-03-06-hda-recognizes-dianne-pfahl-with-dma-for-leadership
The Healthcare Distribution Alliance (HDA) has honored Dianne Pfahl, Vice President, Strategic Sourcing National Brands, Cardinal Health, Inc., with the 2018 Distribution Management Award (DMA) for Industry Leadership. The award was presented at HDA’s Distribution Management Conference and Expo in Austin, Texas.
HDMA Recognizes Mutual Drug Company's Hal Harrison With Distribution Management Award for Industry Leadership
/news/2016-03-08-hdma-recognizes-hal-harrison
Hal Harrison, Senior Vice President of Operations for Mutual Wholesale Drug Company, was honored today with HDMA’s 2016 Distribution Management Award for Industry Leadership.
/news/2016-03-08-hdma-recognizes-hal-harrison
Hal Harrison, Senior Vice President of Operations for Mutual Wholesale Drug Company, was honored today with HDMA’s 2016 Distribution Management Award for Industry Leadership.
HDMA-Championed Bill S. 483 Passed Unanimously by the Senate
/news/2016-03-17-s-483-passes-in-senate
HDMA-championed legislation, the Ensuring Patient Access and Effective Drug Enforcement Act (S. 483) was passed today under unanimous consent by the U.S. Senate. The legislation, sponsored by Senators Orrin Hatch (R-Utah) and Sheldon Whitehouse (D-R.I.), has companion legislation (H.R. 471) in the House of Representatives sponsored by Reps. Tom Marino (R-Pa.), Marsha Blackburn (R-Tenn.) Peter Welch (D-Vt.) and Judy Chu (D-Calif.). H.R. 471 was passed by the House of Representatives in April 2015.
/news/2016-03-17-s-483-passes-in-senate
HDMA-championed legislation, the Ensuring Patient Access and Effective Drug Enforcement Act (S. 483) was passed today under unanimous consent by the U.S. Senate. The legislation, sponsored by Senators Orrin Hatch (R-Utah) and Sheldon Whitehouse (D-R.I.), has companion legislation (H.R. 471) in the House of Representatives sponsored by Reps. Tom Marino (R-Pa.), Marsha Blackburn (R-Tenn.) Peter Welch (D-Vt.) and Judy Chu (D-Calif.). H.R. 471 was passed by the House of Representatives in April 2015.
HDMA-Supported S. 483 Passed by the House; Awaits President Obama's Signature
/news/2016-04-12-s-483-passed-by-the-house
HDMA President and CEO John M. Gray released a statement on the Ensuring Patient Access and Effective Drug Enforcement Act (S. 483), which the U.S. House of Representatives passed today by unanimous consent. The bill is sponsored by Senators Orrin Hatch (R-Utah) and Sheldon Whitehouse (D-R.I.).
/news/2016-04-12-s-483-passed-by-the-house
HDMA President and CEO John M. Gray released a statement on the Ensuring Patient Access and Effective Drug Enforcement Act (S. 483), which the U.S. House of Representatives passed today by unanimous consent. The bill is sponsored by Senators Orrin Hatch (R-Utah) and Sheldon Whitehouse (D-R.I.).
HDA's 2016 Traceability Seminar to Convene Supply Chain Leaders to Gauge DSCSA Implementation Progress and Look to 2023
/news/2016-10-13-hda-to-host-traceability-seminar
The Healthcare Distribution Alliance (HDA, formerly HDMA) will host its annual Traceability Seminar November 9–11, 2016, at the Renaissance Washington, DC Downtown Hotel. The seminar will host supply chain leaders — including distributors, manufacturers, pharmacists, third-party logistics providers — as well as federal/state regulators to discuss upcoming milestones and lessons learned as they continue to implement the Drug Supply Chain Security Act (DSCSA).
/news/2016-10-13-hda-to-host-traceability-seminar
The Healthcare Distribution Alliance (HDA, formerly HDMA) will host its annual Traceability Seminar November 9–11, 2016, at the Renaissance Washington, DC Downtown Hotel. The seminar will host supply chain leaders — including distributors, manufacturers, pharmacists, third-party logistics providers — as well as federal/state regulators to discuss upcoming milestones and lessons learned as they continue to implement the Drug Supply Chain Security Act (DSCSA).
Upsher-Smith's Michael J. McBride Honored With the 2017 Nexus Award for Lifetime Achievement
/news/2017-06-13-mcbride-honored-with-2017-nexus-award
The HDA Research Foundation, the non-profit organization of the Healthcare Distribution Alliance (HDA), along with Genentech Inc., A Member of the Roche Group, and Mylan Inc., presented Michael J. McBride of Upsher-Smith Laboratories, Inc., with the 2017 Nexus Award for Lifetime Achievement.
/news/2017-06-13-mcbride-honored-with-2017-nexus-award
The HDA Research Foundation, the non-profit organization of the Healthcare Distribution Alliance (HDA), along with Genentech Inc., A Member of the Roche Group, and Mylan Inc., presented Michael J. McBride of Upsher-Smith Laboratories, Inc., with the 2017 Nexus Award for Lifetime Achievement.
HDA To Host Fourth Annual International Pharmaceutical Distribution Conference in Geneva
/news/2017-07-10-hda-to-host-fourth-annual-international-pharmaceutical-distribution-conference-in-geneva
HDA will convene the Fourth Annual International Pharmaceutical Distribution Conference (IPDC) at the Grand Hotel Kempinski Geneva in Geneva, Switzerland, October 16–17, 2017.
/news/2017-07-10-hda-to-host-fourth-annual-international-pharmaceutical-distribution-conference-in-geneva
HDA will convene the Fourth Annual International Pharmaceutical Distribution Conference (IPDC) at the Grand Hotel Kempinski Geneva in Geneva, Switzerland, October 16–17, 2017.
HDMA to Host Third Annual International Pharmaceutical Distribution Conference in London
/news/2016-03-02-hdma-to-host-third-annual-ipdc-in-london
The Healthcare Distribution Management Association (HDMA), the U.S.-based trade association representing primary pharmaceutical distributors, announced today that it will convene its Third Annual International Pharmaceutical Distribution Conference (IPDC) in London, England, on September 12-13, 2016, at the Grosvenor House, A JW Marriott Hotel. This year’s conference will be co-hosted with the Healthcare Distribution Association UK (HDA UK), European Healthcare Distribution Association (GIRP) and the International Federation of Pharmaceutical Wholesalers (IFPW). The IPDC was previously held in Beijing and Brussels.
/news/2016-03-02-hdma-to-host-third-annual-ipdc-in-london
The Healthcare Distribution Management Association (HDMA), the U.S.-based trade association representing primary pharmaceutical distributors, announced today that it will convene its Third Annual International Pharmaceutical Distribution Conference (IPDC) in London, England, on September 12-13, 2016, at the Grosvenor House, A JW Marriott Hotel. This year’s conference will be co-hosted with the Healthcare Distribution Association UK (HDA UK), European Healthcare Distribution Association (GIRP) and the International Federation of Pharmaceutical Wholesalers (IFPW). The IPDC was previously held in Beijing and Brussels.
HDMA is One of the Best Places to Work in Virginia for Sixth Consecutive Year
/news/2016-01-05-hdma-named-a-best-place-to-work-in-va
For the sixth year in a row the Healthcare Distribution Management Association (HDMA) has been named one of 100 Best Places to Work in Virginia by Virginia Business magazine and Best Companies Group.
/news/2016-01-05-hdma-named-a-best-place-to-work-in-va
For the sixth year in a row the Healthcare Distribution Management Association (HDMA) has been named one of 100 Best Places to Work in Virginia by Virginia Business magazine and Best Companies Group.
Prescribing Patterns and the Opioid Epidemic
/news/prescribing-patterns-and-the-opioid-epidemic
While the factors driving the opioid epidemic are complex, there is broad recognition among leading public health authorities that opioids have been overprescribed — a trend that began in the 1990s and continues to this day. As the broader healthcare industry looks to reverse and prevent another epidemic in the future, there is greater focus on how to effectively curb overprescribing while balancing the legitimate and diverse health needs of patients across the country.
/news/prescribing-patterns-and-the-opioid-epidemic
While the factors driving the opioid epidemic are complex, there is broad recognition among leading public health authorities that opioids have been overprescribed — a trend that began in the 1990s and continues to this day. As the broader healthcare industry looks to reverse and prevent another epidemic in the future, there is greater focus on how to effectively curb overprescribing while balancing the legitimate and diverse health needs of patients across the country.
HDA Statement on New DEA Assessment Tool and Data
/news/2018-02-15-hda-statement-on-new-dea-assessment-tool-and-data
Following the Drug Enforcement Administration’s (DEA) announcement regarding a new assessment tool for controlled substance orders, Healthcare Distribution Alliance (HDA) President and CEO John M. Gray issued the following statement.
/news/2018-02-15-hda-statement-on-new-dea-assessment-tool-and-data
Following the Drug Enforcement Administration’s (DEA) announcement regarding a new assessment tool for controlled substance orders, Healthcare Distribution Alliance (HDA) President and CEO John M. Gray issued the following statement.
HDA Announces Availability of API Certification Program for Origin
/news/2018-02-14-hda-announces-api-certification-for-origin
The Healthcare Distribution Alliance (HDA) and ValueCentric today announced the introduction of a new certification program for third-party solution providers to exchange data with Origin on behalf of their manufacturer and distributor clients using an Application Programming Interface (API). Adents, a leading provider of premier and versatile serialization and track-and-trace solutions, is the first solution provider that has entered to meet the certification.
/news/2018-02-14-hda-announces-api-certification-for-origin
The Healthcare Distribution Alliance (HDA) and ValueCentric today announced the introduction of a new certification program for third-party solution providers to exchange data with Origin on behalf of their manufacturer and distributor clients using an Application Programming Interface (API). Adents, a leading provider of premier and versatile serialization and track-and-trace solutions, is the first solution provider that has entered to meet the certification.
Annual Survey of HDA Specialty Pharmaceutical Distributors Reveals Rising Importance of Certain Therapeutic Areas
/news/2017-12-12-hda-research-foundation-releases-2017-specialty-pharmaceutical-distribution
Specialty pharmaceutical distributors expect products in the autoimmune/immune and ophthalmology categories to rise in importance over the next 12 months, followed by oncology, central nervous system and inflammatory products. The findings were published in the HDA Research Foundation’s 2017 edition of Specialty Pharmaceutical Distribution: Facts, Figures and Trends.
/news/2017-12-12-hda-research-foundation-releases-2017-specialty-pharmaceutical-distribution
Specialty pharmaceutical distributors expect products in the autoimmune/immune and ophthalmology categories to rise in importance over the next 12 months, followed by oncology, central nervous system and inflammatory products. The findings were published in the HDA Research Foundation’s 2017 edition of Specialty Pharmaceutical Distribution: Facts, Figures and Trends.
HDA Statement on Misreporting by The Washington Post on Distributors, Opioid Epidemic
/news/2017-12-15-hda-statement-on-misreporting-by-the-washington-post
HDA President and CEO John M. Gray released the following statement in response to the latest reporting by The Washington Post.
/news/2017-12-15-hda-statement-on-misreporting-by-the-washington-post
HDA President and CEO John M. Gray released the following statement in response to the latest reporting by The Washington Post.
/news/2018-01-08-hda-president-and-ceo-outlines-2018-alliance-priorities
Efforts to mitigate the prescription drug abuse epidemic and activities surrounding DSCSA implementation once again top the list of priorities HDA will be addressing in the year ahead, according to HDA President and CEO John M. Gray. Mr. Gray provided his perspective, along with other healthcare supply chain leaders, as part of Chain Drug Review’s annual “Pharmacy Outlook” feature, published in the January 1 issue.
HDA, Supply Chain Partners Support Immediate Action on National Recommendations, Solutions to the Opioid Epidemic
/news/2018-02-02-hda-supply-chain-partners-support-immediate-action-on-opioid-epidemic
The Healthcare Distribution Alliance (HDA) and fellow members of the National Conference of Pharmaceutical Organizations (NCPO) have requested a meeting with the Trump Administration to identify and implement specific recommendations included as part of the President’s Commission on Combating Drug Addiction and the Opioid Crisis.
/news/2018-02-02-hda-supply-chain-partners-support-immediate-action-on-opioid-epidemic
The Healthcare Distribution Alliance (HDA) and fellow members of the National Conference of Pharmaceutical Organizations (NCPO) have requested a meeting with the Trump Administration to identify and implement specific recommendations included as part of the President’s Commission on Combating Drug Addiction and the Opioid Crisis.
HDA Statement on FDA Work Group to Examine Prescription Drug Importation
/news/2018-07-20-hda-statement-on-fda-work-group-to-examine-rx-drug-importation
Healthcare Distribution Alliance (HDA) President and CEO John M. Gray released the following statement on the Department of Health and Human Services’ (HHS) recent directive to establish a Food and Drug Administration (FDA) work group to examine prescription drug importation policies.
/news/2018-07-20-hda-statement-on-fda-work-group-to-examine-rx-drug-importation
Healthcare Distribution Alliance (HDA) President and CEO John M. Gray released the following statement on the Department of Health and Human Services’ (HHS) recent directive to establish a Food and Drug Administration (FDA) work group to examine prescription drug importation policies.
HDA 2018 DIANA Awards Honor Manufacturers for Industry Excellence
/news/2018-06-12-hda-names-diana-winners
The Healthcare Distribution Alliance (HDA) honored pharmaceutical and consumer product manufacturers with the annual Distribution Industry Awards for Notable Achievements in Healthcare (DIANA). The awards were distributed at the HDA 2018 Business and Leadership Conference in Colorado Springs, Colo.
/news/2018-06-12-hda-names-diana-winners
The Healthcare Distribution Alliance (HDA) honored pharmaceutical and consumer product manufacturers with the annual Distribution Industry Awards for Notable Achievements in Healthcare (DIANA). The awards were distributed at the HDA 2018 Business and Leadership Conference in Colorado Springs, Colo.
Michael A. Conley of Novartis Pharmaceuticals Recognized with 2018 Nexus Award for Lifetime Achievement
/news/2018-06-12-conley-recognized-with-2018-nexus-award
The HDA Research Foundation, the non-profit organization of the Healthcare Distribution Alliance (HDA), recognized Michael A. Conley of Novartis Pharmaceuticals Corporation with the 2018 Nexus Award for Lifetime Achievement at the HDA Business and Leadership Conference in Colorado Springs. The award is made possible through the support of Genentech, A Member of the Roche Group, and Mylan Inc.
/news/2018-06-12-conley-recognized-with-2018-nexus-award
The HDA Research Foundation, the non-profit organization of the Healthcare Distribution Alliance (HDA), recognized Michael A. Conley of Novartis Pharmaceuticals Corporation with the 2018 Nexus Award for Lifetime Achievement at the HDA Business and Leadership Conference in Colorado Springs. The award is made possible through the support of Genentech, A Member of the Roche Group, and Mylan Inc.
Fact Check: Where 60 Minutes Got it Wrong on the Opioid Crisis
/news/2018-06-17-fact-check-where-60-minutes-got-it-wrong-on-the-opioid-crisis
Over the last year, 60 Minutes, in partnership with The Washington Post, has presented several misleading, inaccurate accounts of pharmaceutical distributors’ role in the opioid crisis, including the subsequent enforcement of The Ensuring Patient Access and Effective Drug Enforcement Act. To understand the country’s opioid epidemic and the solutions needed to reduce diversion and misuse of prescription opioids, we need to separate fact from fiction.
/news/2018-06-17-fact-check-where-60-minutes-got-it-wrong-on-the-opioid-crisis
Over the last year, 60 Minutes, in partnership with The Washington Post, has presented several misleading, inaccurate accounts of pharmaceutical distributors’ role in the opioid crisis, including the subsequent enforcement of The Ensuring Patient Access and Effective Drug Enforcement Act. To understand the country’s opioid epidemic and the solutions needed to reduce diversion and misuse of prescription opioids, we need to separate fact from fiction.
Are You Ready? Prepare for DSCSA Serialization with HDA Origin
/news/2018-04-30-prepare-for-dscsa-serialization-with-hda-origin
Last year, FDA announced a period of “enforcement discretion” related to the deadline for manufacturers to serialize products under the Drug Supply Chain Security Act (DSCSA). As the industry quickly approaches the November 2018 deadline, it is essential for companies to prepare now for the reality of conducting business in a serialized environment. Is your company ready to meet the new requirements?
/news/2018-04-30-prepare-for-dscsa-serialization-with-hda-origin
Last year, FDA announced a period of “enforcement discretion” related to the deadline for manufacturers to serialize products under the Drug Supply Chain Security Act (DSCSA). As the industry quickly approaches the November 2018 deadline, it is essential for companies to prepare now for the reality of conducting business in a serialized environment. Is your company ready to meet the new requirements?
HDA's Pharmaceutical Cargo Security Coalition Recognizes Leaders for Commitment to a Safe and Secure Supply Chain
/news/2018-05-16-hda-pcsc-recognizes-leaders
HDA’s Pharmaceutical Cargo Security Coalition (PCSC) presented three awards at its educational seminar in East Hanover, New Jersey. Presented annually, the PCSC Award recognizes leaders who have exhibited extraordinary standards of honesty and integrity while working tirelessly to protect and serve their communities.
/news/2018-05-16-hda-pcsc-recognizes-leaders
HDA’s Pharmaceutical Cargo Security Coalition (PCSC) presented three awards at its educational seminar in East Hanover, New Jersey. Presented annually, the PCSC Award recognizes leaders who have exhibited extraordinary standards of honesty and integrity while working tirelessly to protect and serve their communities.
HDA Supports Senate Proposals on Enhanced ARCOS Data Sharing, Development of Centralized Suspicious Orders Database
/news/2018-05-22-hda-supports-senate-proposals
In advance of the Senate Judiciary Committee’s hearing to consider, among others, two Senate bills calling for greater coordination and data sharing among distributors, the Drug Enforcement Administration (DEA), state regulatory agencies and local law enforcement, Healthcare Distribution Alliance (HDA) President and CEO John M. Gray issued the following statement.
/news/2018-05-22-hda-supports-senate-proposals
In advance of the Senate Judiciary Committee’s hearing to consider, among others, two Senate bills calling for greater coordination and data sharing among distributors, the Drug Enforcement Administration (DEA), state regulatory agencies and local law enforcement, Healthcare Distribution Alliance (HDA) President and CEO John M. Gray issued the following statement.
Americares Honors Mylan with Power of Partnership Award
/news/2018-06-11-americares-honors-mylan-with-power-of-partnership-award
Americares, in partnership with the Healthcare Distribution Alliance (HDA), has presented its annual Power of Partnership Award to Mylan, in recognition of its outstanding commitment to increasing access to healthcare around the world. Mylan is among Americares most dedicated and longstanding supporters, providing pharmaceutical products for the organization’s health programs for people affected by poverty or disaster.
/news/2018-06-11-americares-honors-mylan-with-power-of-partnership-award
Americares, in partnership with the Healthcare Distribution Alliance (HDA), has presented its annual Power of Partnership Award to Mylan, in recognition of its outstanding commitment to increasing access to healthcare around the world. Mylan is among Americares most dedicated and longstanding supporters, providing pharmaceutical products for the organization’s health programs for people affected by poverty or disaster.
HDA Files Lawsuit to Block New York Opioid Law
/news/2018-07-06-hda-files-lawsuit-to-block-new-york-opioid-law
Today, the Healthcare Distribution Alliance (HDA), the national trade association for pharmaceutical distributors, filed suit in the U.S. District Court for the Southern District of New York to block enforcement of New York’s Opioid Stewardship Act. The act imposes an unconstitutional $600 million punitive surcharge on pharmaceutical distributors and manufacturers. It bypasses judicial due process and impedes the industry’s comprehensive efforts to mitigate opioid abuse and misuse.
/news/2018-07-06-hda-files-lawsuit-to-block-new-york-opioid-law
Today, the Healthcare Distribution Alliance (HDA), the national trade association for pharmaceutical distributors, filed suit in the U.S. District Court for the Southern District of New York to block enforcement of New York’s Opioid Stewardship Act. The act imposes an unconstitutional $600 million punitive surcharge on pharmaceutical distributors and manufacturers. It bypasses judicial due process and impedes the industry’s comprehensive efforts to mitigate opioid abuse and misuse.
HDA Statement on Senator McCaskill’s Opioid Report and the Role of Pharmaceutical Distributors in Addressing National Crisis
/news/2018-07-12-hda-statement-on-senator-mccaskill-opioid-report
/news/2018-07-12-hda-statement-on-senator-mccaskill-opioid-report
HDA Announces Drew and Mauch to Lead Board of Directors
/news/2018-10-02-hda-announces-drew-and-mauch-to-lead-board-of-directors
The Healthcare Distribution Alliance (HDA) announces the election of Greg Drew, President of Value Drug Company, as Chairman of HDA’s Board of Directors. Robert Mauch, PhD, PharmD, EVP and Group President at AmerisourceBergen Corporation, was elected Vice Chairman. The new leadership was announced at the HDA Annual Board and Membership Meeting.
/news/2018-10-02-hda-announces-drew-and-mauch-to-lead-board-of-directors
The Healthcare Distribution Alliance (HDA) announces the election of Greg Drew, President of Value Drug Company, as Chairman of HDA’s Board of Directors. Robert Mauch, PhD, PharmD, EVP and Group President at AmerisourceBergen Corporation, was elected Vice Chairman. The new leadership was announced at the HDA Annual Board and Membership Meeting.
HDA Statement on the Enactment of Bipartisan Opioid Legislation
/news/2018-10-24-hda-statement-on-enactment-of-bipartisan-opioid-legislation
Healthcare Distribution Alliance (HDA) President and CEO John M. Gray issued a statement in response to the enactment of the SUPPORT for Patients and Communities Act.
/news/2018-10-24-hda-statement-on-enactment-of-bipartisan-opioid-legislation
Healthcare Distribution Alliance (HDA) President and CEO John M. Gray issued a statement in response to the enactment of the SUPPORT for Patients and Communities Act.
HDA Statement on Passage of Opioid Excise Tax in New York State
/news/2019-04-01-hda-statement-on-passage-of-opioid-excise-tax-in-ny
Healthcare Distribution Alliance (HDA) President and CEO John M. Gray issued a statement in response to the passage of the New York state budget, which includes an annual excise tax on prescription opioid manufacturers and distributors.
/news/2019-04-01-hda-statement-on-passage-of-opioid-excise-tax-in-ny
Healthcare Distribution Alliance (HDA) President and CEO John M. Gray issued a statement in response to the passage of the New York state budget, which includes an annual excise tax on prescription opioid manufacturers and distributors.
HDA President and CEO John M. Gray Forecasts 2017 Alliance Priorities in Chain Drug Review
/news/2017-01-02-gray-forecasts-2017-priorities-in-chain-drug-review
HDA President and CEO John M. Gray has outlined the organization’s priorities for the upcoming year in his annual “Pharmacy Outlook” column, published in the January 2 issue of Chain Drug Review.
/news/2017-01-02-gray-forecasts-2017-priorities-in-chain-drug-review
HDA President and CEO John M. Gray has outlined the organization’s priorities for the upcoming year in his annual “Pharmacy Outlook” column, published in the January 2 issue of Chain Drug Review.
HDA Statement on Introduction of House Legislation to Support Enhanced Data Sharing Between DEA, Supply Chain Partners
/news/2018-09-14-hda-statement-on-hr-6779
Healthcare Distribution Alliance (HDA) President and CEO John M. Gray released the following statement on the introduction of the Using Data to Prevent Opioid Diversion Act of 2018 (H.R. 6779) by Rep. Ken Buck (R-Colo.)
/news/2018-09-14-hda-statement-on-hr-6779
Healthcare Distribution Alliance (HDA) President and CEO John M. Gray released the following statement on the introduction of the Using Data to Prevent Opioid Diversion Act of 2018 (H.R. 6779) by Rep. Ken Buck (R-Colo.)
HDA Responds to GAO Report on Suspicious Orders
/news/2020-02-03-hda-responds-to-gao-report-on-suspicious-orders
HDA Executive Vice President of Government Affairs Patrick Kelly released the following statement in response to a new Government Accountability Office (GAO) report, Drug Control: Actions Needed to Ensure Usefulness of Data on Suspicious Opioid Orders.
/news/2020-02-03-hda-responds-to-gao-report-on-suspicious-orders
HDA Executive Vice President of Government Affairs Patrick Kelly released the following statement in response to a new Government Accountability Office (GAO) report, Drug Control: Actions Needed to Ensure Usefulness of Data on Suspicious Opioid Orders.
Healthcare Distribution Alliance Names Chip Davis President and Chief Executive Officer
/news/2020-02-10-hda-names-chip-davis-president-and-ceo
The Healthcare Distribution Alliance (HDA) Board of Directors’ Executive Committee today announced the appointment of Chester “Chip” Davis, Jr., JD, to the position of President and Chief Executive Officer. Mr. Davis will join HDA during March of this year. Chip joins HDA coming from the Association for Accessible Medicines (AAM), the nation’s leading trade association for manufacturers of generic and biosimilar medicines, where he has served as President and Chief Executive Officer since 2015.
/news/2020-02-10-hda-names-chip-davis-president-and-ceo
The Healthcare Distribution Alliance (HDA) Board of Directors’ Executive Committee today announced the appointment of Chester “Chip” Davis, Jr., JD, to the position of President and Chief Executive Officer. Mr. Davis will join HDA during March of this year. Chip joins HDA coming from the Association for Accessible Medicines (AAM), the nation’s leading trade association for manufacturers of generic and biosimilar medicines, where he has served as President and Chief Executive Officer since 2015.
New Analysis Notes the Critical and Evolving Role Pharmaceutical Distributors Play in U.S. Healthcare
/news/2019-07-30-analysis-notes-critical-and-evolving-role-of-distributors
A new report published by the Healthcare Distribution Alliance (HDA) and Deloitte Consulting LLP highlights the value distributors provide to the United States healthcare ecosystem and estimates pharmaceutical distributors generate between $33 and $53 billion in cost savings annually. The Role of Distributors in the US Health Care Industry provides insights into the importance of wholesalers in driving efficiency and innovation across the pharmaceutical supply chain — both today and over the next several years.
/news/2019-07-30-analysis-notes-critical-and-evolving-role-of-distributors
A new report published by the Healthcare Distribution Alliance (HDA) and Deloitte Consulting LLP highlights the value distributors provide to the United States healthcare ecosystem and estimates pharmaceutical distributors generate between $33 and $53 billion in cost savings annually. The Role of Distributors in the US Health Care Industry provides insights into the importance of wholesalers in driving efficiency and innovation across the pharmaceutical supply chain — both today and over the next several years.
HDA Statement on HHS-FDA "Safe Importation Action Plan"
/news/2019-07-31-statement-on-hhs-fda-safe-importation-action-plan
The Healthcare Distribution Alliance (HDA) released the following statement on the release of the “Safe Importation Action Plan” by the Department of Health and Human Services (HHS) and U.S. Food and Drug Administration (FDA).
/news/2019-07-31-statement-on-hhs-fda-safe-importation-action-plan
The Healthcare Distribution Alliance (HDA) released the following statement on the release of the “Safe Importation Action Plan” by the Department of Health and Human Services (HHS) and U.S. Food and Drug Administration (FDA).
Analysis: Importation Policies Cost-Prohibitive to U.S. Healthcare System, Pose Risks to Patients
/news/2019-07-15-hda-research-foundation-analyzes-cost-of-federal-importation-policies
A new report published by the HDA Research Foundation concludes that federal proposals to permit the importation of prescription drugs into the U.S. fail to provide comprehensive guidance and funding to meet current federal safety and quality standards.
/news/2019-07-15-hda-research-foundation-analyzes-cost-of-federal-importation-policies
A new report published by the HDA Research Foundation concludes that federal proposals to permit the importation of prescription drugs into the U.S. fail to provide comprehensive guidance and funding to meet current federal safety and quality standards.
HDA Statement on Proposed HHS Rule on Prescription Drug Importation
/news/2019-12-18-hda-statement-on-proposed-hhs-rule-on-prescription-drug-importation
The Healthcare Distribution Alliance (HDA) released the following statement regarding the Department of Health and Human Services' (HHS) proposed rule permitting prescription drug importation.
/news/2019-12-18-hda-statement-on-proposed-hhs-rule-on-prescription-drug-importation
The Healthcare Distribution Alliance (HDA) released the following statement regarding the Department of Health and Human Services' (HHS) proposed rule permitting prescription drug importation.
Conley and Cowman to Lead HDA Research Foundation Board Of Directors
/news/2020-02-25-hda-foundation-announces-board-appointments
The HDA Research Foundation announced Michael Conley, Vice President and Head, Trade Operations and Analytics, Novartis Pharmaceuticals Corporation, as Chairman of its Board of Directors. Craig Cowman, Executive Vice President, Global Sourcing, Cardinal Health, is Vice Chairman.
/news/2020-02-25-hda-foundation-announces-board-appointments
The HDA Research Foundation announced Michael Conley, Vice President and Head, Trade Operations and Analytics, Novartis Pharmaceuticals Corporation, as Chairman of its Board of Directors. Craig Cowman, Executive Vice President, Global Sourcing, Cardinal Health, is Vice Chairman.
AAOA Celebrates Two Years
/news/2020-02-25-aaoa-celebrates-two-years
This month, Allied Against Opioid Abuse (AAOA) celebrates its second year of working with stakeholders across the healthcare industry to raise awareness among patients, pharmacists, providers and the public about prescription opioid safety.
/news/2020-02-25-aaoa-celebrates-two-years
This month, Allied Against Opioid Abuse (AAOA) celebrates its second year of working with stakeholders across the healthcare industry to raise awareness among patients, pharmacists, providers and the public about prescription opioid safety.
HDA Statement on COVID-19 Preparedness
/news/2020-03-05-hda-statement-on-covid-19-preparedness
The Healthcare Distribution Alliance (HDA) released the following statement on distribution industry preparedness for the novel COVID-19 “coronavirus” outbreak.
/news/2020-03-05-hda-statement-on-covid-19-preparedness
The Healthcare Distribution Alliance (HDA) released the following statement on distribution industry preparedness for the novel COVID-19 “coronavirus” outbreak.
HDA Statement on FDA Drug Importation Proposal
/news/2020-03-09-hda-statement-on-fda-drug-importation-proposal
In response to the Food and Drug Administration’s (FDA) proposed rule on prescription drug importation, Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr. released the following statement:
/news/2020-03-09-hda-statement-on-fda-drug-importation-proposal
In response to the Food and Drug Administration’s (FDA) proposed rule on prescription drug importation, Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr. released the following statement:
HDA Statement on “Project Airbridge” Initiative
/news/2020-03-29-hda-statement-on-project-airbridge-initiative
Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr., released the following statement regarding today’s White House Coronavirus Task Force briefing and the “Project Airbridge” initiative.
/news/2020-03-29-hda-statement-on-project-airbridge-initiative
Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr., released the following statement regarding today’s White House Coronavirus Task Force briefing and the “Project Airbridge” initiative.
HDA Video Showcases Distributor COVID-19 Response Efforts
/news/2020-05-20-hda-video-showcases-distributor-covid19-response-efforts
HDA released a two-minute video that further reinforces the pharmaceutical distribution industry’s critical function as it adapts and rises to the challenge of COVID-19, while also continuing the vital work of delivering the medicines Americans rely on to manage their daily healthcare needs.
/news/2020-05-20-hda-video-showcases-distributor-covid19-response-efforts
HDA released a two-minute video that further reinforces the pharmaceutical distribution industry’s critical function as it adapts and rises to the challenge of COVID-19, while also continuing the vital work of delivering the medicines Americans rely on to manage their daily healthcare needs.
Medline Industries
//www.hda.org/member-spotlight/medline-industries
Medline is a manufacturer and distributor serving the healthcare industry with pharmaceuticals, medical supplies, and clinical solutions that help customers achieve both clinical and financial success. Headquartered in Northfield, Ill., the company offers medical products and pharmaceuticals through direct sales representatives who are dedicated points of contact for customers across the continuum of care.
//www.hda.org/member-spotlight/medline-industries
Medline is a manufacturer and distributor serving the healthcare industry with pharmaceuticals, medical supplies, and clinical solutions that help customers achieve both clinical and financial success. Headquartered in Northfield, Ill., the company offers medical products and pharmaceuticals through direct sales representatives who are dedicated points of contact for customers across the continuum of care.
Associated Pharmacies
//www.hda.org/member-spotlight/associated-pharmacies
Associated Pharmacies, Inc. (API), the warehouse subsidiary of American Associated Pharmacies (AAP), is designed to lower operating costs and increase margins on Brand Rx, Generic Rx, and OTC’s. API is member-owned, which means the profits make their way back to retail independent pharmacy. Click her for more information.
//www.hda.org/member-spotlight/associated-pharmacies
Associated Pharmacies, Inc. (API), the warehouse subsidiary of American Associated Pharmacies (AAP), is designed to lower operating costs and increase margins on Brand Rx, Generic Rx, and OTC’s. API is member-owned, which means the profits make their way back to retail independent pharmacy. Click her for more information.
Prodigy Health Supplier Corporation
//www.hda.org/member-spotlight/prodigy-health-supplier-corporation
//www.hda.org/member-spotlight/prodigy-health-supplier-corporation
Real Value Rx dba Hospital Pharmaceutical Consulting
//www.hda.org/member-spotlight/real-value-rx-dba-hospital-pharmaceutical-consulting
Real Value Rx dba Hospital Pharmaceutical Consulting is a subsidiary of a 33-year-old wholesale distribution company and has been licensed to distribute prescription drugs in the United States since 2011. The company is licensed in 47 states to serve the pharmacy industry at a national level.
//www.hda.org/member-spotlight/real-value-rx-dba-hospital-pharmaceutical-consulting
Real Value Rx dba Hospital Pharmaceutical Consulting is a subsidiary of a 33-year-old wholesale distribution company and has been licensed to distribute prescription drugs in the United States since 2011. The company is licensed in 47 states to serve the pharmacy industry at a national level.
Quality Care Products
//www.hda.org/member-spotlight/quality-care-products
QCP is a national distributor of generic drugs, injectable, vaccines, OTC, medical supplies, and Rx/OTC repackaging in low, unit-of-use products in an FDA- and DEA-compliant, secure, state-of-the-art CGMP manufacturing facility. QCP is a primary supplier to 2,546 national healthcare facilities, including retail pharma, dispensing physicians, urgent care, LTC, mail order and surgical centers, as well as institutional and government entities.
//www.hda.org/member-spotlight/quality-care-products
QCP is a national distributor of generic drugs, injectable, vaccines, OTC, medical supplies, and Rx/OTC repackaging in low, unit-of-use products in an FDA- and DEA-compliant, secure, state-of-the-art CGMP manufacturing facility. QCP is a primary supplier to 2,546 national healthcare facilities, including retail pharma, dispensing physicians, urgent care, LTC, mail order and surgical centers, as well as institutional and government entities.
Sponsorship
//www.hda.org/sponsorship
An HDA sponsorship puts your company front and center with trading partners and colleagues.
//www.hda.org/sponsorship
An HDA sponsorship puts your company front and center with trading partners and colleagues.
Sponsorship Photos
//www.hda.org/sponsorship/sponsorship-photos
Examples of how your logo can be incorporated into an HDA sponsorship package.
//www.hda.org/sponsorship/sponsorship-photos
Examples of how your logo can be incorporated into an HDA sponsorship package.
Testimony
//www.hda.org/news/testimony
As part of its advocacy efforts, HDMA is regularly asked to testify on Capitol Hill and in statehouses on issues of importance to primary pharmaceutical distributors.
//www.hda.org/news/testimony
As part of its advocacy efforts, HDMA is regularly asked to testify on Capitol Hill and in statehouses on issues of importance to primary pharmaceutical distributors.
The Vital Link in Healthcare
//www.hda.org/resources/the-vital-link
HDA's "Vital Link Toolkit" was created to inform and educate the public on the role of pharmaceutical distributors in the healthcare industry.
//www.hda.org/resources/the-vital-link
HDA's "Vital Link Toolkit" was created to inform and educate the public on the role of pharmaceutical distributors in the healthcare industry.
What is a Distributor?
//www.hda.org/about/role-of-distributors
Every day, pharmaceutical distributors sustain a complex supply chain, serving as an important link in the healthcare system and delivering medicines safely, securely and efficiently.
//www.hda.org/about/role-of-distributors
Every day, pharmaceutical distributors sustain a complex supply chain, serving as an important link in the healthcare system and delivering medicines safely, securely and efficiently.
Member Directory
//www.hda.org/about/member-directory
Need to contact a trading partner? The HDA Member Directory includes contact information for thousands of healthcare product distributors, manufacturers and service providers.
//www.hda.org/about/member-directory
Need to contact a trading partner? The HDA Member Directory includes contact information for thousands of healthcare product distributors, manufacturers and service providers.
Industry Recognition
//www.hda.org/about/industry-recognition
HDA has a proud history of honoring companies and individuals for support of the distribution industry and lifetime achievement through its awards program.
//www.hda.org/about/industry-recognition
HDA has a proud history of honoring companies and individuals for support of the distribution industry and lifetime achievement through its awards program.
//www.hda.org/about/board-of-directors
HDA is governed by a Board of Directors responsible for identification and development of priorities, policies and positions of the organization.
Executive Committee
//www.hda.org/about/executive-committee
The Executive Committee consists of the members of the Board of Directors representing each distributor member at the capped dues level, and an equal number plus one of the Board members representing distributor members not at the capped dues level, as selected by the Board. Among the members of the Executive Committee is a chairperson and a vice-chairperson.
//www.hda.org/about/executive-committee
The Executive Committee consists of the members of the Board of Directors representing each distributor member at the capped dues level, and an equal number plus one of the Board members representing distributor members not at the capped dues level, as selected by the Board. Among the members of the Executive Committee is a chairperson and a vice-chairperson.
Issues in Distribution
//www.hda.org/issues
HDA reviews key priority issues and advocates on behalf of its pharmaceutical distributor members for standards, public policies and business processes that ensure a safe and efficient supply chain.
//www.hda.org/issues
HDA reviews key priority issues and advocates on behalf of its pharmaceutical distributor members for standards, public policies and business processes that ensure a safe and efficient supply chain.
Grassroots Advocacy
//www.hda.org/issues/grassroots-advocacy
HDA member companies' involvement in advocacy and legislative outreach is important to supporting, protecting and promoting the pharmaceutical distribution industry. As an organization that fosters productive partnerships between supply chain stakeholders and lawmakers, HDA facilitates this outreach by encouraging grassroots member participation in the legislative process.
//www.hda.org/issues/grassroots-advocacy
HDA member companies' involvement in advocacy and legislative outreach is important to supporting, protecting and promoting the pharmaceutical distribution industry. As an organization that fosters productive partnerships between supply chain stakeholders and lawmakers, HDA facilitates this outreach by encouraging grassroots member participation in the legislative process.
Distributor Licensure
//www.hda.org/issues/distributor-licensure
The introduction of counterfeit or adulterated medicines into the supply chain is a serious issue that could adversely affect the safety of prescription medicines and the health of patients. To that end, HDA strongly supports tough, rigorous and consistent standards for state licensing of pharmaceutical distributors as required under federal law.
//www.hda.org/issues/distributor-licensure
The introduction of counterfeit or adulterated medicines into the supply chain is a serious issue that could adversely affect the safety of prescription medicines and the health of patients. To that end, HDA strongly supports tough, rigorous and consistent standards for state licensing of pharmaceutical distributors as required under federal law.
Taxes
//www.hda.org/issues/taxes
HDA opposes repeal of the Last in, First Out (LIFO) accounting method and establishment of gross receipts taxes. Healthcare distribution represents a high-volume, low-profit margin business that is impacted disproportionately under certain tax proposals, including repeal of LIFO and instituting gross receipts taxes.
//www.hda.org/issues/taxes
HDA opposes repeal of the Last in, First Out (LIFO) accounting method and establishment of gross receipts taxes. Healthcare distribution represents a high-volume, low-profit margin business that is impacted disproportionately under certain tax proposals, including repeal of LIFO and instituting gross receipts taxes.
Mobile App
//www.hda.org/mobile
HDA’s mobile app is an essential event resource. After installing the app, select the meeting you are attending from the “Events” menu and log in using the password you normally use to log into HDA’s website to gain instant access to information on the go. Event features include an attendee list, daily schedule, hotel floor plan and more. Additionally, access basic information about HDA, including staff contacts and a link to @HDAconnect on Twitter.
//www.hda.org/mobile
HDA’s mobile app is an essential event resource. After installing the app, select the meeting you are attending from the “Events” menu and log in using the password you normally use to log into HDA’s website to gain instant access to information on the go. Event features include an attendee list, daily schedule, hotel floor plan and more. Additionally, access basic information about HDA, including staff contacts and a link to @HDAconnect on Twitter.
Antitrust Policy
//www.hda.org/antitrust
It is the unqualified policy of HDA and all of its operating committees to conduct their operations in strict compliance with the antitrust laws of the United States.
//www.hda.org/antitrust
It is the unqualified policy of HDA and all of its operating committees to conduct their operations in strict compliance with the antitrust laws of the United States.
HDA Outlines Principles for Pandemic and Public Health Emergency Response
/news/2020-06-11-hda-outlines-principles-for-pandemic-and-public-health-emergency-response
The Healthcare Distribution Alliance (HDA) released policy principles reaffirming the pharmaceutical distribution industry’s commitment to assisting the country and frontline healthcare providers during pandemics and public health emergencies.
/news/2020-06-11-hda-outlines-principles-for-pandemic-and-public-health-emergency-response
The Healthcare Distribution Alliance (HDA) released policy principles reaffirming the pharmaceutical distribution industry’s commitment to assisting the country and frontline healthcare providers during pandemics and public health emergencies.
Emergency Preparedness and Response Efforts
//www.hda.org/issues/emergency-preparedness
Pharmaceutical distributors have emergency preparedness plans in place to ensure continued operations in emergencies, and they actively collaborate with their supply chain partners to solve challenges created by a pandemic or severe emergency scenario.
//www.hda.org/issues/emergency-preparedness
Pharmaceutical distributors have emergency preparedness plans in place to ensure continued operations in emergencies, and they actively collaborate with their supply chain partners to solve challenges created by a pandemic or severe emergency scenario.
Staff
//www.hda.org/foundation/staff
The HDA Research Foundation is the 501(c)(3) non-profit charitable organization that serves as the knowledge partner of HDA.
//www.hda.org/foundation/staff
The HDA Research Foundation is the 501(c)(3) non-profit charitable organization that serves as the knowledge partner of HDA.
Research Foundation
//www.hda.org/foundation
The HDA Research Foundation is a 501(c)(3) non-profit organization. Founded in 1980, the organization has undertaken projects that fulfill the charitable, research and education priorities of the healthcare supply chain.
//www.hda.org/foundation
The HDA Research Foundation is a 501(c)(3) non-profit organization. Founded in 1980, the organization has undertaken projects that fulfill the charitable, research and education priorities of the healthcare supply chain.
HDA Statement on President's "Buy American" Executive Order
/news/2020-08-07-hda-statement-on-buy-american-eo
In response to President Trump’s “Buy American” Executive Order (EO), Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr., released the following statement.
/news/2020-08-07-hda-statement-on-buy-american-eo
In response to President Trump’s “Buy American” Executive Order (EO), Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr., released the following statement.
HDA Statement on the President's Drug Affordability Executive Orders
/news/2020-07-24-hda-statement-on-the-presidents-drug-affordability-executive-orders
In response to President Trump signing drug pricing Executive Orders (EOs), Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr. released the following statement.
/news/2020-07-24-hda-statement-on-the-presidents-drug-affordability-executive-orders
In response to President Trump signing drug pricing Executive Orders (EOs), Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr. released the following statement.
HDA Statement on COVID-19 Vaccine Distribution
/news/2020-08-14-hda-statement-on-covid19-vaccine-distribution
Healthcare Distribution Alliance (HDA) President and CEO Chester "Chip" Davis, Jr., released the following statement regarding the distribution of COVID-19 vaccines and supplies through Operation Warp Speed.
/news/2020-08-14-hda-statement-on-covid19-vaccine-distribution
Healthcare Distribution Alliance (HDA) President and CEO Chester "Chip" Davis, Jr., released the following statement regarding the distribution of COVID-19 vaccines and supplies through Operation Warp Speed.
HDA Celebrates Manufacturers' New Product Introductions With 2020 DIANA Awards
/news/2020-07-20-hda-celebrates-manufacturers-with-diana-awards
The Healthcare Distribution Alliance (HDA) honored five pharmaceutical and consumer product manufacturers with the Distribution Industry Award for Notable Achievements in Healthcare (DIANA). Awardees were recognized in the “Best New Product Introductions or Promotions” categories. Annually presented at the Business and Leadership Conference (BLC), the awards were given virtually during the 2020 BLC Online.
/news/2020-07-20-hda-celebrates-manufacturers-with-diana-awards
The Healthcare Distribution Alliance (HDA) honored five pharmaceutical and consumer product manufacturers with the Distribution Industry Award for Notable Achievements in Healthcare (DIANA). Awardees were recognized in the “Best New Product Introductions or Promotions” categories. Annually presented at the Business and Leadership Conference (BLC), the awards were given virtually during the 2020 BLC Online.
HDA Research Foundation Selects Supply Chain Scholars
/news/2020-01-30-hda-research-foundation-selects-supply-chain-scholars
The HDA Research Foundation honored three graduate students as the recipients of its second annual scholarship.
/news/2020-01-30-hda-research-foundation-selects-supply-chain-scholars
The HDA Research Foundation honored three graduate students as the recipients of its second annual scholarship.
HDA Research Foundation Launches Scholarship Program
/news/2018-10-11-hda-research-foundation-launches-scholarship-program
The HDA Research Foundation is seeking to support the next generation of supply chain leaders through a new scholarship program. Created in conjunction with HDA’s professional development program, Convene, the HDA Research Foundation Scholarship is available biannually to graduate-level students currently working within HDA-member distributor and manufacturer companies.
/news/2018-10-11-hda-research-foundation-launches-scholarship-program
The HDA Research Foundation is seeking to support the next generation of supply chain leaders through a new scholarship program. Created in conjunction with HDA’s professional development program, Convene, the HDA Research Foundation Scholarship is available biannually to graduate-level students currently working within HDA-member distributor and manufacturer companies.
HDA Research Foundation Announces Inaugural Scholarship Recipients
/news/2019-02-14-hda-research-foundation-announces-scholarship-program-winners
The HDA Research Foundation today announced the selection of four HDA-member professionals as the inaugural recipients of its graduate-level scholarship program.
/news/2019-02-14-hda-research-foundation-announces-scholarship-program-winners
The HDA Research Foundation today announced the selection of four HDA-member professionals as the inaugural recipients of its graduate-level scholarship program.
HDA Foundation Factbook Provides Data on Industry Operations and Trends
/news/2018-12-11-hda-foundation-factbook-provides-data-on-industry-operations-and-trends
The HDA Research Foundation released the 89th Edition HDA Factbook: The Facts, Figures and Trends in Healthcare (2018–2019), featuring updated data trends on the pharmaceutical distribution industry. According to the latest findings, chain drug stores remained the largest customer segment for distributors in 2017, representing 42.6 percent of all sales — a 10.2 percent increase from the previous year. Correspondingly, the total number of sales that went through primary pharmaceutical distributors in 2017 is estimated at 92 percent (or $461 billion).
/news/2018-12-11-hda-foundation-factbook-provides-data-on-industry-operations-and-trends
The HDA Research Foundation released the 89th Edition HDA Factbook: The Facts, Figures and Trends in Healthcare (2018–2019), featuring updated data trends on the pharmaceutical distribution industry. According to the latest findings, chain drug stores remained the largest customer segment for distributors in 2017, representing 42.6 percent of all sales — a 10.2 percent increase from the previous year. Correspondingly, the total number of sales that went through primary pharmaceutical distributors in 2017 is estimated at 92 percent (or $461 billion).
Pharmaceutical Sales Through Distributors Reach $493 Billion
/news/2019-12-06-hda-foundation-releases-new-factbook
In 2018, sales through pharmaceutical distributors increased by 6.7 percent, reaching $492.54 billion, according to a new report by the HDA Research Foundation. The 90th Edition HDA Factbook: The Facts, Figures and Trends in Healthcare (2019–2020) also notes that chain drug stores were the largest customer base for pharmaceutical wholesalers — accounting for 44.6 percent of all sales, a slight increase from 2017. Distributor margins, however, continued a four-year slide though they showed increases in efficiency.
/news/2019-12-06-hda-foundation-releases-new-factbook
In 2018, sales through pharmaceutical distributors increased by 6.7 percent, reaching $492.54 billion, according to a new report by the HDA Research Foundation. The 90th Edition HDA Factbook: The Facts, Figures and Trends in Healthcare (2019–2020) also notes that chain drug stores were the largest customer base for pharmaceutical wholesalers — accounting for 44.6 percent of all sales, a slight increase from 2017. Distributor margins, however, continued a four-year slide though they showed increases in efficiency.
HDA Traceability Seminar to Bring Together Pharmaceutical Supply Chain Professionals
/news/2018-09-12-traceability-seminar-to-bring-together-rx-supply-chain-professionals
The Healthcare Distribution Alliance (HDA) will convene pharmaceutical supply chain industry leaders at its Traceability Seminar, October 17–19 in Washington, D.C. The 2018 seminar will educate attendees about where the pharmaceutical supply chain is in relation to achieving full implementation of the Drug Supply Chain Security Act (DSCSA) in 2023; what to expect in the future as the industry approaches the final deadline; and available resources, tools and guidance on a range of traceability topics.
/news/2018-09-12-traceability-seminar-to-bring-together-rx-supply-chain-professionals
The Healthcare Distribution Alliance (HDA) will convene pharmaceutical supply chain industry leaders at its Traceability Seminar, October 17–19 in Washington, D.C. The 2018 seminar will educate attendees about where the pharmaceutical supply chain is in relation to achieving full implementation of the Drug Supply Chain Security Act (DSCSA) in 2023; what to expect in the future as the industry approaches the final deadline; and available resources, tools and guidance on a range of traceability topics.
HDA is One of The Best Places to Work in Virginia for the Eighth Year in a Row
/news/2018-02-01-hda-is-one-of-the-best-places-to-work-in-virginia-for-the-eighth-year-in-a-row
The Healthcare Distribution Alliance (HDA) was named one of the Best Places to Work in Virginia by Virginia Business magazine and Best Companies Group.
/news/2018-02-01-hda-is-one-of-the-best-places-to-work-in-virginia-for-the-eighth-year-in-a-row
The Healthcare Distribution Alliance (HDA) was named one of the Best Places to Work in Virginia by Virginia Business magazine and Best Companies Group.
HDA Honors Manufacturers With 2019 DIANA Awards
/news/2019-06-04-hda-honors-manufacturers-with-2019-diana-awards
The Healthcare Distribution Alliance (HDA) honored pharmaceutical and consumer product manufacturers with the annual Distribution Industry Awards for Notable Achievements in Healthcare (DIANA). The honorees were formally recognized during the DIANA and Nexus Awards dinner at the HDA 2019 Business and Leadership Conference in Orlando, Fla.
/news/2019-06-04-hda-honors-manufacturers-with-2019-diana-awards
The Healthcare Distribution Alliance (HDA) honored pharmaceutical and consumer product manufacturers with the annual Distribution Industry Awards for Notable Achievements in Healthcare (DIANA). The honorees were formally recognized during the DIANA and Nexus Awards dinner at the HDA 2019 Business and Leadership Conference in Orlando, Fla.
Five HDA Member Companies Honored with 2019 Distribution Management Award for the MediLedger Project
/news/2019-03-12-five-hda-member-companies-honored-with-2019-dma
The Healthcare Distribution Alliance recognized AbbVie US; AmerisourceBergen Corporation; Genentech, a Member of the Roche Group; McKesson Corporation and Pfizer, Inc., with the 2019 Distribution Management Award (DMA) for the MediLedger Project, a blockchain-enabled traceability initiative. The companies were honored today at the HDA Distribution Management Conference and Expo in Palm Desert, Calif.
/news/2019-03-12-five-hda-member-companies-honored-with-2019-dma
The Healthcare Distribution Alliance recognized AbbVie US; AmerisourceBergen Corporation; Genentech, a Member of the Roche Group; McKesson Corporation and Pfizer, Inc., with the 2019 Distribution Management Award (DMA) for the MediLedger Project, a blockchain-enabled traceability initiative. The companies were honored today at the HDA Distribution Management Conference and Expo in Palm Desert, Calif.
Novartis and Sandoz Honored with Power of Partnership Award
/news/2019-06-03-novartis-and-sandoz-honored-with-power-of-partnership-award
Americares, in partnership with the Healthcare Distribution Alliance (HDA), has presented its annual Power of Partnership Award to Novartis and its Sandoz division, in recognition of their outstanding commitment to increasing access to health care around the world.
/news/2019-06-03-novartis-and-sandoz-honored-with-power-of-partnership-award
Americares, in partnership with the Healthcare Distribution Alliance (HDA), has presented its annual Power of Partnership Award to Novartis and its Sandoz division, in recognition of their outstanding commitment to increasing access to health care around the world.
HDA Expands Membership Offerings Through Addition of the Pharmaceutical Cargo Security Coalition
/news/2017-11-03-hda-announces-enhanced-membership-offering-through-pcsc
The Healthcare Distribution Alliance (HDA) today announces an expansion of its membership offerings and expertise by adding the Pharmaceutical Cargo Security Coalition (PCSC) to its organization. This new service offering will go into full effect as of January 1, 2018. PCSC’s founder, Chuck Forsaith, will continue to lead the coalition as Senior Director with HDA.
/news/2017-11-03-hda-announces-enhanced-membership-offering-through-pcsc
The Healthcare Distribution Alliance (HDA) today announces an expansion of its membership offerings and expertise by adding the Pharmaceutical Cargo Security Coalition (PCSC) to its organization. This new service offering will go into full effect as of January 1, 2018. PCSC’s founder, Chuck Forsaith, will continue to lead the coalition as Senior Director with HDA.
Supply Chain Security Leaders Honored at HDA's PCSC Educational Seminar
/news/2019-05-09-supply-chain-security-leaders-honored-at-hdas-pcsc-educational-seminar
/news/2019-05-09-supply-chain-security-leaders-honored-at-hdas-pcsc-educational-seminar
2020 BLC Online
//www.hda.org/events/2020-blc-online
The 2020 Business and Leadership Conference has been moved to an online format. Building on the strong attributes associated with our annual member conference, the HDA BLC Online will provide an opportunity to connect with your supply chain partners though a virtual setting.
//www.hda.org/events/2020-blc-online
The 2020 Business and Leadership Conference has been moved to an online format. Building on the strong attributes associated with our annual member conference, the HDA BLC Online will provide an opportunity to connect with your supply chain partners though a virtual setting.
Speaker Resource Center
//www.hda.org/events/speaker-resource-center
Congratulations! You have been invited to speak at a Healthcare Distribution Alliance (HDA) event. This resource center provides guidance on the various items HDA needs from you to properly market and promote your session; information about what to expect during the session; and tips for preparing a professional presentation. Please read through this information carefully.
//www.hda.org/events/speaker-resource-center
Congratulations! You have been invited to speak at a Healthcare Distribution Alliance (HDA) event. This resource center provides guidance on the various items HDA needs from you to properly market and promote your session; information about what to expect during the session; and tips for preparing a professional presentation. Please read through this information carefully.
2022 Business and Leadership Conference
//www.hda.org/events/2022-business-and-leadership-conference
HDA’s Business and Leadership Conference (BLC) is the healthcare distribution industry’s signature annual conference, developed by and for healthcare supply chain leaders and innovators.
//www.hda.org/events/2022-business-and-leadership-conference
HDA’s Business and Leadership Conference (BLC) is the healthcare distribution industry’s signature annual conference, developed by and for healthcare supply chain leaders and innovators.
2022 Distribution Management Conference and Expo
//www.hda.org/events/2022-distribution-management-conference-and-expo
The Distribution Management Conference and Expo is HDA's largest supply chain education event, attended by 600 manufacturers, distributors, consultants and third parties who keep the pharmaceutical distribution industry moving.
//www.hda.org/events/2022-distribution-management-conference-and-expo
The Distribution Management Conference and Expo is HDA's largest supply chain education event, attended by 600 manufacturers, distributors, consultants and third parties who keep the pharmaceutical distribution industry moving.
2023 Business and Leadership Conference
//www.hda.org/events/2023-business-and-leadership-conference
HDA’s Business and Leadership Conference (BLC) is the healthcare distribution industry’s signature annual conference, developed by and for healthcare supply chain leaders and innovators.
//www.hda.org/events/2023-business-and-leadership-conference
HDA’s Business and Leadership Conference (BLC) is the healthcare distribution industry’s signature annual conference, developed by and for healthcare supply chain leaders and innovators.
2020 Distribution Management Conference and Expo Canceled
//www.hda.org/events/2020-distribution-management-conference-and-expo
After much deliberation and thoughtful consideration, HDA has canceled the 2020 Distribution Management Conference and Expo (DMC) that was slated to begin Sunday, March 8, in San Diego.
//www.hda.org/events/2020-distribution-management-conference-and-expo
After much deliberation and thoughtful consideration, HDA has canceled the 2020 Distribution Management Conference and Expo (DMC) that was slated to begin Sunday, March 8, in San Diego.
HDA Statement on FDA Drug Importation Final Rule
/news/2020-09-25-hda-statement-on-fda-drug-importation-final-rule
In response to the Food and Drug Administration’s (FDA) final rule permitting prescription drug importation, Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr., released the following statement.
/news/2020-09-25-hda-statement-on-fda-drug-importation-final-rule
In response to the Food and Drug Administration’s (FDA) final rule permitting prescription drug importation, Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr., released the following statement.
Importation of Prescription Medicines
//www.hda.org/issues/importation-of-prescription-medicines
HDA opposes permitting the importation into the U.S. of pharmaceuticals sold or designated for sale in foreign countries. HDA firmly believes that allowing importation increases the likelihood of counterfeit or adulterated drugs entering the United States and will not ensure meaningful reductions in the cost of prescription drugs.
//www.hda.org/issues/importation-of-prescription-medicines
HDA opposes permitting the importation into the U.S. of pharmaceuticals sold or designated for sale in foreign countries. HDA firmly believes that allowing importation increases the likelihood of counterfeit or adulterated drugs entering the United States and will not ensure meaningful reductions in the cost of prescription drugs.
The First 90 Days: U.S. Biopharmaceutical Finished Goods Supply Chain Response to COVID-19
//www.hda.org/events/the-first-90-days-response-to-covid-19-webinar
Developed in collaboration with Deloitte Consulting LLP, the US Biopharmaceutical Finished Goods Supply Chain Response to COVID-19 report provides insights into the role that the supply chain played in ensuring delivery and availability of medicines during the first 90 days of the COVID-19 pandemic
//www.hda.org/events/the-first-90-days-response-to-covid-19-webinar
Developed in collaboration with Deloitte Consulting LLP, the US Biopharmaceutical Finished Goods Supply Chain Response to COVID-19 report provides insights into the role that the supply chain played in ensuring delivery and availability of medicines during the first 90 days of the COVID-19 pandemic
HDA Announces Robert Mauch and Chad Gielen to Lead Board of Directors
/news/2020-10-05-hda-announces-mauch-and-gielen-to-lead-board
The Healthcare Distribution Alliance today announces the election of Robert Mauch, PharmD, PhD, EVP and Group President of AmerisourceBergen Corporation, as Chairman of the HDA Board of Directors. Chad Gielen, President/CEO of Louisiana Wholesale Drug Co. Inc., will serve as Vice Chairman.
/news/2020-10-05-hda-announces-mauch-and-gielen-to-lead-board
The Healthcare Distribution Alliance today announces the election of Robert Mauch, PharmD, PhD, EVP and Group President of AmerisourceBergen Corporation, as Chairman of the HDA Board of Directors. Chad Gielen, President/CEO of Louisiana Wholesale Drug Co. Inc., will serve as Vice Chairman.
HDA's PCSC Recognizes Supply Chain Security Leaders
/news/2020-10-08-supply-chain-security-leaders-recognized
HDA’s Pharmaceutical Cargo Security Coalition recognized three outstanding supply chain security professionals today through the annual PCSC Awards.
/news/2020-10-08-supply-chain-security-leaders-recognized
HDA’s Pharmaceutical Cargo Security Coalition recognized three outstanding supply chain security professionals today through the annual PCSC Awards.
HDA Releases Policy Principles for COVID-19 Vaccine Distribution
/news/2020-10-08-hda-releases-policy-principles-for-covid19-vaccine-distribution
The Healthcare Distribution Alliance (HDA) today released policy principles reaffirming the pharmaceutical distribution industry’s commitment to ensuring — in partnership with federal and state governments — the safe and efficient distribution of COVID-19 vaccines once they are approved by the Food and Drug Administration.
/news/2020-10-08-hda-releases-policy-principles-for-covid19-vaccine-distribution
The Healthcare Distribution Alliance (HDA) today released policy principles reaffirming the pharmaceutical distribution industry’s commitment to ensuring — in partnership with federal and state governments — the safe and efficient distribution of COVID-19 vaccines once they are approved by the Food and Drug Administration.
HDA Statement on FDA’s Drug Supply Chain Security Act-Related Enforcement Discretion
/news/2020-10-22-hda-statement-on-fda-dscsa-enforcement-discretion
In response to the Food and Drug Administration’s (FDA) decision to extend enforcement discretion related to certain Drug Supply Chain Security Act requirements, the Healthcare Distribution Alliance (HDA) released the following statement.
/news/2020-10-22-hda-statement-on-fda-dscsa-enforcement-discretion
In response to the Food and Drug Administration’s (FDA) decision to extend enforcement discretion related to certain Drug Supply Chain Security Act requirements, the Healthcare Distribution Alliance (HDA) released the following statement.
US Biopharmaceutical Supply Chain Resilient and Effective During Early COVID-19 Response
/news/2020-10-26-us-biopharma-supply-chain-resilient-during-early-covid19
A report published by the Healthcare Distribution Alliance (HDA) Research Foundation and Deloitte Consulting LLP found that during the first 90 days of the COVID-19 pandemic, the biopharmaceutical finished goods industry quickly adapted and adjusted to deliver medicines safely and efficiently to patients, with only minimal disruptions.
/news/2020-10-26-us-biopharma-supply-chain-resilient-during-early-covid19
A report published by the Healthcare Distribution Alliance (HDA) Research Foundation and Deloitte Consulting LLP found that during the first 90 days of the COVID-19 pandemic, the biopharmaceutical finished goods industry quickly adapted and adjusted to deliver medicines safely and efficiently to patients, with only minimal disruptions.
2020 HDA PCSC Online Seminar
//www.hda.org/events/2020-hda-pcsc-educational-seminar
HDA's 2020 Pharmaceutical Cargo Security Coalition (PCSC) Educational Seminar will now take place virtually. The Pharmaceutical Cargo Security Coalition (PCSC) Online Seminar will bring together those within healthcare, as well as many other industries, that ship and store sensitive, high-risk/high-value products — anywhere in the world.
//www.hda.org/events/2020-hda-pcsc-educational-seminar
HDA's 2020 Pharmaceutical Cargo Security Coalition (PCSC) Educational Seminar will now take place virtually. The Pharmaceutical Cargo Security Coalition (PCSC) Online Seminar will bring together those within healthcare, as well as many other industries, that ship and store sensitive, high-risk/high-value products — anywhere in the world.
EDI Guidelines for 810 Invoice
/resources/edi-guidelines-for-810-invoice
Developed by HDMA’s eCommerce Task Force, the 810 Invoice Guidelines for EDI support the order-to-cash cycle.
/resources/edi-guidelines-for-810-invoice
Developed by HDMA’s eCommerce Task Force, the 810 Invoice Guidelines for EDI support the order-to-cash cycle.
EDI Guidelines for 845 844 849 Contract and Chargeback Administration
/resources/edi-guidelines-for-845-844-849-contract-and-chargeback-administration
Developed by HDMA’s eCommerce Task Force, these three electronic data interchange (EDI) sets are used to administer contract and chargeback transactions.
/resources/edi-guidelines-for-845-844-849-contract-and-chargeback-administration
Developed by HDMA’s eCommerce Task Force, these three electronic data interchange (EDI) sets are used to administer contract and chargeback transactions.
EDI Guidelines for 180 Return Merchandise Authorization/Notification and 812 Credit/Debit Adjustment
/resources/edi-guidelines-for-180-and-812
Developed by HDMA’s eCommerce Task Force, these electronic data interchange sets provide guidance to trading partners on business practices related to merchandise returns and debit or memos that can be exchanged between distributors and manufacturers.
/resources/edi-guidelines-for-180-and-812
Developed by HDMA’s eCommerce Task Force, these electronic data interchange sets provide guidance to trading partners on business practices related to merchandise returns and debit or memos that can be exchanged between distributors and manufacturers.
CSOS Controlled Substance Ordering and Electronic Contract Re-Submittal Guidelines EDI
/resources/csos-controlled-substance-ordering-and-electronic-contract-re-submittal-guidelines-edi
This easy-to-use, tandem reference tool includes information and guidelines in support of two distinct business processes: controlled substance ordering and electronic contract re-submittals.
/resources/csos-controlled-substance-ordering-and-electronic-contract-re-submittal-guidelines-edi
This easy-to-use, tandem reference tool includes information and guidelines in support of two distinct business processes: controlled substance ordering and electronic contract re-submittals.
A Snapshot of Returned Goods and Manufacturer Policies
/resources/a-snapshot-of-returned-goods-and-manufacturer-policies
Developed by HDMA’s Returns Task Force, this summary reports the volume and average dollar value of returned prescription and over-the-counter products processed by reverse logistics providers.
/resources/a-snapshot-of-returned-goods-and-manufacturer-policies
Developed by HDMA’s Returns Task Force, this summary reports the volume and average dollar value of returned prescription and over-the-counter products processed by reverse logistics providers.
2017 HDA Origin Update
/resources/webinar-2017-hda-origin-update
This webinar will provide a demonstration of HDA’s Origin — a high-powered, central data repository, hosting verified Global Trade Item Number (GTIN) information — and review key features of the service.
/resources/webinar-2017-hda-origin-update
This webinar will provide a demonstration of HDA’s Origin — a high-powered, central data repository, hosting verified Global Trade Item Number (GTIN) information — and review key features of the service.
Pharmacist and Patient Conversations at Independent Pharmacy
/resources/pharmacist-and-patient-conversations-at-independent-pharmacy
Each day pharmacists meet with patients to discuss their health and wellbeing. As part of that dialogue and as a normal course of business, pharmacists are suggesting non-prescription products — an average of six to 10 non-Rx recommendations each day.
/resources/pharmacist-and-patient-conversations-at-independent-pharmacy
Each day pharmacists meet with patients to discuss their health and wellbeing. As part of that dialogue and as a normal course of business, pharmacists are suggesting non-prescription products — an average of six to 10 non-Rx recommendations each day.
DSCSA 2023: A Look Ahead to Enhanced Traceability Requirements
/resources/webinar-dscsa-2023-a-look-ahead-to-enhanced-traceability-requirements
This webinar will examine the 2023 provisions to facilitate unit-level traceability across the U.S. supply chain, including changes in transaction data, trading partner obligations in the event of certain investigations, when verification is and is not mandated and how the statute addresses inference and aggregation.
/resources/webinar-dscsa-2023-a-look-ahead-to-enhanced-traceability-requirements
This webinar will examine the 2023 provisions to facilitate unit-level traceability across the U.S. supply chain, including changes in transaction data, trading partner obligations in the event of certain investigations, when verification is and is not mandated and how the statute addresses inference and aggregation.
Role of the Specialty Distributor in the Pharmaceuticals Value Chain
/resources/role-of-the-specialty-distributor-in-the-pharmaceutical-value-chain
Through interviews, survey work and secondary data, Role of Distributors in the U.S. Specialty Pharmaceutical Value Chain provides an understanding of the role distributors play to ensure the efficient and effective distribution of specialty medications.
/resources/role-of-the-specialty-distributor-in-the-pharmaceutical-value-chain
Through interviews, survey work and secondary data, Role of Distributors in the U.S. Specialty Pharmaceutical Value Chain provides an understanding of the role distributors play to ensure the efficient and effective distribution of specialty medications.
HDMA's Practical Tips to Address Returns Drivers
/resources/practical-tips-to-address-returns-drivers
This article identifies ways to reduce unsalable returns and reduce supply chain waste.
/resources/practical-tips-to-address-returns-drivers
This article identifies ways to reduce unsalable returns and reduce supply chain waste.
The Role of Reverse Distribution
/resources/the-role-of-reverse-distribution
Product returns are inevitable; annually, more than 120 million product units — exceeding $13 billion in value — move through the reverse distribution process.
/resources/the-role-of-reverse-distribution
Product returns are inevitable; annually, more than 120 million product units — exceeding $13 billion in value — move through the reverse distribution process.
GLN Adoption for the Pharmaceutical Supply Chain
/resources/gln-adoption-for-the-pharmaceutical-supply-chain
This paper further explains the process used to evaluate the numbering schema used by the pharmaceutical supply chain.
/resources/gln-adoption-for-the-pharmaceutical-supply-chain
This paper further explains the process used to evaluate the numbering schema used by the pharmaceutical supply chain.
HDMA Returned Goods Debit Memo Template
/resources/hdma-returned-goods-debit-memo-template
Trading partners may use this sample returned goods debit memo template to clearly convey the pertinent information about returned pharmaceuticals and facilitate the credit reconciliation process.
/resources/hdma-returned-goods-debit-memo-template
Trading partners may use this sample returned goods debit memo template to clearly convey the pertinent information about returned pharmaceuticals and facilitate the credit reconciliation process.
HDMA Guidelines for Managing Cold Chain and Temperature Sensitive Products
/resources/hdma-guidelines-for-managing-cold-chain-and-temperature-sensitive-products
From the point of receipt by a distributor to the point of delivery to a customer, the proper temperature of cold chain or frozen products must be maintained during product storage and transportation.
/resources/hdma-guidelines-for-managing-cold-chain-and-temperature-sensitive-products
From the point of receipt by a distributor to the point of delivery to a customer, the proper temperature of cold chain or frozen products must be maintained during product storage and transportation.
HDMA Security Guidelines Protecting Last Mile Pharmaceutical Shipments
/resources/hdma-security-guidelines-protecting-last-mile-pharmaceutical-shipments
Violent attacks are increasing in the last mile for pharmaceutical supply chain distribution. These suggested guidelines offer companies seeking to strengthen their in-transit security program a directed approach to reducing risk.
/resources/hdma-security-guidelines-protecting-last-mile-pharmaceutical-shipments
Violent attacks are increasing in the last mile for pharmaceutical supply chain distribution. These suggested guidelines offer companies seeking to strengthen their in-transit security program a directed approach to reducing risk.
Supply Chain Security Guidelines
/resources/supply-chain-security-guidelines
Developed by HDMA’s Logistics Operations Committee, these guidelines outline steps pharmaceutical supply chain stakeholders can take to protect products while in transit.
/resources/supply-chain-security-guidelines
Developed by HDMA’s Logistics Operations Committee, these guidelines outline steps pharmaceutical supply chain stakeholders can take to protect products while in transit.
Understanding the Drivers of Expired Pharmaceutical Returns
/resources/understanding-the-drivers-of-expired-pharmaceutical-returns
Developed for HDMA’s Returns Task Force (RTF) by Raftery Resource Network, this report describes the major causes of unsalable pharmaceutical returns and actions an individual company may take to address and evaluate progress in decreasing them.
/resources/understanding-the-drivers-of-expired-pharmaceutical-returns
Developed for HDMA’s Returns Task Force (RTF) by Raftery Resource Network, this report describes the major causes of unsalable pharmaceutical returns and actions an individual company may take to address and evaluate progress in decreasing them.
Supply Chain Collaboration: Maximizing Health, Beauty and Wellness Product Sales in Independent Pharmacy
/resources/supply-chain-collaboration
This white paper, produced by Hamacher Resource Group in partnership with HDMA and the Consumer Healthcare Products Association (CHPA), identifies six health, beauty and wellness (HBW) categories that have experienced increased sales within the independent pharmacy sector and now outpace the food, drug and mass channels.
/resources/supply-chain-collaboration
This white paper, produced by Hamacher Resource Group in partnership with HDMA and the Consumer Healthcare Products Association (CHPA), identifies six health, beauty and wellness (HBW) categories that have experienced increased sales within the independent pharmacy sector and now outpace the food, drug and mass channels.
HDMA White Paper on Product Availability
/resources/hdma-white-paper-on-product-availability
This white paper provides a brief overview of the pharmaceutical supply chain, product supply issues and current processes that can result in product shortages.
/resources/hdma-white-paper-on-product-availability
This white paper provides a brief overview of the pharmaceutical supply chain, product supply issues and current processes that can result in product shortages.
HDMA Guidelines for Optimizing the Contract Administration and Chargeback Process
/resources/hdma-guidelines-for-optimizing-the-contract-administration-and-chargeback-process
These guidelines educate trading partners across the healthcare supply chain in the processes used for the negotiation and administration of contracts, as well as the submission, validation and reconciliation of chargebacks.
/resources/hdma-guidelines-for-optimizing-the-contract-administration-and-chargeback-process
These guidelines educate trading partners across the healthcare supply chain in the processes used for the negotiation and administration of contracts, as well as the submission, validation and reconciliation of chargebacks.
/resources/webinar-are-you-ready-communicating-product-information-through-hda-origin
(Webinar date: June 25, 2018) The federal deadline is approaching for all Rx products to be marked by new Global Trade Item Numbers (GTINs), the crucial identifier that links a scan of a barcode to the data associated with that product.
The 340B Drug Pricing Program: Evolution and Looking Forward
/resources/the-340b-drug-pricing-program-evolution-and-looking-forward
Since 1992, the 340B Drug Pricing Program has played a modest, but increasingly important, role in the U.S. healthcare market.
/resources/the-340b-drug-pricing-program-evolution-and-looking-forward
Since 1992, the 340B Drug Pricing Program has played a modest, but increasingly important, role in the U.S. healthcare market.
Loss of Exclusivity: An Inventory Management Case Study
/resources/loss-of-exclusivity
This report focuses on the opportunities to improve communications between trading partners as a branded pharmaceutical product nears the end of its patent protection to better manage inventory and reduce costly returns.
/resources/loss-of-exclusivity
This report focuses on the opportunities to improve communications between trading partners as a branded pharmaceutical product nears the end of its patent protection to better manage inventory and reduce costly returns.
Returns Logistics Practices
/resources/returns-logistics-practices
This publication recommends process improvements for returned and/or unsalable healthcare products.
/resources/returns-logistics-practices
This publication recommends process improvements for returned and/or unsalable healthcare products.
EDI Guidelines for 845 Price Authorization Acknowledgment/Status (2019)
/resources/edi-guidelines-for-845-price-authorization-acknowledgment-status-2019
Developed by HDA’s eCommerce Task Force, this electronic data interchange (EDI) set is intended for use in the healthcare manufacturer bid award/change notice process.
/resources/edi-guidelines-for-845-price-authorization-acknowledgment-status-2019
Developed by HDA’s eCommerce Task Force, this electronic data interchange (EDI) set is intended for use in the healthcare manufacturer bid award/change notice process.
2020 Serialization Readiness Survey
/resources/2020-serialization-readiness-survey
The fifth edition of the HDA Research Foundation's survey provides objective data on the current readiness of manufacturers and distributors to meet Drug Supply Chain Security Act (DSCSA) requirements.
/resources/2020-serialization-readiness-survey
The fifth edition of the HDA Research Foundation's survey provides objective data on the current readiness of manufacturers and distributors to meet Drug Supply Chain Security Act (DSCSA) requirements.
DSCSA Overview for Dispensers
/resources/webinar-dscsa-overview-for-dispensers
This webinar, designed for the dispenser audience ― including pharmacy, hospitals, healthcare providers and others who dispense prescription pharmaceuticals ― provides an overview of the Drug Supply Chain Security Act (DSCSA), which paved the way for a single, federal framework to trace prescription medications through the supply chain.
/resources/webinar-dscsa-overview-for-dispensers
This webinar, designed for the dispenser audience ― including pharmacy, hospitals, healthcare providers and others who dispense prescription pharmaceuticals ― provides an overview of the Drug Supply Chain Security Act (DSCSA), which paved the way for a single, federal framework to trace prescription medications through the supply chain.
EPA Proposed Rule on Hazardous Waste Pharmaceuticals
/resources/webinar-epa-waste-rule
Designed for reverse distributors, hazardous waste handlers, healthcare facilities and others who support hazardous waste management activities, this webinar provides an overview on the EPA’s proposed rule, “Management Standards for Hazardous Waste Pharmaceuticals.”
/resources/webinar-epa-waste-rule
Designed for reverse distributors, hazardous waste handlers, healthcare facilities and others who support hazardous waste management activities, this webinar provides an overview on the EPA’s proposed rule, “Management Standards for Hazardous Waste Pharmaceuticals.”
HDA Saleable Returns Pilots Report
/resources/hda-saleable-returns-pilots-report
This report summarizes the results of the pilot study conducted by HDA, working with Ernst & Young LLP (EY) and HDA’s Traceability Pilots Work Group (Work Group).
/resources/hda-saleable-returns-pilots-report
This report summarizes the results of the pilot study conducted by HDA, working with Ernst & Young LLP (EY) and HDA’s Traceability Pilots Work Group (Work Group).
HDMA ASN Exceptions Guidelines for the DSCSA
/resources/hdma-asn-exceptions-guidelines-for-the-dscsa
These guidelines offer HDMA’s interpretation of how trading partners might choose to address the exceptions that may arise when passing the information required by the Drug Supply Chain Security Act (DSCSA).
/resources/hdma-asn-exceptions-guidelines-for-the-dscsa
These guidelines offer HDMA’s interpretation of how trading partners might choose to address the exceptions that may arise when passing the information required by the Drug Supply Chain Security Act (DSCSA).
Independent Pharmacy Front-End Opportunities – Infographics
/resources/independent-pharmacy-front-end-opportunity-infographics
This series of infographics highlights key findings from research conducted by Hamacher Resource Group focusing on the opportunities for supply chain partnerships that support the front-of-store in independent pharmacy.
/resources/independent-pharmacy-front-end-opportunity-infographics
This series of infographics highlights key findings from research conducted by Hamacher Resource Group focusing on the opportunities for supply chain partnerships that support the front-of-store in independent pharmacy.
HDA Guidelines for Bar Coding in the Pharmaceutical Supply Chain
/resources/hda-guidelines-for-bar-coding-in-the-pharmaceutical-supply-chain
HDA’s Guidelines for Bar Coding in the Pharmaceutical Supply Chain provides specifications for bar coding and labeling healthcare products.
/resources/hda-guidelines-for-bar-coding-in-the-pharmaceutical-supply-chain
HDA’s Guidelines for Bar Coding in the Pharmaceutical Supply Chain provides specifications for bar coding and labeling healthcare products.
FDA Perspectives on Implementation of the Drug Supply Chain Security Act
/resources/webinar-fda-perspectives-on-implmentation-of-the-dscsa
/resources/webinar-fda-perspectives-on-implmentation-of-the-dscsa
The Drug Quality and Security Act (H.R. 3204): A Traceability Overview
/resources/webinar-the-drug-quality-and-security-act
/resources/webinar-the-drug-quality-and-security-act
Serialization, Pedigree and Traceability: The Path to Data Exchange
/resources/webinar-the-path-to-data-exchange
/resources/webinar-the-path-to-data-exchange
DSCSA Overview for Association Partners
/resources/webinar-dscsa-for-association-partners
This webinar for prescription drug supply chain stakeholder associations provides an overview of the Drug Supply Chain Security Act (DSCSA), a single, federal framework for tracing prescription medications through the supply chain.
/resources/webinar-dscsa-for-association-partners
This webinar for prescription drug supply chain stakeholder associations provides an overview of the Drug Supply Chain Security Act (DSCSA), a single, federal framework for tracing prescription medications through the supply chain.
Health, Beauty & Wellness: Opportunities to Enhance Independent Pharmacy Services
/resources/health-beauty-and-wellness-opportunities-to-enhance-independent-pharmacy-services
Produced by HDMA in cooperation with Hamacher Research Group, this white paper identifies and explores the challenges and changes ahead that will test the industry, as pharmacies face new competitive pressures and reimbursement challenges.
/resources/health-beauty-and-wellness-opportunities-to-enhance-independent-pharmacy-services
Produced by HDMA in cooperation with Hamacher Research Group, this white paper identifies and explores the challenges and changes ahead that will test the industry, as pharmacies face new competitive pressures and reimbursement challenges.
Independent Pharmacy Shoppers
/resources/independent-pharmacy-shoppers
Produced by Hamacher Resource Group, in partnership with HDMA and its member sponsors, this study examines HBW/OTC shopper behaviors, the market basket and threats and opportunities in the independent pharmacy channel.
/resources/independent-pharmacy-shoppers
Produced by Hamacher Resource Group, in partnership with HDMA and its member sponsors, this study examines HBW/OTC shopper behaviors, the market basket and threats and opportunities in the independent pharmacy channel.
Driving Toward DSCSA Implementation
/resources/webinar-driving-toward-dscsa-implementation-managing-asn-exceptions
This webinar, designed for manufacturers and other supply chain parties supporting DSCSA implementation activities, provides an update on traceability implementation from a systems and technology perspective.
/resources/webinar-driving-toward-dscsa-implementation-managing-asn-exceptions
This webinar, designed for manufacturers and other supply chain parties supporting DSCSA implementation activities, provides an update on traceability implementation from a systems and technology perspective.
Dispenser Q-and-A for DSCSA
/resources/webinar-dispenser-q-and-a-for-dscsa
The Dispenser Q-and-A for DSCSA webinar is a follow-up to the HDMA April 21 Webinar: DSCSA Overview for Dispensers.
/resources/webinar-dispenser-q-and-a-for-dscsa
The Dispenser Q-and-A for DSCSA webinar is a follow-up to the HDMA April 21 Webinar: DSCSA Overview for Dispensers.
Understanding Pharmaceutical Distribution
/resources/2020-understanding-pharmaceutical-distribution
This new, interactive course is made up of 11 modules illustrating the key pharmaceutical supply chain stakeholders and their functions as products move from the manufacturer to the customer.
/resources/2020-understanding-pharmaceutical-distribution
This new, interactive course is made up of 11 modules illustrating the key pharmaceutical supply chain stakeholders and their functions as products move from the manufacturer to the customer.
The Role of Distributors in the US Health Care Industry
/resources/the-role-of-distributors-in-the-us-health-care-industry
Published in collaboration with Deloitte Consulting LLP, The Role of Distributors in the US Health Care Industry provides insights into the importance of wholesalers in driving efficiency and innovation across the pharmaceutical supply chain.
/resources/the-role-of-distributors-in-the-us-health-care-industry
Published in collaboration with Deloitte Consulting LLP, The Role of Distributors in the US Health Care Industry provides insights into the importance of wholesalers in driving efficiency and innovation across the pharmaceutical supply chain.
DSCSA Overview for NCPA Members
/resources/webinar-dscsa-overview-for-ncpa-members
This webinar, designed for the dispenser audience, provides an overview of the Drug Supply Chain Security Act (DSCSA), which enacted a single, federal framework for tracing prescription medications through the supply chain.
/resources/webinar-dscsa-overview-for-ncpa-members
This webinar, designed for the dispenser audience, provides an overview of the Drug Supply Chain Security Act (DSCSA), which enacted a single, federal framework for tracing prescription medications through the supply chain.
Change Leadership
/resources/webinar-change-leadership
Leading large-scale change is one of the most difficult challenges we will face during our careers. The most sought-after leaders know how to implement complex change in a way that achieves expected benefits and is grounded in respect for people. Additionally, the leadership actions that lead to successful change, whether small adjustments or enterprise transformation, are specific and repeatable. In this webinar, learn how to differentiate yourself and raise your level of influence through successful change leadership.
/resources/webinar-change-leadership
Leading large-scale change is one of the most difficult challenges we will face during our careers. The most sought-after leaders know how to implement complex change in a way that achieves expected benefits and is grounded in respect for people. Additionally, the leadership actions that lead to successful change, whether small adjustments or enterprise transformation, are specific and repeatable. In this webinar, learn how to differentiate yourself and raise your level of influence through successful change leadership.
EDI 849 Response to Product Transfer Account Adjustment
/resources/edi-guidelines-for-849
Developed by HDA’s eCommerce Task Force, this electronic data interchange (EDI) set is intended for use within the chargeback process (i.e., reconciliation).
/resources/edi-guidelines-for-849
Developed by HDA’s eCommerce Task Force, this electronic data interchange (EDI) set is intended for use within the chargeback process (i.e., reconciliation).
The First 90 Days: U.S. Biopharmaceutical Finished Goods Supply Chain Response to COVID-19
/resources/webinar-the-first-90-days
Developed in collaboration with Deloitte Consulting LLP, the US Biopharmaceutical Finished Goods Supply Chain Response to COVID-19 report provides insights into the role that the supply chain played in ensuring delivery and availability of medicines during the first 90 days of the COVID-19 pandemic.
/resources/webinar-the-first-90-days
Developed in collaboration with Deloitte Consulting LLP, the US Biopharmaceutical Finished Goods Supply Chain Response to COVID-19 report provides insights into the role that the supply chain played in ensuring delivery and availability of medicines during the first 90 days of the COVID-19 pandemic.
DSCSA Webinar: HDA 2019 Saleable Returns Requirements Pilot Update
/resources/webinar-hda-2019-saleable-returns-requirements-pilot-update
This webinar provides an update on the Alliance-led DSCSA pilot examining methods for verifying product identifiers as the supply chain prepares to meet the November 2019 deadline when wholesale distributors are required to certify serialized saleable pharmaceutical returns from customers.
/resources/webinar-hda-2019-saleable-returns-requirements-pilot-update
This webinar provides an update on the Alliance-led DSCSA pilot examining methods for verifying product identifiers as the supply chain prepares to meet the November 2019 deadline when wholesale distributors are required to certify serialized saleable pharmaceutical returns from customers.
Elements of Persuasion
/resources/webinar-elements-of-persuasion
This webinar will help participants determine the best way to create their message and learn the key principles of successful persuasion to effectively influence the audience.
/resources/webinar-elements-of-persuasion
This webinar will help participants determine the best way to create their message and learn the key principles of successful persuasion to effectively influence the audience.
Biosimilars: The State of the U.S. Market
/resources/biosimilars-the-state-of-the-us-market
This whitepaper provides an analysis of the current market for biosimilars in the U.S. through interviews conducted with senior executives from specialty pharmaceutical manufacturing and distribution companies.
/resources/biosimilars-the-state-of-the-us-market
This whitepaper provides an analysis of the current market for biosimilars in the U.S. through interviews conducted with senior executives from specialty pharmaceutical manufacturing and distribution companies.
Rutgers 2019 Final Project Presentation to HDA
/resources/webinar-rutgers-2019-final-project-presentation-to-hda
(Webinar Held: December 16, 2019) The HDA Research Foundation partnered with Rutgers University’s Business School for the fall 2019 semester.
/resources/webinar-rutgers-2019-final-project-presentation-to-hda
(Webinar Held: December 16, 2019) The HDA Research Foundation partnered with Rutgers University’s Business School for the fall 2019 semester.
America's Agenda: COVID-19 and a Responsive Rx Supply Chain
/resources/webinar-covid19-and-a-responsive-rx-supply-chain
Join HDA and The Hill for a virtual conversation between policymakers, health officials and healthcare stakeholders on ensuring resilience in the pharmaceutical supply chain — whether in the face of COVID-19 or future health crises.
/resources/webinar-covid19-and-a-responsive-rx-supply-chain
Join HDA and The Hill for a virtual conversation between policymakers, health officials and healthcare stakeholders on ensuring resilience in the pharmaceutical supply chain — whether in the face of COVID-19 or future health crises.
/resources/webinar-simplifying-your-master-data-workflow-with-hda-origin
(Webinar Held: November 28, 2018) The clock is ticking — and all Rx products packaged after November 27, 2019, will be serialized with GTINs printed on the packaging. In preparing for this deadline companies have been focused not only on the physical packages, but also the data that need to be communicated. To have serialized packages scanned and understood downstream, trading partners need master data.
Rutgers 2018 Final Project Presentation to HDA
/resources/webinar-rutgers-2018-final-project-presentation-to-hda
The HDA Research Foundation partnered with Rutgers University’s Business School for the fall 2018 semester.
/resources/webinar-rutgers-2018-final-project-presentation-to-hda
The HDA Research Foundation partnered with Rutgers University’s Business School for the fall 2018 semester.
The Risks and Realities of Commercial Drug Importation
/resources/the-risks-and-realities-of-commercial-drug-importation
This report explores proposed drug importation policy — in general, and with an emphasis on federal legislation proposed since 2013.
/resources/the-risks-and-realities-of-commercial-drug-importation
This report explores proposed drug importation policy — in general, and with an emphasis on federal legislation proposed since 2013.
Pharmacist and Patient Conversations at Independent Pharmacy
/resources/webinar-pharmacist-and-patient-conversations-at-independent-pharmacy
This webinar highlights the key findings from a new study released by HDMA, “Pharmacist and Patient Conversations at Independent Pharmacy” ― produced in cooperation with Hamacher Resource Group (HRG) ― which aims to bridge the gap between opportunity and execution in the non-prescription areas (front-of-store) of independent pharmacy.
/resources/webinar-pharmacist-and-patient-conversations-at-independent-pharmacy
This webinar highlights the key findings from a new study released by HDMA, “Pharmacist and Patient Conversations at Independent Pharmacy” ― produced in cooperation with Hamacher Resource Group (HRG) ― which aims to bridge the gap between opportunity and execution in the non-prescription areas (front-of-store) of independent pharmacy.
The Art of the Ask - Negotiating with Confidence
/resources/webinar-the-art-of-the-ask-negotiating-with-confidence
/resources/webinar-the-art-of-the-ask-negotiating-with-confidence
Prioritization Hacks: How to Maximize Your Day
/resources/webinar-prioritization-hacks-how-to-maximize-your-day
Overloaded inboxes, overflowing to-do lists, endless meetings and only one you. How could you possibly get everything done? You work late hours, bring work home and still the pile gets bigger.
/resources/webinar-prioritization-hacks-how-to-maximize-your-day
Overloaded inboxes, overflowing to-do lists, endless meetings and only one you. How could you possibly get everything done? You work late hours, bring work home and still the pile gets bigger.
The Role of Distributors in the US Health Care Industry
/resources/webinar-the-role-of-distributors-in-the-us-health-care-industry
/resources/webinar-the-role-of-distributors-in-the-us-health-care-industry
Leveraging 3PL Partnerships for Innovation and Reliability
/resources/webinar-leveraging-3pl-partnerships
(Webinar Held: October 21, 2020) Whether you are in the process of selecting a 3PL provider for a new product launch, or have an established relationship, productive partnerships between biopharma companies and 3PL providers can go beyond shipping product.
/resources/webinar-leveraging-3pl-partnerships
(Webinar Held: October 21, 2020) Whether you are in the process of selecting a 3PL provider for a new product launch, or have an established relationship, productive partnerships between biopharma companies and 3PL providers can go beyond shipping product.
HDMA Product Recall and Withdrawal Notification Guidelines
/resources/hdma-product-recall-and-withdrawal-notification-guidelines
Developed by HDMA’s Returns Task Force, these voluntary guidelines provide insights into industry recall and withdrawal practices, as well as strategies for manufacturers and distributors to effectively communicate product recall or withdrawal information to trading partners.
/resources/hdma-product-recall-and-withdrawal-notification-guidelines
Developed by HDMA’s Returns Task Force, these voluntary guidelines provide insights into industry recall and withdrawal practices, as well as strategies for manufacturers and distributors to effectively communicate product recall or withdrawal information to trading partners.
Origin: HDA's Product Data Source
/resources/webinar-origin-hdas-product-data-source
HDA’s Origin is an easy-to-use central data repository that will ensure the efficient and accurate exchange of pharmaceutical product master data between manufacturers and their supply chain partners. The repository stores Global Trade Item Numbers (GTINs), the critical product identifier that links a product with its master data to provide a foundation for the industry to initiate using the product identifier required by the Drug Supply Chain Security Act (DSCSA).
/resources/webinar-origin-hdas-product-data-source
HDA’s Origin is an easy-to-use central data repository that will ensure the efficient and accurate exchange of pharmaceutical product master data between manufacturers and their supply chain partners. The repository stores Global Trade Item Numbers (GTINs), the critical product identifier that links a product with its master data to provide a foundation for the industry to initiate using the product identifier required by the Drug Supply Chain Security Act (DSCSA).
Growth Drivers: The Factors Behind Independent Pharmacy OTC Sales
/resources/growth-drivers-the-factors-behind-independent-pharmacy-otc-sales
This white paper, produced by Hamacher Resource Group in partnership with HDMA and the Consumer Healthcare Products Association, is a follow-up to the 2011 white paper, “Supply Chain Collaboration: Maximizing Health, Beauty, and Wellness Product Sales in Independent Pharmacy.”
/resources/growth-drivers-the-factors-behind-independent-pharmacy-otc-sales
This white paper, produced by Hamacher Resource Group in partnership with HDMA and the Consumer Healthcare Products Association, is a follow-up to the 2011 white paper, “Supply Chain Collaboration: Maximizing Health, Beauty, and Wellness Product Sales in Independent Pharmacy.”
EDI Guidelines for 856 Advance Ship Notice
/resources/edi-guidelines-for-856-advance-ship-notice
This implementation guideline is intended to support compliance with the Drug Supply Chain Security Act (DSCSA) of 2013, Title II of the Drug Quality and Security Act. (Public Law 113-54).
/resources/edi-guidelines-for-856-advance-ship-notice
This implementation guideline is intended to support compliance with the Drug Supply Chain Security Act (DSCSA) of 2013, Title II of the Drug Quality and Security Act. (Public Law 113-54).
EDI Guidelines for 867 Product Transfer and Resale Report to Support Distributor Service Agreements
/resources/edi-guidelines-for-867-product-transfer-and-resale-report-to-support-distributor-service-agreements
Developed by HDMA’s eCommerce Task Force, this electronic data interchange (EDI) set supports the customary and established business and industry practices surrounding sales reporting.
/resources/edi-guidelines-for-867-product-transfer-and-resale-report-to-support-distributor-service-agreements
Developed by HDMA’s eCommerce Task Force, this electronic data interchange (EDI) set supports the customary and established business and industry practices surrounding sales reporting.
"GTIN 101" with GS1 and HDA
/resources/webinar-gtin-101-with-gs1-and-hda
This webinar, sponsored by Axway, introduces the Global Trade Item Number™ (GTIN®), and how to use this standard to uniquely identify your products in the pharmaceutical supply chain. GS1 US covers how to get a licensed GS1 company prefix, GTIN allocation, assigning indicator digits and how to build a product hierarchy. Participants then hear from a wholesale distributor on the importance of getting GTINs right and common mistakes currently seen today.
/resources/webinar-gtin-101-with-gs1-and-hda
This webinar, sponsored by Axway, introduces the Global Trade Item Number™ (GTIN®), and how to use this standard to uniquely identify your products in the pharmaceutical supply chain. GS1 US covers how to get a licensed GS1 company prefix, GTIN allocation, assigning indicator digits and how to build a product hierarchy. Participants then hear from a wholesale distributor on the importance of getting GTINs right and common mistakes currently seen today.
Tips for HDMA Mentees
/resources/webinar-tips-for-mentees
This webinar, designed for mentees participating in the HDMA Mentoring Program, provides tips on making the most of your relationships and answers some frequently asked questions.
/resources/webinar-tips-for-mentees
This webinar, designed for mentees participating in the HDMA Mentoring Program, provides tips on making the most of your relationships and answers some frequently asked questions.
Preparing for Serialization: HDMA Bar Coding Quick Start Guide Updates
/resources/webinar-preparing-for-serialization-hdma-bar-coding-quick-start-guide-updates
/resources/webinar-preparing-for-serialization-hdma-bar-coding-quick-start-guide-updates
Deciphering the Final AMP Rule
/resources/webinar-final-amp-rule
This webinar focuses on the changes to the calculation of Average Manufacturer Price (AMP) for products reimbursed through the Medicaid Program.
/resources/webinar-final-amp-rule
This webinar focuses on the changes to the calculation of Average Manufacturer Price (AMP) for products reimbursed through the Medicaid Program.
Tips for HDMA Mentors
/resources/webinar-tips-for-mentors
This webinar, designed for mentors participating in the HDMA Mentoring Program, provides tips on making the most of your relationships and answers some frequently asked questions.
/resources/webinar-tips-for-mentors
This webinar, designed for mentors participating in the HDMA Mentoring Program, provides tips on making the most of your relationships and answers some frequently asked questions.
2020 Understanding Specialty Distribution Presentation
/resources/2020-understanding-specialty-distribution-presentation
This turnkey presentation includes an explanation of the specialty pharmaceutical supply chain players and a discussion on the economics of specialty pharmaceutical distribution.
/resources/2020-understanding-specialty-distribution-presentation
This turnkey presentation includes an explanation of the specialty pharmaceutical supply chain players and a discussion on the economics of specialty pharmaceutical distribution.
EDI Guidelines for 850 Purchase Order
/resources/edi-guidelines-for-850-purchase-order
Developed by HDMA’s eCommerce Task Force, this electronic data interchange (EDI) transaction set supports the order-to-cash cycle.
/resources/edi-guidelines-for-850-purchase-order
Developed by HDMA’s eCommerce Task Force, this electronic data interchange (EDI) transaction set supports the order-to-cash cycle.
Management of Specialty Therapies in Today’s Complex Supply Chain
/resources/webinar-management-of-specialty-therapies
(Webinar Held: September 16) With more specialty medicines coming to market, the care coordination and financial management associated with high-value therapies is increasing in complexity. Cell and gene therapies have ushered in a new era of logistics where treatments are patient specific. At the same time, the financial management for these therapies is creating new paradigms for sites of care and biopharma sponsors.
/resources/webinar-management-of-specialty-therapies
(Webinar Held: September 16) With more specialty medicines coming to market, the care coordination and financial management associated with high-value therapies is increasing in complexity. Cell and gene therapies have ushered in a new era of logistics where treatments are patient specific. At the same time, the financial management for these therapies is creating new paradigms for sites of care and biopharma sponsors.
HDMA Recommendations for Securing Pharmaceutical Storage Facilities
/resources/hdma-recommendations-for-securing-pharmaceutical-storage-facilities
These recommendations suggest practices that a pharmaceutical entity could employ to identify and help minimize the risks associated with storing pharmaceutical products.
/resources/hdma-recommendations-for-securing-pharmaceutical-storage-facilities
These recommendations suggest practices that a pharmaceutical entity could employ to identify and help minimize the risks associated with storing pharmaceutical products.
EDI Guidelines for 852 Product Activity Data
/resources/edi-guidelines-for-852-product-activity-data
Developed by HDMA’s eCommerce Task Force, this electronic data interchange (EDI) set is designed to help distributors efficiently provide inventory, sales and other product information to manufacturers as part of service or inventory management agreements.
/resources/edi-guidelines-for-852-product-activity-data
Developed by HDMA’s eCommerce Task Force, this electronic data interchange (EDI) set is designed to help distributors efficiently provide inventory, sales and other product information to manufacturers as part of service or inventory management agreements.
EDI Guidelines for 855 Purchase Order Acknowledgement
/resources/edi-guidelines-for-855-purchase-order-acknowledgement
Updated by HDMA’s eCommerce Task Force, the 855 Purchase Order Acknowledgement Guidelines for EDI support the order-to-cash cycle. In this release, codes have been edited at the line level to indicate acceptance, rejection or backorder of an item.
/resources/edi-guidelines-for-855-purchase-order-acknowledgement
Updated by HDMA’s eCommerce Task Force, the 855 Purchase Order Acknowledgement Guidelines for EDI support the order-to-cash cycle. In this release, codes have been edited at the line level to indicate acceptance, rejection or backorder of an item.
HBW Webinar: Who Shops at the Independent Pharmacy?
/resources/hbw-webinar-independent-pharmacy
In this 2013 webinar, HDMA and Dave Wendland, Vice President, Hamacher Resource Group (HRG) present the results of a research study ― supported by members of HDMA’s Health, Beauty and Wellness Committee, and designed and conducted by HRG ― that explores how and why shoppers make their purchases at independent pharmacies.
/resources/hbw-webinar-independent-pharmacy
In this 2013 webinar, HDMA and Dave Wendland, Vice President, Hamacher Resource Group (HRG) present the results of a research study ― supported by members of HDMA’s Health, Beauty and Wellness Committee, and designed and conducted by HRG ― that explores how and why shoppers make their purchases at independent pharmacies.
Webinar: Leveraging EDI
/resources/webinar-leveraging-edi
Using EDI to accurately and efficiently exchange business transactions (i.e., purchase orders, acknowledgements, ship notices, invoices, etc.) between distributors and manufacturers in the healthcare supply chain is critical. The development and use of voluntary guidelines for specific EDI standards provide industry trading partners with a means to effectively convey the necessary information.
/resources/webinar-leveraging-edi
Using EDI to accurately and efficiently exchange business transactions (i.e., purchase orders, acknowledgements, ship notices, invoices, etc.) between distributors and manufacturers in the healthcare supply chain is critical. The development and use of voluntary guidelines for specific EDI standards provide industry trading partners with a means to effectively convey the necessary information.
Webinar: Leveraging Returns Data
/resources/webinar-leveraging-returns-data
As the use of electronic data interchange (EDI) standards has grown in recent years in forward logistics, companies have looked to leverage these transactions in reverse logistics. The exchange of electronic returns data can streamline the handling process and reduce the cycle time involved in processing returns.
/resources/webinar-leveraging-returns-data
As the use of electronic data interchange (EDI) standards has grown in recent years in forward logistics, companies have looked to leverage these transactions in reverse logistics. The exchange of electronic returns data can streamline the handling process and reduce the cycle time involved in processing returns.
HDA Research Foundation Survey Depicts Supply Chain's DSCSA Implementation Progress
/news/2020-11-02-foundation-survey-depicts-dscsa-preparedness
A survey released today by the Healthcare Distribution Alliance (HDA) Research Foundation indicates the pharmaceutical supply chain continues to make steady progress to comply with the 2013 Drug Supply Chain Security Act (DSCSA); however, some implementation priorities have shifted amid the initial industry response to the COVID-19 pandemic.
/news/2020-11-02-foundation-survey-depicts-dscsa-preparedness
A survey released today by the Healthcare Distribution Alliance (HDA) Research Foundation indicates the pharmaceutical supply chain continues to make steady progress to comply with the 2013 Drug Supply Chain Security Act (DSCSA); however, some implementation priorities have shifted amid the initial industry response to the COVID-19 pandemic.
HDA Statement on Proposed DEA Rule on Suspicious Orders
/news/2020-11-02-hda-statement-on-dea-som-proposal
Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr., released the following statement regarding the Drug Enforcement Administration’s (DEA) proposed rule on suspicious orders.
/news/2020-11-02-hda-statement-on-dea-som-proposal
Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr., released the following statement regarding the Drug Enforcement Administration’s (DEA) proposed rule on suspicious orders.
The U.S. Pharmaceutical Market During COVID-19
/resources/webinar-us-rx-market-during-covid19
COVID-19 continues to have a far-reaching effect on the nation's economy, including the pharmaceutical sector.
/resources/webinar-us-rx-market-during-covid19
COVID-19 continues to have a far-reaching effect on the nation's economy, including the pharmaceutical sector.
HDA Conferences and Seminars
//www.hda.org/events
HDA regularly brings members and key healthcare supply chain stakeholders together to share industry information, learn about best practices, and be introduced to new products and services.
//www.hda.org/events
HDA regularly brings members and key healthcare supply chain stakeholders together to share industry information, learn about best practices, and be introduced to new products and services.
HDA Statement on 2020 Presidential Election
/news/2020-11-08-hda-statement-on-2020-presidential-election
Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr., released the following statement.
/news/2020-11-08-hda-statement-on-2020-presidential-election
Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr., released the following statement.
2020 Traceability Online Seminar
//www.hda.org/events/2020-traceability-seminar
HDA's 2020 Traceability Seminar will now take place virtually. Implementation of the Drug Supply Chain Security Act (DSCSA) continues to transform the pharmaceutical supply chain. HDA’s annual Traceability Seminar brings together healthcare supply chain leaders to learn more about upcoming DSCSA implementation milestones — as well as innovative approaches and lessons learned — as distributors, manufacturers and dispensers implement serialization and traceability technologies to further preserve the safety and security of the healthcare supply chain.
//www.hda.org/events/2020-traceability-seminar
HDA's 2020 Traceability Seminar will now take place virtually. Implementation of the Drug Supply Chain Security Act (DSCSA) continues to transform the pharmaceutical supply chain. HDA’s annual Traceability Seminar brings together healthcare supply chain leaders to learn more about upcoming DSCSA implementation milestones — as well as innovative approaches and lessons learned — as distributors, manufacturers and dispensers implement serialization and traceability technologies to further preserve the safety and security of the healthcare supply chain.
Professional Development
//www.hda.org/professional-development
Convene: HDA’s Professional Development Program brings together supply chain executives and future leaders to create the next generation of distribution leaders, discuss unique experiences and share tips and tools for developing your career as an industry professional.
//www.hda.org/professional-development
Convene: HDA’s Professional Development Program brings together supply chain executives and future leaders to create the next generation of distribution leaders, discuss unique experiences and share tips and tools for developing your career as an industry professional.
Emerging Leaders
//www.hda.org/professional-development/emerging-leaders
To develop the next generation of supply chain leaders, the Healthcare Distribution Alliance (HDA) is further expanding its professional development program, Convene, to include the Emerging Leaders program.
//www.hda.org/professional-development/emerging-leaders
To develop the next generation of supply chain leaders, the Healthcare Distribution Alliance (HDA) is further expanding its professional development program, Convene, to include the Emerging Leaders program.
Mentoring Program
//www.hda.org/professional-development/mentoring
Since 2014, HDA's Mentoring Program has established professional relationships for more than 100 men and women, at all stages of their careers. Open to HDA members, the program pairs manufacturers with distributors or third-party service provider professionals to avoid conflicts of interest.
//www.hda.org/professional-development/mentoring
Since 2014, HDA's Mentoring Program has established professional relationships for more than 100 men and women, at all stages of their careers. Open to HDA members, the program pairs manufacturers with distributors or third-party service provider professionals to avoid conflicts of interest.
Women's Executive Forum
//www.hda.org/professional-development/womens-executive-forum
The Women’s Executive Forum, organized through HDA, is a network of female professionals brought together to discuss issues of common interest in the workplace.
//www.hda.org/professional-development/womens-executive-forum
The Women’s Executive Forum, organized through HDA, is a network of female professionals brought together to discuss issues of common interest in the workplace.
Industry Perspectives on the Personalized Medicine Supply Chain
/resources/industry-perspectives-on-the-personalized-medicine-supply-chain
Personalized medicine is a rapidly evolving and growing field. The shift from one-size-fits-all medicine to a more targeted, individualized approach has broad implications for the healthcare supply chain and its supporting services.
/resources/industry-perspectives-on-the-personalized-medicine-supply-chain
Personalized medicine is a rapidly evolving and growing field. The shift from one-size-fits-all medicine to a more targeted, individualized approach has broad implications for the healthcare supply chain and its supporting services.
Living at Work
/resources/webinar-living-at-work
(Webinar held: November 10, 2020) With the lines between work and life blurred during the pandemic, this professional development webinar explores how to strike a better balance during this uncertain time.
/resources/webinar-living-at-work
(Webinar held: November 10, 2020) With the lines between work and life blurred during the pandemic, this professional development webinar explores how to strike a better balance during this uncertain time.
HDA Statement on Drug Affordability Policies
/news/2020-11-23-hda-statement-on-drug-affordability-policies
HDA President and CEO Chester “Chip” Davis, Jr., released the following statement on the announcement by the Department of Health and Human Services (HHS) of an interim final rule to implement a “Most Favored Nation Model” for Medicare Part B and a final rule eliminating the prescription drug rebate system for Medicare Part D.
/news/2020-11-23-hda-statement-on-drug-affordability-policies
HDA President and CEO Chester “Chip” Davis, Jr., released the following statement on the announcement by the Department of Health and Human Services (HHS) of an interim final rule to implement a “Most Favored Nation Model” for Medicare Part B and a final rule eliminating the prescription drug rebate system for Medicare Part D.
Councils and Committees
//www.hda.org/about/councils-and-committees
HDA has a variety of standing or special councils, committees and task forces that operate at the direction of its Board of Directors.
//www.hda.org/about/councils-and-committees
HDA has a variety of standing or special councils, committees and task forces that operate at the direction of its Board of Directors.
91st Edition HDA Factbook: The Facts, Figures and Trends in Healthcare
/resources/91st-edition-hda-factbook-the-facts-figures-and-trends-in-healthcare
The 91st Edition HDA Factbook (2020–2021) provides comprehensive distribution performance metrics that highlight growth and trends in the pharmaceutical industry.
/resources/91st-edition-hda-factbook-the-facts-figures-and-trends-in-healthcare
The 91st Edition HDA Factbook (2020–2021) provides comprehensive distribution performance metrics that highlight growth and trends in the pharmaceutical industry.
HDA Resources
//www.hda.org/resources
HDA and the HDA Research Foundation produce a variety of resources to enhance the value of the supply chain and increase industry knowledge.
//www.hda.org/resources
HDA and the HDA Research Foundation produce a variety of resources to enhance the value of the supply chain and increase industry knowledge.
HDA Pharmaceutical Distributors Manage 93 Percent of 2019 U.S. Sales
/news/2020-12-03-distributors-manage-93-percent-of-us-sales
Data published today by the HDA Research Foundation reveal an estimated 93 percent of all U.S. pharmaceutical sales were completed through HDA-member traditional pharmaceutical distributors in 2019. As illustrated in the 91st Edition HDA Factbook, total distributor sales reached $519 billion.
/news/2020-12-03-distributors-manage-93-percent-of-us-sales
Data published today by the HDA Research Foundation reveal an estimated 93 percent of all U.S. pharmaceutical sales were completed through HDA-member traditional pharmaceutical distributors in 2019. As illustrated in the 91st Edition HDA Factbook, total distributor sales reached $519 billion.
Drug Product Availability
//www.hda.org/issues/drug-shortages
Drug shortages have challenged regulatory and supply chain stakeholders alike in recent years. While there are many factors that may result in a product being in short supply, HDA pharmaceutical distributor members play a central role in exchanging and coordinating information when a shortage occurs.
//www.hda.org/issues/drug-shortages
Drug shortages have challenged regulatory and supply chain stakeholders alike in recent years. While there are many factors that may result in a product being in short supply, HDA pharmaceutical distributor members play a central role in exchanging and coordinating information when a shortage occurs.
AAOA, NHMA Release Bilingual Toolkit Focused on Prescription Opioid Safety and Pain Management
/news/2020-12-08-aaoa-nhma-release-bilingual-toolkit
Allied Against Opioid Abuse (AAOA) and the National Hispanic Medical Association (NHMA) released a new suite of resources to help educate the Hispanic community about the rights, risks and responsibilities associated with prescription opioids. The toolkit was developed by an advisory committee of NHMA members and features resources available in both Spanish and English.
/news/2020-12-08-aaoa-nhma-release-bilingual-toolkit
Allied Against Opioid Abuse (AAOA) and the National Hispanic Medical Association (NHMA) released a new suite of resources to help educate the Hispanic community about the rights, risks and responsibilities associated with prescription opioids. The toolkit was developed by an advisory committee of NHMA members and features resources available in both Spanish and English.
2020 Specialty Pharmaceutical Distribution Facts, Figures and Trends
/resources/2020-specialty-pharmaceutical-distribution-facts-figures-and-trends
The 12th edition of the HDA Research Foundation’s annual benchmarking publication on specialty pharmaceuticals offers insight into this unique marketplace, and closely examines specialty distribution measures and trends.
/resources/2020-specialty-pharmaceutical-distribution-facts-figures-and-trends
The 12th edition of the HDA Research Foundation’s annual benchmarking publication on specialty pharmaceuticals offers insight into this unique marketplace, and closely examines specialty distribution measures and trends.
Analysis of Specialty Distributors Reveals Continued Growth
/news/2019-12-13-analysis-of-specialty-distributors-reveals-continued-growth
A new analysis published by the HDA Research Foundation indicates that oncology drugs, autoimmune and HIV therapeutics fueled specialty pharmaceutical segment growth in 2018. The 2019 Specialty Pharmaceutical Distribution: Facts, Figures and Trends indicates that oncology therapeutics account for most specialty distributor sales at 48.4 percent.
/news/2019-12-13-analysis-of-specialty-distributors-reveals-continued-growth
A new analysis published by the HDA Research Foundation indicates that oncology drugs, autoimmune and HIV therapeutics fueled specialty pharmaceutical segment growth in 2018. The 2019 Specialty Pharmaceutical Distribution: Facts, Figures and Trends indicates that oncology therapeutics account for most specialty distributor sales at 48.4 percent.
HDA Research Foundation Quantifies Efficiencies Provided by Specialty Rx Distributors
/news/2020-12-10-hda-foundation-quantifies-efficiencies-of-specialty-distribution
New data released by the HDA Research Foundation illustrate the continued supply chain efficiencies generated by HDA-member specialty distributors. According to the latest edition of Specialty Pharmaceutical Distribution: Facts, Figures and Trends, specialty distributors are a vital nexus between 176 manufacturers and more than 49,000 provider ship-to points for administration or dispensing to patients.
/news/2020-12-10-hda-foundation-quantifies-efficiencies-of-specialty-distribution
New data released by the HDA Research Foundation illustrate the continued supply chain efficiencies generated by HDA-member specialty distributors. According to the latest edition of Specialty Pharmaceutical Distribution: Facts, Figures and Trends, specialty distributors are a vital nexus between 176 manufacturers and more than 49,000 provider ship-to points for administration or dispensing to patients.
History
//www.hda.org/about/hda-history
HDA was founded as the Western Wholesale Druggists Association (WWDA) on March 15, 1876 at the Exchange Hall in Indianapolis.
//www.hda.org/about/hda-history
HDA was founded as the Western Wholesale Druggists Association (WWDA) on March 15, 1876 at the Exchange Hall in Indianapolis.
Mission and Values
//www.hda.org/about/mission-and-values
HDA is committed to and focused on the safety of the pharmaceutical supply chain.
//www.hda.org/about/mission-and-values
HDA is committed to and focused on the safety of the pharmaceutical supply chain.
Healthcare Affordability
//www.hda.org/issues/reimbursement-issues
With HDA distributors providing between $33–$53 billion in cost savings to the U.S. healthcare economy each year, our industry is committed to improving access to lower-cost, high-quality medicines for patients.
//www.hda.org/issues/reimbursement-issues
With HDA distributors providing between $33–$53 billion in cost savings to the U.S. healthcare economy each year, our industry is committed to improving access to lower-cost, high-quality medicines for patients.
HDA Statement on FDA Authorization of First COVID-19 Vaccine
/news/2020-12-11-hda-statement-on-fda-eua-of-covid19-vaccine
HDA President and CEO Chester “Chip” Davis, Jr., released the following statement on the U.S. Food and Drug Administration’s (FDA) decision to grant Emergency Use Authorization of the first COVID-19 vaccine, manufactured by Pfizer and BioNTech.
/news/2020-12-11-hda-statement-on-fda-eua-of-covid19-vaccine
HDA President and CEO Chester “Chip” Davis, Jr., released the following statement on the U.S. Food and Drug Administration’s (FDA) decision to grant Emergency Use Authorization of the first COVID-19 vaccine, manufactured by Pfizer and BioNTech.
Maximizing Your HDA Membership
/resources/webinar-maximizing-your-hda-membership
HDA wants to keep you informed of the many benefits of membership to you and your company.
/resources/webinar-maximizing-your-hda-membership
HDA wants to keep you informed of the many benefits of membership to you and your company.
Join HDA
//www.hda.org/about/membership
HDA membership provides access to networking opportunities, research, member-developed education and resources for the healthcare supply chain.
//www.hda.org/about/membership
HDA membership provides access to networking opportunities, research, member-developed education and resources for the healthcare supply chain.
Pharmaceutical Traceability
//www.hda.org/issues/pharmaceutical-traceability
HDA is now leading industry efforts to implement the 2013 Drug Supply Chain Security Act (DSCSA) that replaced a 50-state patchwork of pedigree requirements with one federal solution to trace prescription medications through the supply chain.
//www.hda.org/issues/pharmaceutical-traceability
HDA is now leading industry efforts to implement the 2013 Drug Supply Chain Security Act (DSCSA) that replaced a 50-state patchwork of pedigree requirements with one federal solution to trace prescription medications through the supply chain.
HDA Statement on FDA Authorization of Moderna Vaccine
/news/2020-12-18-hda-statement-on-fda-authorization-of-moderna-vaccine
HDA President and CEO Chester “Chip” Davis, Jr., released a statement following the U.S. Food and Drug Administration’s (FDA) granting of an Emergency Use Authorization for the Moderna COVID-19 vaccine candidate.
/news/2020-12-18-hda-statement-on-fda-authorization-of-moderna-vaccine
HDA President and CEO Chester “Chip” Davis, Jr., released a statement following the U.S. Food and Drug Administration’s (FDA) granting of an Emergency Use Authorization for the Moderna COVID-19 vaccine candidate.
Prescription Drug Abuse and Diversion
//www.hda.org/issues/prescription-drug-abuse-and-diversion
HDA and our primary pharmaceutical distributor members are committed to bringing industry and government together to tackle our nation’s complex prescription drug abuse and diversion epidemic, a serious healthcare challenge that threatens both patient safety and the security of the healthcare supply chain.
//www.hda.org/issues/prescription-drug-abuse-and-diversion
HDA and our primary pharmaceutical distributor members are committed to bringing industry and government together to tackle our nation’s complex prescription drug abuse and diversion epidemic, a serious healthcare challenge that threatens both patient safety and the security of the healthcare supply chain.
HDA Publications
//www.hda.org/foundation/resources
HDA and the HDA Research Foundation produce a variety of resources to enhance the value of the supply chain and increase industry knowledge.
//www.hda.org/foundation/resources
HDA and the HDA Research Foundation produce a variety of resources to enhance the value of the supply chain and increase industry knowledge.
Careers
//www.hda.org/about/careers
HDA proudly supports a positive working environment for our staff that allows each individual (and department) to deliver high-quality services to our members, which represent the vital link between the nation’s pharmaceutical manufacturers, pharmacies, hospitals and other providers.
//www.hda.org/about/careers
HDA proudly supports a positive working environment for our staff that allows each individual (and department) to deliver high-quality services to our members, which represent the vital link between the nation’s pharmaceutical manufacturers, pharmacies, hospitals and other providers.
2020 Annual Board and Membership Meeting
//www.hda.org/events/2020-annual-board-and-membership-meeting
The senior executives of HDA's active distributor member companies come together at the Annual Board and Membership Meeting to set the Alliance's strategy for the coming year and discuss developments in health policy and the pharmaceutical supply chain with national experts and thought leaders.
//www.hda.org/events/2020-annual-board-and-membership-meeting
The senior executives of HDA's active distributor member companies come together at the Annual Board and Membership Meeting to set the Alliance's strategy for the coming year and discuss developments in health policy and the pharmaceutical supply chain with national experts and thought leaders.
Scholarship Program
//www.hda.org/professional-development/scholarship-program
As part of its mission to foster industry knowledge, the HDA Research Foundation is expanding its offerings, via a graduate scholarship program, to help cultivate the next generation of supply chain leaders.
//www.hda.org/professional-development/scholarship-program
As part of its mission to foster industry knowledge, the HDA Research Foundation is expanding its offerings, via a graduate scholarship program, to help cultivate the next generation of supply chain leaders.
Scholarship Program
//www.hda.org/foundation/scholarship-program
As part of its mission to foster industry knowledge, the HDA Research Foundation is expanding its offerings, via a graduate scholarship program, to help cultivate the next generation of supply chain leaders.
//www.hda.org/foundation/scholarship-program
As part of its mission to foster industry knowledge, the HDA Research Foundation is expanding its offerings, via a graduate scholarship program, to help cultivate the next generation of supply chain leaders.
HDA Research Foundation Names Supply Chain Scholars
/news/2021-01-13-hda-research-foundation-names-supply-chain-scholars
The HDA Research Foundation has conferred four graduate-level scholarships to pharmaceutical supply chain leaders.
/news/2021-01-13-hda-research-foundation-names-supply-chain-scholars
The HDA Research Foundation has conferred four graduate-level scholarships to pharmaceutical supply chain leaders.
2021 Business and Leadership Conference
//www.hda.org/events/2021-business-and-leadership-conference
HDA’s Business and Leadership Conference (BLC) is the healthcare distribution industry’s signature annual conference, developed by and for healthcare supply chain leaders and innovators. Exclusive to HDA member companies, the conference brings together high-level executives, thought leaders and influential managers from across the healthcare supply chain to hold strategic business discussions on the most pressing industry issues.
//www.hda.org/events/2021-business-and-leadership-conference
HDA’s Business and Leadership Conference (BLC) is the healthcare distribution industry’s signature annual conference, developed by and for healthcare supply chain leaders and innovators. Exclusive to HDA member companies, the conference brings together high-level executives, thought leaders and influential managers from across the healthcare supply chain to hold strategic business discussions on the most pressing industry issues.
HDA Statement on Biden Administration COVID-19 Relief and Vaccine Distribution Plan
/news/2021-01-16-hda-statement-on-biden-administration-covid19-relief-and-vaccine-distribution
HDA President and CEO Chester “Chip” Davis, Jr., released a statement following President-elect Biden’s introduction of a COVID-19 vaccination plan.
/news/2021-01-16-hda-statement-on-biden-administration-covid19-relief-and-vaccine-distribution
HDA President and CEO Chester “Chip” Davis, Jr., released a statement following President-elect Biden’s introduction of a COVID-19 vaccination plan.
HDA Statement on COVID-19 Emergency Relief Package
/news/2020-12-22-hda-statment-on-covid-19-emergency-relief-package
HDA President and CEO Chester “Chip” Davis, Jr., released a statement commenting on passage of the COVID-19 emergency relief package by the U.S. House of Representatives and the U.S. Senate.
/news/2020-12-22-hda-statment-on-covid-19-emergency-relief-package
HDA President and CEO Chester “Chip” Davis, Jr., released a statement commenting on passage of the COVID-19 emergency relief package by the U.S. House of Representatives and the U.S. Senate.
HDA Statement on Biden-Harris Inauguration
/news/2021-01-20-hda-statement-on-biden-harris-inauguration
Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr., issued a statement on the inauguration of President Joe Biden and Vice President Kamala Harris.
/news/2021-01-20-hda-statement-on-biden-harris-inauguration
Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr., issued a statement on the inauguration of President Joe Biden and Vice President Kamala Harris.
2021 Traceability Seminar
//www.hda.org/events/2021-traceability-seminar
Implementation of the Drug Supply Chain Security Act (DSCSA) continues to transform the pharmaceutical supply chain. HDA’s annual Traceability Seminar brings together healthcare supply chain leaders to learn more about upcoming DSCSA implementation milestones — as well as innovative approaches and lessons learned — as distributors, manufacturers and dispensers implement serialization and traceability technologies to further preserve the safety and security of the healthcare supply chain.
//www.hda.org/events/2021-traceability-seminar
Implementation of the Drug Supply Chain Security Act (DSCSA) continues to transform the pharmaceutical supply chain. HDA’s annual Traceability Seminar brings together healthcare supply chain leaders to learn more about upcoming DSCSA implementation milestones — as well as innovative approaches and lessons learned — as distributors, manufacturers and dispensers implement serialization and traceability technologies to further preserve the safety and security of the healthcare supply chain.
News
/news
Read press releases, public testimony and executive statements about HDA's efforts on behalf of pharmaceutical distributors and the entire supply chain.
/news
Read press releases, public testimony and executive statements about HDA's efforts on behalf of pharmaceutical distributors and the entire supply chain.
HDA Statement on COVID-19 Vaccine Distribution and Role of Distribution Industry
/news/2021-01-22-hda-statement-on-covid19-vaccine-distribution-and-distributor-role
HDA President and CEO Chester “Chip” Davis, Jr., released the following statement in response to recent commentary related to the COVID-19 vaccination effort.
/news/2021-01-22-hda-statement-on-covid19-vaccine-distribution-and-distributor-role
HDA President and CEO Chester “Chip” Davis, Jr., released the following statement in response to recent commentary related to the COVID-19 vaccination effort.
COVID-19 Response
//www.hda.org/issues/covid19-response
HDA and its primary pharmaceutical distributor members — a critical link between 1,400 manufacturers and more than 180,000 healthcare providers — are continuing to rise to the challenge of the COVID-19 pandemic.
//www.hda.org/issues/covid19-response
HDA and its primary pharmaceutical distributor members — a critical link between 1,400 manufacturers and more than 180,000 healthcare providers — are continuing to rise to the challenge of the COVID-19 pandemic.
2021 Annual Board and Membership Meeting
//www.hda.org/events/2021-annual-board-and-membership-meeting
//www.hda.org/events/2021-annual-board-and-membership-meeting
2021 Distribution Management Conference and Expo
//www.hda.org/events/2021-distribution-management-conference-and-expo
The Distribution Management Conference and Expo is HDA's largest supply chain education event, attended by 600 manufacturers, distributors, consultants and third parties who keep the pharmaceutical distribution industry moving.
//www.hda.org/events/2021-distribution-management-conference-and-expo
The Distribution Management Conference and Expo is HDA's largest supply chain education event, attended by 600 manufacturers, distributors, consultants and third parties who keep the pharmaceutical distribution industry moving.
Michael Leiter
/persons/michael-leiter
Michael E. Leiter served as the director of the National Counterterrorism Center until July 2011, and is a National Security and Counterterrorism Analyst for NBC News.
/persons/michael-leiter
Michael E. Leiter served as the director of the National Counterterrorism Center until July 2011, and is a National Security and Counterterrorism Analyst for NBC News.
Scott Emerson
/persons/scott-emerson
Scott Emerson has over 30 years of experience with CPG companies and is the founder of The Emerson Group, a forward-thinking consumer products equity organization singularly focused on helping brands reach their maximum potential.
/persons/scott-emerson
Scott Emerson has over 30 years of experience with CPG companies and is the founder of The Emerson Group, a forward-thinking consumer products equity organization singularly focused on helping brands reach their maximum potential.
Lisa Scholz
/persons/lisa-scholz
Lisa Scholz joins Sentry as SVP of Market Strategy after three years as COO and SVP at 340B Health (formerly Safety Net Hospitals for Pharmaceutical Access, or SNHPA).
/persons/lisa-scholz
Lisa Scholz joins Sentry as SVP of Market Strategy after three years as COO and SVP at 340B Health (formerly Safety Net Hospitals for Pharmaceutical Access, or SNHPA).
Marijo Bustos
/persons/marijo-bustos
Marijo Bustos is the Manager of Chargebacks with Fresenius Kabi USA located in Lake Zurich, Illinois.
/persons/marijo-bustos
Marijo Bustos is the Manager of Chargebacks with Fresenius Kabi USA located in Lake Zurich, Illinois.
Chris Anderson
/persons/christopher-anderson
Chris Anderson is Director of Operations and has been with Cardinal Health, Inc. since 1987.
/persons/christopher-anderson
Chris Anderson is Director of Operations and has been with Cardinal Health, Inc. since 1987.
John Munson
/persons/john-munson
John Munson is the Vice President of Global Accounts at Mylan and is responsible for the account management of key customers across Europe and North America.
/persons/john-munson
John Munson is the Vice President of Global Accounts at Mylan and is responsible for the account management of key customers across Europe and North America.
Bill Henderson
/persons/bill-henderson
Bill Henderson is Executive Vice President, Commercial Development, for ValueCentric, LLC.
/persons/bill-henderson
Bill Henderson is Executive Vice President, Commercial Development, for ValueCentric, LLC.
Mick Ebeling
/persons/mick-ebeling
Mick Ebeling is a film/television/commercial producer, philanthropist, technology trailblazer, author, entrepreneur and public speaker, and is the CEO of Not Impossible Labs, whose mission is to develop creative solutions to address real-world problems.
/persons/mick-ebeling
Mick Ebeling is a film/television/commercial producer, philanthropist, technology trailblazer, author, entrepreneur and public speaker, and is the CEO of Not Impossible Labs, whose mission is to develop creative solutions to address real-world problems.
Stephen Kindler
/persons/stephen-kindler
Stephen Kindler is a founding partner of Kindler & Crimmins Associates, LLC (KCA).
/persons/stephen-kindler
Stephen Kindler is a founding partner of Kindler & Crimmins Associates, LLC (KCA).
Carla Howard
/persons/carla-howard
Carla Howard is a change management expert and a trusted advisor for leaders of transformational change initiatives.
/persons/carla-howard
Carla Howard is a change management expert and a trusted advisor for leaders of transformational change initiatives.
Miguel Rodriguez
/persons/miguel-rodriguez
Miguel Rodriguez is Senior Product Manager at CuraScript SD Specialty Distribution, An Express Scripts Company.
/persons/miguel-rodriguez
Miguel Rodriguez is Senior Product Manager at CuraScript SD Specialty Distribution, An Express Scripts Company.
Ronan Brett
/persons/ronan-brett
Ronan is a qualified pharmacist, and over the years has worked in a broad range of healthcare settings. He currently leads Celeiso’s External Affairs team.
/persons/ronan-brett
Ronan is a qualified pharmacist, and over the years has worked in a broad range of healthcare settings. He currently leads Celeiso’s External Affairs team.
Mark Caverly
/persons/mark-caverly
Mark W. Caverly is the Senior Regulatory Consultant at BuzzeoPDMA, now part of IMS Health.
/persons/mark-caverly
Mark W. Caverly is the Senior Regulatory Consultant at BuzzeoPDMA, now part of IMS Health.
Kevan MacKenzie
/persons/kevan-mackenzie
Kevan MacKenzie is Director, Serialization Technology and Six Sigma Blackbelt in the Information Technology Group at McKesson Corporation.
/persons/kevan-mackenzie
Kevan MacKenzie is Director, Serialization Technology and Six Sigma Blackbelt in the Information Technology Group at McKesson Corporation.
Cheryl Rice
/persons/cheryl-rice
Cheryl Rice delivers powerful seminars inspiring women to use their voice and vision for maximum impact.
/persons/cheryl-rice
Cheryl Rice delivers powerful seminars inspiring women to use their voice and vision for maximum impact.
Kay Morgan
/persons/kay-morgan
Kay Morgan is the Senior Vice President of Drug Products and Industry Standards Research and Compliance for Elsevier/Gold Standard. Kay’s responsibilities include product content for Elsevier/Gold Standard products and reviewing existing and new Elsevier/Gold Standard products for compliance with industry standards.
/persons/kay-morgan
Kay Morgan is the Senior Vice President of Drug Products and Industry Standards Research and Compliance for Elsevier/Gold Standard. Kay’s responsibilities include product content for Elsevier/Gold Standard products and reviewing existing and new Elsevier/Gold Standard products for compliance with industry standards.
Jon Andresen
/persons/jon-andresen
Jon Andresen is the President and Principal Consultant of Technology Solutions, an international aviation consultancy focusing on business and technology integration including Spec 2000 eBusiness, UID, RFID, bar coded part marking, part traceability, reliability, and data lifecycle. Clients include the US Dept. of Defense, Boeing, Boeing Helicopter, Bombardier, Honeywell, Fujitsu, Northrop Grumman and other major corporations.
/persons/jon-andresen
Jon Andresen is the President and Principal Consultant of Technology Solutions, an international aviation consultancy focusing on business and technology integration including Spec 2000 eBusiness, UID, RFID, bar coded part marking, part traceability, reliability, and data lifecycle. Clients include the US Dept. of Defense, Boeing, Boeing Helicopter, Bombardier, Honeywell, Fujitsu, Northrop Grumman and other major corporations.
Joshua Bolin
/persons/joshua-bolin
Josh Bolin is the Membership Relations and Government Affairs Director for the National Association of Boards of Pharmacy (NABP), an international organization whose membership includes every state board of pharmacy in the United States and state or provincial pharmacy regulating agencies in Canada, Australia, New Zealand and South Africa. Bolin joined NABP in late 2005
/persons/joshua-bolin
Josh Bolin is the Membership Relations and Government Affairs Director for the National Association of Boards of Pharmacy (NABP), an international organization whose membership includes every state board of pharmacy in the United States and state or provincial pharmacy regulating agencies in Canada, Australia, New Zealand and South Africa. Bolin joined NABP in late 2005
Bruce Harold
/persons/bruce-harold
Bruce Harold is the Manager, Software Engineering at The Harvard Drug Group, a Cardinal Health company.
/persons/bruce-harold
Bruce Harold is the Manager, Software Engineering at The Harvard Drug Group, a Cardinal Health company.
Julie Kuhn
/persons/julie-kuhn
Julie Kuhn is Vice President Supply Chain Integrity at H. D. Smith. Julie has more than 20 years of distribution experience, with over 10 years in pharmaceutical distribution
/persons/julie-kuhn
Julie Kuhn is Vice President Supply Chain Integrity at H. D. Smith. Julie has more than 20 years of distribution experience, with over 10 years in pharmaceutical distribution
Frank Lee
/persons/frank-lee
Frank Lee is Vice President, Strategic Development and Support with Smith Drug Company and is tasked with facilitating and guiding the analysis, plan development and implementation of a number of Smith's strategic initiatives.
/persons/frank-lee
Frank Lee is Vice President, Strategic Development and Support with Smith Drug Company and is tasked with facilitating and guiding the analysis, plan development and implementation of a number of Smith's strategic initiatives.
Charlie Cook
/persons/charlie-cook
Charlie Cook is Washington’s most trusted and most accurate voice on all things political. As the editor and publisher of The Cook Political Report, his prodigious writing is a direct line to the heart of politics.
/persons/charlie-cook
Charlie Cook is Washington’s most trusted and most accurate voice on all things political. As the editor and publisher of The Cook Political Report, his prodigious writing is a direct line to the heart of politics.
Fred Fieder
/persons/fred-fieder
In his current role, Fred Fieder is primarily responsible for Manufacturer Services across McKesson Financial Center in Carrollton, Texas.
/persons/fred-fieder
In his current role, Fred Fieder is primarily responsible for Manufacturer Services across McKesson Financial Center in Carrollton, Texas.
Liz Carbon
/persons/liz-carbon
Liz Carbon is a Vice President, National Accounts (Health Systems) working in the National Sales Department.
/persons/liz-carbon
Liz Carbon is a Vice President, National Accounts (Health Systems) working in the National Sales Department.
Dina Barton
/persons/dina-barton
Dina Barton is the Director of Contracts Administration. During her 16-year tenure at AmerisourceBergen, she has held various managerial positions within the Contracts and Chargebacks area.
/persons/dina-barton
Dina Barton is the Director of Contracts Administration. During her 16-year tenure at AmerisourceBergen, she has held various managerial positions within the Contracts and Chargebacks area.
Michael Nyenhuis
/persons/michael-nyenhuis
AmeriCares President and CEO Michael J. Nyenhuis leads a global health and emergency response organization increasing access to care in more than 90 countries.
/persons/michael-nyenhuis
AmeriCares President and CEO Michael J. Nyenhuis leads a global health and emergency response organization increasing access to care in more than 90 countries.
Kian Kazemi
/persons/kian-kazemi
Kian Kazemi is Vice President of Sales – Generics for Mallinckrodt Pharmaceuticals and has been in the pharmaceutical industry for over 23 years.
/persons/kian-kazemi
Kian Kazemi is Vice President of Sales – Generics for Mallinckrodt Pharmaceuticals and has been in the pharmaceutical industry for over 23 years.
Michael Murphy
/persons/michael-murphy
Michael Murphy is Political Strategist, Political Analyst for NBC News and Contributing Editor for TIME magazine.
/persons/michael-murphy
Michael Murphy is Political Strategist, Political Analyst for NBC News and Contributing Editor for TIME magazine.
Kimberly Mazza
/persons/kimberly-mazza
Kim Mazza is a Senior Consultant in Operations Technology at Cardinal Health with the responsibility of developing and implementing the DSCSA requirements for the Pharmaceutical Distribution operations teams.
/persons/kimberly-mazza
Kim Mazza is a Senior Consultant in Operations Technology at Cardinal Health with the responsibility of developing and implementing the DSCSA requirements for the Pharmaceutical Distribution operations teams.
Kevin Kallaugher
/persons/kevin-kallaugher
Kevin Kallaugher (Kal) is the international award-winning editorial cartoonist for the Economist and the Baltimore Sun.
/persons/kevin-kallaugher
Kevin Kallaugher (Kal) is the international award-winning editorial cartoonist for the Economist and the Baltimore Sun.
Andrew Wilson
/persons/andrew-wilson
Andrew Wilson is Vice President for 340B Solutions with McKesson and is responsible for guiding and coordinating McKesson 340B strategy and business oversight.
/persons/andrew-wilson
Andrew Wilson is Vice President for 340B Solutions with McKesson and is responsible for guiding and coordinating McKesson 340B strategy and business oversight.
Melissa Laber
/persons/melissa-laber
Melissa Laber is Senior Vice President, Global Sourcing for National Brands, and leads a team with responsibility for negotiation and management of branded fee-for-service agreements.
/persons/melissa-laber
Melissa Laber is Senior Vice President, Global Sourcing for National Brands, and leads a team with responsibility for negotiation and management of branded fee-for-service agreements.
JoAnn Gaio
/persons/joann-gaio
JoAnn Gaio has held a variety of Sales and Management positions at Upsher-Smith Laboratories, Inc. since joining them in 2001, both on the pharmaceutical side of the business, as well as with the Consumer Products business.
/persons/joann-gaio
JoAnn Gaio has held a variety of Sales and Management positions at Upsher-Smith Laboratories, Inc. since joining them in 2001, both on the pharmaceutical side of the business, as well as with the Consumer Products business.
Todd Hutsko
/persons/todd-hutsko
Todd Hutsko serves as Vice President of Sales for Fleet Laboratories responsible for Fleet’s North American business, where he is directly responsible for the consumer sales function that includes Customer Strategy, Shopper Marketing and Sales Operations.
/persons/todd-hutsko
Todd Hutsko serves as Vice President of Sales for Fleet Laboratories responsible for Fleet’s North American business, where he is directly responsible for the consumer sales function that includes Customer Strategy, Shopper Marketing and Sales Operations.
Kay Gard
/persons/kay-gard
Kay Gard is a Senior Manager in the Supply Chain Management group at Genentech.
/persons/kay-gard
Kay Gard is a Senior Manager in the Supply Chain Management group at Genentech.
Adrian Bailey
/persons/adrian-bailey
As a Healthcare Industry Engagement Consultant for GS1 US, Adrian Bailey is responsible for supporting GS1 US healthcare companies, both pharmaceutical and medical device.
/persons/adrian-bailey
As a Healthcare Industry Engagement Consultant for GS1 US, Adrian Bailey is responsible for supporting GS1 US healthcare companies, both pharmaceutical and medical device.
Ryan Kelly
/persons/ryan-kelly
Ryan Kelly is a Senior Manager in the Advisory Services practice of Ernst & Young LLP. He serves as a Serialization and Track-and-Trace Lead for the EY advisory practice and has 10 years of experience across pharmaceutical packaging distribution, mergers & acquisitions and business technology implementation.
/persons/ryan-kelly
Ryan Kelly is a Senior Manager in the Advisory Services practice of Ernst & Young LLP. He serves as a Serialization and Track-and-Trace Lead for the EY advisory practice and has 10 years of experience across pharmaceutical packaging distribution, mergers & acquisitions and business technology implementation.
Martha Torres-Morgan
/persons/martha-torres-morgan
Martha Torres-Morgan is the Vice President, Brand Program Management and has responsibility for providing strategic direction for critical new company-wide initiatives in Diabetic, Flu/Core Vaccine and Prescription Vials businesses, as well as to create opportunities and grow business across the Retail and Hospital customer segments.
/persons/martha-torres-morgan
Martha Torres-Morgan is the Vice President, Brand Program Management and has responsibility for providing strategic direction for critical new company-wide initiatives in Diabetic, Flu/Core Vaccine and Prescription Vials businesses, as well as to create opportunities and grow business across the Retail and Hospital customer segments.
Vincent Kosewski
/persons/vincent-kosewski
As Vice President, Supply Chain Operations at Sunovion Pharmaceuticals Inc., Vincent is responsible for contract manufacturing operations, production planning, technical services, warehousing and distribution.
/persons/vincent-kosewski
As Vice President, Supply Chain Operations at Sunovion Pharmaceuticals Inc., Vincent is responsible for contract manufacturing operations, production planning, technical services, warehousing and distribution.
Sean Spears
/persons/sean-spears
Sean Spears serves as the Senior Director of Trade and Pharmacy Relations and is responsible for business to business interactions with Eisai’s Direct Wholesale and Specialty Distributors along with downstream retail pharmacies and chains.
/persons/sean-spears
Sean Spears serves as the Senior Director of Trade and Pharmacy Relations and is responsible for business to business interactions with Eisai’s Direct Wholesale and Specialty Distributors along with downstream retail pharmacies and chains.
Vicki Einhellig
/persons/vicki-einhellig
Vicki Einhellig is a pharmacist and the President of Good Day Pharmacies in Northern Colorado.
/persons/vicki-einhellig
Vicki Einhellig is a pharmacist and the President of Good Day Pharmacies in Northern Colorado.
Mark Karhoff
/persons/mark-karhoff
Mark Karhoff is the Program Manager for the U.S. Serialization Program at Genentech.
/persons/mark-karhoff
Mark Karhoff is the Program Manager for the U.S. Serialization Program at Genentech.
Keith Vance
/persons/keith-vance
Keith is the owner and pharmacist manager of Lewisville Drug Company, a Mutual Drug independent pharmacy located in Lewisville, N.C.
/persons/keith-vance
Keith is the owner and pharmacist manager of Lewisville Drug Company, a Mutual Drug independent pharmacy located in Lewisville, N.C.
Brad Hood
/persons/brad-hood
Brad Hood is currently the Traceability Coordinator at H. D. Smith and has 15 years of experience in the Logistics and Supply Chain industry.
/persons/brad-hood
Brad Hood is currently the Traceability Coordinator at H. D. Smith and has 15 years of experience in the Logistics and Supply Chain industry.
Chuck Biss
/persons/chuck-biss
Chuck Biss is Senior Director, AIDC Healthcare at GS1. Active in the AIDC industry since 1973, he has focused on bar code, image analysis, scanning, verification and standards development, along with technical support as well as training and education.
/persons/chuck-biss
Chuck Biss is Senior Director, AIDC Healthcare at GS1. Active in the AIDC industry since 1973, he has focused on bar code, image analysis, scanning, verification and standards development, along with technical support as well as training and education.
James Stavridis
/persons/james-stavridis
A highly decorated Navy admiral and the longest-serving global combatant commander in recent American military history, James Stavridis is a “Renaissance Admiral” according to The New York Times.
/persons/james-stavridis
A highly decorated Navy admiral and the longest-serving global combatant commander in recent American military history, James Stavridis is a “Renaissance Admiral” according to The New York Times.
Nate Taninecz
/persons/nathan-taninecz
Since joining Product Management in 2011, Nate's focus has been on leading the design of new products and features for the Revenue Management Cloud Commercial Applications suite.
/persons/nathan-taninecz
Since joining Product Management in 2011, Nate's focus has been on leading the design of new products and features for the Revenue Management Cloud Commercial Applications suite.
Kathleen Kulp
/persons/kathleen-kulp
Kathleen Kulp is a Senior Principal with the Managed Markets Services practice of IMS Health with a focus in the Systems Integration Center of Excellence.
/persons/kathleen-kulp
Kathleen Kulp is a Senior Principal with the Managed Markets Services practice of IMS Health with a focus in the Systems Integration Center of Excellence.
Dave Ulrich
/persons/dave-ulrich
Dave Ulrich is the QA Director for Distribution and Logistics for AbbVie’s Global Pharmaceutical Operations (GPO) division.
/persons/dave-ulrich
Dave Ulrich is the QA Director for Distribution and Logistics for AbbVie’s Global Pharmaceutical Operations (GPO) division.
Lisa Gutierrez
/persons/lisa-gutierrez
Lisa Gutierrez serves as Vice President of Diversity and Inclusion for Cardinal Health and leads the development and deployment of strategies that support a diverse and inclusive culture and programs.
/persons/lisa-gutierrez
Lisa Gutierrez serves as Vice President of Diversity and Inclusion for Cardinal Health and leads the development and deployment of strategies that support a diverse and inclusive culture and programs.
Oliver Nuernberg
/persons/oliver-nuernberg
Dr. Oliver Nuernberg architected SAP’s Track-and-Trace strategy for the pharmaceutical industry.
/persons/oliver-nuernberg
Dr. Oliver Nuernberg architected SAP’s Track-and-Trace strategy for the pharmaceutical industry.
Maryann Nelson
/persons/maryann-nelson
Maryann Nelson is a Regulatory Manager with Cardinal Health, Inc. responsible for developing strategies to insure supply chain integrity, preventing prescription drug diversion and complying with state and federal legislative requirements.
/persons/maryann-nelson
Maryann Nelson is a Regulatory Manager with Cardinal Health, Inc. responsible for developing strategies to insure supply chain integrity, preventing prescription drug diversion and complying with state and federal legislative requirements.
Ming Chang
/persons/ming-chang
Ming Chang worked in SAP premium support focusing on the security of SAP solution for six years and recently joined the Cloud Information Security Awareness (CISA) team six months ago.
/persons/ming-chang
Ming Chang worked in SAP premium support focusing on the security of SAP solution for six years and recently joined the Cloud Information Security Awareness (CISA) team six months ago.
Erin Estey Hertzog
/persons/erin-estey-hertzog
Erin Estey Hertzog is the Director of Health Law and Policy at the Biotechnology Innovation Organization (BIO), where she advocates on behalf of the biopharmaceutical industry on topics related to the Medicare, Medicaid and Public Health Service (340B) programs at both the state and federal levels.
/persons/erin-estey-hertzog
Erin Estey Hertzog is the Director of Health Law and Policy at the Biotechnology Innovation Organization (BIO), where she advocates on behalf of the biopharmaceutical industry on topics related to the Medicare, Medicaid and Public Health Service (340B) programs at both the state and federal levels.
Tomas Rodriguez Weber
/persons/tomas-rodriguez-weber
Tomas Rodriguez Weber is currently an independent consultant and Executive President for Diprofar (Mexican Pharmaceutical Wholesaler Association).
/persons/tomas-rodriguez-weber
Tomas Rodriguez Weber is currently an independent consultant and Executive President for Diprofar (Mexican Pharmaceutical Wholesaler Association).
Dianne Pfahl
/persons/dianne-pfahl
Dianne Pfahl is the Vice President of Industry and Manufacturer Relations at Cardinal Health and has been an employee there for almost 15 years.
/persons/dianne-pfahl
Dianne Pfahl is the Vice President of Industry and Manufacturer Relations at Cardinal Health and has been an employee there for almost 15 years.
Mary Tim Smith
/persons/mary-tim-smith
Mary Tim (Timi) Smith is the Executive Vice President of R&S Northeast LLC and is responsible for the organization’s financial performance and the executive sponsor of the R&S Traceability Team.
/persons/mary-tim-smith
Mary Tim (Timi) Smith is the Executive Vice President of R&S Northeast LLC and is responsible for the organization’s financial performance and the executive sponsor of the R&S Traceability Team.
Machelle Neal
/persons/machelle-neal
Machelle Neal holds the position of Principal, U.S. Compliance for IMS Health (formerly BuzzeoPDMA).
/persons/machelle-neal
Machelle Neal holds the position of Principal, U.S. Compliance for IMS Health (formerly BuzzeoPDMA).
Jason Atlas
/persons/jason-atlas
Jason Atlas is responsible for educating directors of pharmacy, clinicians, and hospital executives on the value of the 340B program and of Apexus, as the 340B Prime Vendor.
/persons/jason-atlas
Jason Atlas is responsible for educating directors of pharmacy, clinicians, and hospital executives on the value of the 340B program and of Apexus, as the 340B Prime Vendor.
Chris Clement
/persons/chris-clement
Chris started with Apexus nearly 2 years ago, and is responsible for Apexus' authorized distributor network.
/persons/chris-clement
Chris started with Apexus nearly 2 years ago, and is responsible for Apexus' authorized distributor network.
Charles Bennett
/persons/charles-bennett
Charles Bennett is the Senior Director of Information Technology with Smith Drug Company.
/persons/charles-bennett
Charles Bennett is the Senior Director of Information Technology with Smith Drug Company.
Brian Purscell
/persons/brian-purscell
Brian Purscell has developed and launched programs that maximize efficiency and productivity with technology solutions.
/persons/brian-purscell
Brian Purscell has developed and launched programs that maximize efficiency and productivity with technology solutions.
Mike Kozin
/persons/mike-kozin
Mike Kozin is the Director of Sales, Drug Wholesale and Managed Markets at Reckitt Benckiser and is responsible for a variety of areas including: Drug Wholesale, Managed Care, Institutional Sales and Independent Pharmacy.
/persons/mike-kozin
Mike Kozin is the Director of Sales, Drug Wholesale and Managed Markets at Reckitt Benckiser and is responsible for a variety of areas including: Drug Wholesale, Managed Care, Institutional Sales and Independent Pharmacy.
Ilona Birenbaum
/persons/ilona-birenbaum
Ilona Birenbaum is a leadership and organizational consultant/leadership coach with over 20 years of experience and a diverse organizational development background.
/persons/ilona-birenbaum
Ilona Birenbaum is a leadership and organizational consultant/leadership coach with over 20 years of experience and a diverse organizational development background.
Susan Camean
/persons/susan-camean
Susan Camean is Vice President of Strategic Implementation at H. D. Smith, where she is currently developing a team of high performing future senior leaders.
/persons/susan-camean
Susan Camean is Vice President of Strategic Implementation at H. D. Smith, where she is currently developing a team of high performing future senior leaders.
Chad Snyder
/persons/chad-snyder
Chad has been with Cardinal for the last three years, and is currently a Supervisor in the Pharmaceutical Chargeback department.
/persons/chad-snyder
Chad has been with Cardinal for the last three years, and is currently a Supervisor in the Pharmaceutical Chargeback department.
Ted Peterson
/persons/ted-peterson
Ted Peterson is President of CPG Linkages, LLC, a corporate development firm helping trade associations and their members connect with each other and their retailer and wholesaler customers to identify and execute business growth opportunities.
/persons/ted-peterson
Ted Peterson is President of CPG Linkages, LLC, a corporate development firm helping trade associations and their members connect with each other and their retailer and wholesaler customers to identify and execute business growth opportunities.
Alex Kandybin
/persons/alex-kandybin
Dr. Kandybin is a Vice President with Strategy&, based in the New York office.
/persons/alex-kandybin
Dr. Kandybin is a Vice President with Strategy&, based in the New York office.
Jane McGonigal
/persons/jane-mcgonigal
Jane McGonigal is today's leading speaker on the engagement economy and the application of game-design to the real world.
/persons/jane-mcgonigal
Jane McGonigal is today's leading speaker on the engagement economy and the application of game-design to the real world.
Roxana Levine
/persons/roxana-levine
Roxana Levine has been with Innovatix for 10 years and is currently Senior Director, Contract Attachment. She works closely with wholesalers and manufacturers to verify member eligibility and confirm attachment to the Innovatix contract portfolios.
/persons/roxana-levine
Roxana Levine has been with Innovatix for 10 years and is currently Senior Director, Contract Attachment. She works closely with wholesalers and manufacturers to verify member eligibility and confirm attachment to the Innovatix contract portfolios.
Leslie Sanchez
/persons/leslie-sanchez
Since 2003, Leslie Sanchez has served as a leader in public opinion research specializing in presidential and statewide elections, as well as the women’s and Hispanic-Latino marketplace.
/persons/leslie-sanchez
Since 2003, Leslie Sanchez has served as a leader in public opinion research specializing in presidential and statewide elections, as well as the women’s and Hispanic-Latino marketplace.
Scott Sopher
/persons/scott-sopher
Scott is a Principal and is the Global Supply Chain Service Line Leader for Deloitte and has 30 years of supply chain and manufacturing experience in both consulting and industry.
/persons/scott-sopher
Scott is a Principal and is the Global Supply Chain Service Line Leader for Deloitte and has 30 years of supply chain and manufacturing experience in both consulting and industry.
Jeff Uligian
/persons/jeff-uligian
Jeff Uligian has been with Genentech for ten years and was responsible for opening the Kentucky Distribution Center in Louisville, Kentucky in 2006. He currently has process responsibility for all U.S. Commercial Distribution for Roche.
/persons/jeff-uligian
Jeff Uligian has been with Genentech for ten years and was responsible for opening the Kentucky Distribution Center in Louisville, Kentucky in 2006. He currently has process responsibility for all U.S. Commercial Distribution for Roche.
Bridgette Baker
/persons/bridgette-baker
Bridgette Baker is a Manager, Vendor & GPO Contract Operations with H. D. Smith where she is a member of the Finance Shared Services Team.
/persons/bridgette-baker
Bridgette Baker is a Manager, Vendor & GPO Contract Operations with H. D. Smith where she is a member of the Finance Shared Services Team.
Jeff Denton
/persons/jeff-denton
Over the last 12 years, Jeff has been very involved in a variety of aspects around the supply chain security initiative.
/persons/jeff-denton
Over the last 12 years, Jeff has been very involved in a variety of aspects around the supply chain security initiative.
John Gilbert
/persons/john-gilbert
John Gilbert is a Director with the law firm of Hyman, Phelps & McNamara, P.C. and advises clients extensively on legal and regulatory issues concerning controlled substances, prescription drugs, and precursor chemicals.
/persons/john-gilbert
John Gilbert is a Director with the law firm of Hyman, Phelps & McNamara, P.C. and advises clients extensively on legal and regulatory issues concerning controlled substances, prescription drugs, and precursor chemicals.
Teri Coward
/persons/teri-coward
Teri Coward serves as Senior Director of Sales and Trade Relations for Teva Pharmaceuticals USA.
/persons/teri-coward
Teri Coward serves as Senior Director of Sales and Trade Relations for Teva Pharmaceuticals USA.
Debbie Adair
/persons/debbie-adair
Debbie Adair is the Manager of Operations Support and Traceability at R&S Northeast LLC and is responsible for the implementation of systems and processes to support traceability and serialization.
/persons/debbie-adair
Debbie Adair is the Manager of Operations Support and Traceability at R&S Northeast LLC and is responsible for the implementation of systems and processes to support traceability and serialization.
Larry Sabato
/persons/larry-sabato
Dr. Larry J. Sabato is the founder and director of the University of Virginia Center for Politics and is also the University Professor of Politics at the University of Virginia.
/persons/larry-sabato
Dr. Larry J. Sabato is the founder and director of the University of Virginia Center for Politics and is also the University Professor of Politics at the University of Virginia.
Chris Reed
/persons/chris-reed
As Lead, Product Serialization and Traceability, Chris led a cross functional team to bring Johnson & Johnson to Drug Supply Chain Security Act Lot Level compliance.
/persons/chris-reed
As Lead, Product Serialization and Traceability, Chris led a cross functional team to bring Johnson & Johnson to Drug Supply Chain Security Act Lot Level compliance.
Quentin Dittman
/persons/quentin-dittman
Quentin has been with Cardinal Health for eight years and has held roles in corporate medical and pharmaceutical warehouse operations, and as a Lean Six Sigma Black Belt within the Operational Excellence team.
/persons/quentin-dittman
Quentin has been with Cardinal Health for eight years and has held roles in corporate medical and pharmaceutical warehouse operations, and as a Lean Six Sigma Black Belt within the Operational Excellence team.
Richard Sieg
/persons/richard-sieg
Richard joined Inmar as Regulatory Counsel in March 2014, managing legal and regulatory considerations for Inmar’s Healthcare and Supply Chain Networks.
/persons/richard-sieg
Richard joined Inmar as Regulatory Counsel in March 2014, managing legal and regulatory considerations for Inmar’s Healthcare and Supply Chain Networks.
Sue Pifer
/persons/sue-pifer
Sue Pifer is the Vice President of Compliance for the Retail Industry Leaders Association and currently leads RILA’s Environmental Compliance, Internal Audit and Financial Leadership Counsels.
/persons/sue-pifer
Sue Pifer is the Vice President of Compliance for the Retail Industry Leaders Association and currently leads RILA’s Environmental Compliance, Internal Audit and Financial Leadership Counsels.
Chris Giessinger
/persons/chris-giessinger
Chris has been in the pharmaceutical industry for over 16 years and has spent the majority of his career in trade distribution.
/persons/chris-giessinger
Chris has been in the pharmaceutical industry for over 16 years and has spent the majority of his career in trade distribution.
Dan Schawbel
/persons/dan-schawbel
Dan Schawbel is a New York Times bestselling author, serial entrepreneur, Fortune 500 consultant, millennial TV personality, global keynote speaker, career and workplace expert and startup advisor.
/persons/dan-schawbel
Dan Schawbel is a New York Times bestselling author, serial entrepreneur, Fortune 500 consultant, millennial TV personality, global keynote speaker, career and workplace expert and startup advisor.
Sergio Santiviago
/persons/sergio-santiviago
Sergio is Director of Government Affairs for Express Scripts Holding Company and develops and advocates for its public policy interests before the U.S. Congress and Federal government agencies as a lobbyist.
/persons/sergio-santiviago
Sergio is Director of Government Affairs for Express Scripts Holding Company and develops and advocates for its public policy interests before the U.S. Congress and Federal government agencies as a lobbyist.
Scott Bradford
/persons/scott-bradford
Scott Bradford is owner and principal of Bradford Rx Solutions, a consulting company delivering solutions to assist companies manage the complex and costly reverse distribution processes and implement best practices to significantly improve financial performance.
/persons/scott-bradford
Scott Bradford is owner and principal of Bradford Rx Solutions, a consulting company delivering solutions to assist companies manage the complex and costly reverse distribution processes and implement best practices to significantly improve financial performance.
Robert Brown
/persons/rob-brown
Rob Brown joined Omnicare in April 2013 as Vice President of Business Development for the Specialty Care Group division.
/persons/rob-brown
Rob Brown joined Omnicare in April 2013 as Vice President of Business Development for the Specialty Care Group division.
Vijay Karwal
/persons/vijay-karwal
Vijay Karway is head of Industrials, Consumer & Healthcare advisory with CIMB following its acquisition of the Asia Pacific advisory and equities businesses of RBS in early 2012
/persons/vijay-karwal
Vijay Karway is head of Industrials, Consumer & Healthcare advisory with CIMB following its acquisition of the Asia Pacific advisory and equities businesses of RBS in early 2012
Cameron Hall
/persons/cameron-hall
Cameron Hall serves as Vice President of Products at ValueCentric, leading the company's Marketing and Product Management divisions
/persons/cameron-hall
Cameron Hall serves as Vice President of Products at ValueCentric, leading the company's Marketing and Product Management divisions
Wayne McDonnell
/persons/wayne-mcdonnell
Wayne McDonnell has over 25 years of experience in life sciences operations and supply chain.
/persons/wayne-mcdonnell
Wayne McDonnell has over 25 years of experience in life sciences operations and supply chain.
Timothy Buskey
/persons/timothy-buskey
Timothy Buskey serves as Vice President of Consumer Health for AmerisourceBergen, a leading global pharmaceutical sourcing and distribution services company.
/persons/timothy-buskey
Timothy Buskey serves as Vice President of Consumer Health for AmerisourceBergen, a leading global pharmaceutical sourcing and distribution services company.
Edward Crimmins
/persons/edward-crimmins
Edward Crimmins is a founding partner of Kindler & Crimmins Associates, LLC (KCA).
/persons/edward-crimmins
Edward Crimmins is a founding partner of Kindler & Crimmins Associates, LLC (KCA).
J. Mark Bover
/persons/j-mark-bover
J.Mark is currently the Director of Category Management with Value Drug Company. He started his career as a clerk in an independent pharmacy when he was in the eighth grade.
/persons/j-mark-bover
J.Mark is currently the Director of Category Management with Value Drug Company. He started his career as a clerk in an independent pharmacy when he was in the eighth grade.
D. Linden Barber
/persons/d-linden-barber
D. Linden Barber is the Director of the DEA Compliance and Litigation Practice Group at Quarles and Brady, LLP, and the Managing Partner of the firm's Indianapolis Office. Since joining Quarles & Brady in 2011, Linden has advised and represented a variety of firms and companies registered with the Drug Enforcement Administration (DEA).
/persons/d-linden-barber
D. Linden Barber is the Director of the DEA Compliance and Litigation Practice Group at Quarles and Brady, LLP, and the Managing Partner of the firm's Indianapolis Office. Since joining Quarles & Brady in 2011, Linden has advised and represented a variety of firms and companies registered with the Drug Enforcement Administration (DEA).
Charlotte Smith
/persons/charlotte-smith
Charlotte Smith is Senior Regulatory Advisor, PharmEcology Services, a business unit of WM National Services, Inc.
/persons/charlotte-smith
Charlotte Smith is Senior Regulatory Advisor, PharmEcology Services, a business unit of WM National Services, Inc.
Rosemary Schaab
/persons/rosemary-schaab
Rosemary Schaab is the Controller and Director of Chargeback Administration. During her 10-year tenure at AmerisourceBergen, Rose has been responsible for establishing the Chargeback Accounting and Reporting Team which provides accurate robust data and metrics to support a culture of continuous improvement.
/persons/rosemary-schaab
Rosemary Schaab is the Controller and Director of Chargeback Administration. During her 10-year tenure at AmerisourceBergen, Rose has been responsible for establishing the Chargeback Accounting and Reporting Team which provides accurate robust data and metrics to support a culture of continuous improvement.
Kristin Gorski
/persons/kristin-gorski
Kristin Gorski is the Director of New Business Development at The Nielsen Company.
/persons/kristin-gorski
Kristin Gorski is the Director of New Business Development at The Nielsen Company.
Kurt Proctor
/persons/kurt-proctor
Kurt A. Proctor, Ph.D., RPh is the Senior Vice President, Strategic Initiatives with the National Community Pharmacists Association (NCPA).
/persons/kurt-proctor
Kurt A. Proctor, Ph.D., RPh is the Senior Vice President, Strategic Initiatives with the National Community Pharmacists Association (NCPA).
Stephanie Trunk
/persons/stephanie-trunk
Stephanie Trunk is a Partner in the Health Law Group at Arent Fox LLP in Washington, D.C. Ms. Trunk counsels pharmaceutical and device manufacturers, distributors and their customers, including pharmacy benefit managers, on regulatory, reimbursement and compliance matters.
/persons/stephanie-trunk
Stephanie Trunk is a Partner in the Health Law Group at Arent Fox LLP in Washington, D.C. Ms. Trunk counsels pharmaceutical and device manufacturers, distributors and their customers, including pharmacy benefit managers, on regulatory, reimbursement and compliance matters.
Susan Pilch
/persons/susan-pilch
Susan Pilch is Vice President, Policy and Regulatory Affairs, National Community Pharmacists Association (NCPA).
/persons/susan-pilch
Susan Pilch is Vice President, Policy and Regulatory Affairs, National Community Pharmacists Association (NCPA).
Lisa Pepper
/persons/lisa-pepper
Lisa Pepper has 8 years of Chargeback experience and played a key role in AmerisourceBergen's SAP Business Transformation Project.
/persons/lisa-pepper
Lisa Pepper has 8 years of Chargeback experience and played a key role in AmerisourceBergen's SAP Business Transformation Project.
Angelie Grant
/persons/angelie-grant
Angelie is responsible for the day-to-day HIN operations at HIBCC and oversees a dozen HIN staff that maintain the HIN database.
/persons/angelie-grant
Angelie is responsible for the day-to-day HIN operations at HIBCC and oversees a dozen HIN staff that maintain the HIN database.
Dan Nielsen
/persons/dan-nielsen
Dan Nielsen spent much of his career as a healthcare executive, and he is now a leader, speaker and author with a broad area of interest.
/persons/dan-nielsen
Dan Nielsen spent much of his career as a healthcare executive, and he is now a leader, speaker and author with a broad area of interest.
Steven Johnson
/persons/steven-johnson
Steven Johnson’s writings have influenced everything from cutting-edge ideas in urban planning to the battle against 21st-century terrorism.
/persons/steven-johnson
Steven Johnson’s writings have influenced everything from cutting-edge ideas in urban planning to the battle against 21st-century terrorism.
Brian Waldman
/persons/brian-waldman
Brian Waldman concentrates his practice in the area of food and drug law and advertising law, counseling clients primarily on pharmaceutical, medical device, food, dietary supplement and cosmetic issues, with particular emphasis on developing effective strategies for introducing and distributing new products.
/persons/brian-waldman
Brian Waldman concentrates his practice in the area of food and drug law and advertising law, counseling clients primarily on pharmaceutical, medical device, food, dietary supplement and cosmetic issues, with particular emphasis on developing effective strategies for introducing and distributing new products.
Naomi Duvall
/persons/naomi-duvall
Naomi is Director of Consumer Health at Cardinal Health. In this role, Naomi oversees Category Management, shopper insights and collaboration with manufacturer partners.
/persons/naomi-duvall
Naomi is Director of Consumer Health at Cardinal Health. In this role, Naomi oversees Category Management, shopper insights and collaboration with manufacturer partners.
Peggy Staver
/persons/peggy-staver
Peggy Staver is Director of Product Integrity with Pfizer Inc. Her responsibilities include developing and implementing strategies to enhance patient safety and further secure the U.S. pharmaceutical supply chain.
/persons/peggy-staver
Peggy Staver is Director of Product Integrity with Pfizer Inc. Her responsibilities include developing and implementing strategies to enhance patient safety and further secure the U.S. pharmaceutical supply chain.
Dave Wendland
/persons/dave-wendland
Dave Wendland is a 20+ year veteran of the consumer packaged goods industry.
/persons/dave-wendland
Dave Wendland is a 20+ year veteran of the consumer packaged goods industry.
Priya Gopal
/persons/priya-gopal
Priya Gopal is an Associate Director of Strategic Planning and Projects for Novartis Pharmaceuticals.
/persons/priya-gopal
Priya Gopal is an Associate Director of Strategic Planning and Projects for Novartis Pharmaceuticals.
Heather Zenk
/persons/heather-zenk
Heather Zenk, PharmD is Vice President, Secure Supply Chain at AmerisourceBergen Corporation.
/persons/heather-zenk
Heather Zenk, PharmD is Vice President, Secure Supply Chain at AmerisourceBergen Corporation.
Donna Wall
/persons/donna-wall
Donna Wall is Senior Manager of Supply Chain Processes with McKesson Pharmaceutical since 1994
/persons/donna-wall
Donna Wall is Senior Manager of Supply Chain Processes with McKesson Pharmaceutical since 1994
Rebecca Hehnly
/persons/rebecca-hehnly
Rebecca Hehnly is the End-to-End Traceability Leader, North America (NA) for Johnson & Johnson.
/persons/rebecca-hehnly
Rebecca Hehnly is the End-to-End Traceability Leader, North America (NA) for Johnson & Johnson.
Henry Elphick
/persons/henry-elphick
Henry Elphick is the European Joint Head of Healthcare Investment Banking at Jefferies, the global, sector-led investment bank.
/persons/henry-elphick
Henry Elphick is the European Joint Head of Healthcare Investment Banking at Jefferies, the global, sector-led investment bank.
Brian Timple
/persons/brian-timple
Brian is the Director of Financial Operations at Cardinal Health, leading the Pharmaceutical Distribution Chargebacks and Dropship Invoicing teams.
/persons/brian-timple
Brian is the Director of Financial Operations at Cardinal Health, leading the Pharmaceutical Distribution Chargebacks and Dropship Invoicing teams.
Morgan White
/persons/morgan-white
Morgan White is Sr. Director, Business Platforms at Upsher-Smith Laboratories with 20 years of experience leading transformational business process projects including ERP and CRM implementations.
/persons/morgan-white
Morgan White is Sr. Director, Business Platforms at Upsher-Smith Laboratories with 20 years of experience leading transformational business process projects including ERP and CRM implementations.
Matt Sample
/persons/matt-sample
Matt Sample is currently the business lead for the serialization efforts at AmerisourceBergen.
/persons/matt-sample
Matt Sample is currently the business lead for the serialization efforts at AmerisourceBergen.
Timothy Hogan
/persons/timothy-hogan
Tim Hogan is the solution leader for the healthcare and life-sciences product portfolio at Axway.
/persons/timothy-hogan
Tim Hogan is the solution leader for the healthcare and life-sciences product portfolio at Axway.
Stacey Swartz
/persons/stacey-swartz
Stacey Swartz, PharmD is the co-owner and pharmacist in charge for the Neighborhood Pharmacy of Del Ray, an independent pharmacy in Alexandria, VA.
/persons/stacey-swartz
Stacey Swartz, PharmD is the co-owner and pharmacist in charge for the Neighborhood Pharmacy of Del Ray, an independent pharmacy in Alexandria, VA.
Ronald Bone
/persons/ronald-bone
Ron Bone is a consultant in the area of Pharmaceutical Traceability and is currently focusing on the implementation of the US 2013 Drug Quality and Security Act.
/persons/ronald-bone
Ron Bone is a consultant in the area of Pharmaceutical Traceability and is currently focusing on the implementation of the US 2013 Drug Quality and Security Act.
Shaun Kirkpatrick
/persons/shaun-kirkpatrick
Shaun Kirkpatrick is Manager of Track and Trace Operations at GSK.
/persons/shaun-kirkpatrick
Shaun Kirkpatrick is Manager of Track and Trace Operations at GSK.
Horst Matzer
/persons/horst-matzer
Horst Matzer is the Director of Business Area Solutions at KNAPP Logistics Automation.
/persons/horst-matzer
Horst Matzer is the Director of Business Area Solutions at KNAPP Logistics Automation.
Joseph Hill
/persons/joseph-hill
Joseph Hill currently serves as Director of the Government Relations division for the American Society of Health-System Pharmacists.
/persons/joseph-hill
Joseph Hill currently serves as Director of the Government Relations division for the American Society of Health-System Pharmacists.
Amy Winnen
/persons/amy-winnen
Amy A. Winnen leads the Product Availability and Pricing Administration functions for Merrimack Pharmaceuticals based in Cambridge, MA.
/persons/amy-winnen
Amy A. Winnen leads the Product Availability and Pricing Administration functions for Merrimack Pharmaceuticals based in Cambridge, MA.
Hashim Zaibak
/persons/hashim-zaibak
Hashim Zaibak started his career as a Pharmacist in 1999 and is the majority owner of Hayat Pharmacy in Milwaukee and runs seven central city pharmacies.
/persons/hashim-zaibak
Hashim Zaibak started his career as a Pharmacist in 1999 and is the majority owner of Hayat Pharmacy in Milwaukee and runs seven central city pharmacies.
Anne Johnston
/persons/anne-johnston
Anne Johnston, MPA, RPh, is Senior Director of Data Management for Express Scripts.
/persons/anne-johnston
Anne Johnston, MPA, RPh, is Senior Director of Data Management for Express Scripts.
Lucy Deus
/persons/lucy-deus
Lucy Deus is the Vice President of Product Management at TraceLink, helping drive the vision, design and capabilities for TraceLink’s Life Science Cloud global network application platform.
/persons/lucy-deus
Lucy Deus is the Vice President of Product Management at TraceLink, helping drive the vision, design and capabilities for TraceLink’s Life Science Cloud global network application platform.
Lloyd Mager
/persons/lloyd-mager
Lloyd Mager is the Global Lead for AbbVie’s Traceability program and has 30 years of experience in the pharmaceutical industry.
/persons/lloyd-mager
Lloyd Mager is the Global Lead for AbbVie’s Traceability program and has 30 years of experience in the pharmaceutical industry.
Lisa Hamlin
/persons/lisa-hamlin
Lisa Hamlin has been providing IT support for the pharmaceutical industry for the past 20 years, and is currently the IT work stream lead for the Actavis Global Serialization team.
/persons/lisa-hamlin
Lisa Hamlin has been providing IT support for the pharmaceutical industry for the past 20 years, and is currently the IT work stream lead for the Actavis Global Serialization team.
Kristin Fitzgerald
/persons/kristin-fitzgerald
Kristin Fitzgerald is with U.S. EPA’s Office of Resource Conservation and Recovery in Washington, DC. She has been with the Agency for fourteen years, working primarily on hazardous waste generator issues.
/persons/kristin-fitzgerald
Kristin Fitzgerald is with U.S. EPA’s Office of Resource Conservation and Recovery in Washington, DC. She has been with the Agency for fourteen years, working primarily on hazardous waste generator issues.
Josh Smeraldi
/persons/josh-smeraldi
Josh Smeraldi is with U.S. EPA’s Office of Resource Conservation and Recovery and has been with the Agency for 1 year, working primarily on hazardous waste issues.
/persons/josh-smeraldi
Josh Smeraldi is with U.S. EPA’s Office of Resource Conservation and Recovery and has been with the Agency for 1 year, working primarily on hazardous waste issues.
David Rurka
/persons/david-rurka
David Rurka is the current Director, Rx Inventory Management Operations for Walgreens.
/persons/david-rurka
David Rurka is the current Director, Rx Inventory Management Operations for Walgreens.
Eero Hautaniemi
/persons/eero-hautaniemi
Mr. Eero Hautaniemi has been President and CEO of Oriola-KD Corporation since the establishment in 2006.
/persons/eero-hautaniemi
Mr. Eero Hautaniemi has been President and CEO of Oriola-KD Corporation since the establishment in 2006.
David Magargee
/persons/david-magargee
David Magargee is currently the Global Programs Manager in Sensitech’s Professional Services Life Science team.
/persons/david-magargee
David Magargee is currently the Global Programs Manager in Sensitech’s Professional Services Life Science team.
Connie Jung, RPh, PhD
/persons/connie-jung
Dr. Jung is currently Acting Associate Director for Policy and Communications in the new Office of Drug Security, Integrity, and Recalls in FDA’s Center for Drug Evaluation and Research, Office of Compliance.
/persons/connie-jung
Dr. Jung is currently Acting Associate Director for Policy and Communications in the new Office of Drug Security, Integrity, and Recalls in FDA’s Center for Drug Evaluation and Research, Office of Compliance.
Dale Smith
/persons/dale-smith-jr-ipdc
Dale Smith is chairman and CEO of the parent holding company of H. D. Smith.
/persons/dale-smith-jr-ipdc
Dale Smith is chairman and CEO of the parent holding company of H. D. Smith.
Jamie Hintlian
/persons/jamie-hintlian
Jamie Hintlian is a Principal in the Advisory Services practice of Ernst & Young LLP and leads the Life Sciences Supply Chain practice.
/persons/jamie-hintlian
Jamie Hintlian is a Principal in the Advisory Services practice of Ernst & Young LLP and leads the Life Sciences Supply Chain practice.
Haris Kamal
/persons/haris-kamal
Haris Kamal serves as Vice President of Sales, Health and Life Sciences at Frequentz.
/persons/haris-kamal
Haris Kamal serves as Vice President of Sales, Health and Life Sciences at Frequentz.
Bob Candelora
/persons/bob-candelora
Bob Candelora is Managing Partner of Retail Insights, LLC, a data management solution company.
/persons/bob-candelora
Bob Candelora is Managing Partner of Retail Insights, LLC, a data management solution company.
Greg Yonko
/persons/greg-yonko
Greg Yonko serves as Senior Vice President for Global Sourcing and Purchasing for McKesson Corporation, a $160B, Fortune 15 Global health care company.
/persons/greg-yonko
Greg Yonko serves as Senior Vice President for Global Sourcing and Purchasing for McKesson Corporation, a $160B, Fortune 15 Global health care company.
Brad Pine
/persons/brad-pine
Brad Pine is currently the Vice President, Brand/Specialty Rx and Regulatory for Smith Drug Company; he has over 25 years of experience in the pharmaceutical wholesale industry.
/persons/brad-pine
Brad Pine is currently the Vice President, Brand/Specialty Rx and Regulatory for Smith Drug Company; he has over 25 years of experience in the pharmaceutical wholesale industry.
Ashlee Hamski
/persons/ashlee-hamski
Ashlee Hamski is the Manager of Account Management with Cardinal Health, Inc
/persons/ashlee-hamski
Ashlee Hamski is the Manager of Account Management with Cardinal Health, Inc
Atif Chaughtai
/persons/atif-chaughtai
Atif Chaughtai is the Director, Healthcare Solutions at Axway.
/persons/atif-chaughtai
Atif Chaughtai is the Director, Healthcare Solutions at Axway.
Chris Savage
/persons/chris-savage
Chris Savage is results-driven consumer team leader with extensive industry experience demonstrated through a skill set built on progressive roles of national account management, category leadership, customer marketing and financial analysis.
/persons/chris-savage
Chris Savage is results-driven consumer team leader with extensive industry experience demonstrated through a skill set built on progressive roles of national account management, category leadership, customer marketing and financial analysis.
Selena Rezvani
/persons/selena-rezvani
Selena Rezvani is VP of Consulting and Research at Be Leaderly and a recognized consultant, speaker and author on women and leadership.
/persons/selena-rezvani
Selena Rezvani is VP of Consulting and Research at Be Leaderly and a recognized consultant, speaker and author on women and leadership.
Patricia Scott
/persons/patricia-scott
Dr. Patricia Scott is a leader in the field of communication and provides her students and her clients a unique blend of time-tests strategies and real-world application, with more than 15 years of corporate leadership experience.
/persons/patricia-scott
Dr. Patricia Scott is a leader in the field of communication and provides her students and her clients a unique blend of time-tests strategies and real-world application, with more than 15 years of corporate leadership experience.
Mike McBride
/persons/michael-mcbride
Mike McBride is Vice President, Partner Relations at Upsher-Smith Laboratories and has more than 25 years of experience in the consumer products and pharmaceutical industry.
/persons/michael-mcbride
Mike McBride is Vice President, Partner Relations at Upsher-Smith Laboratories and has more than 25 years of experience in the consumer products and pharmaceutical industry.
Mark Parrish
/persons/mark-parrish
Mark Parrish, currently President of the International Federation of Pharmaceutical Wholesalers (IFPW),
/persons/mark-parrish
Mark Parrish, currently President of the International Federation of Pharmaceutical Wholesalers (IFPW),
Dr. Martin Friedrich
/persons/martin-friedrich
Dr. Martin Friedrich is head of Product Tracking and Authentication with Bayer Technology Services and has been employed with Bayer since 1992.
/persons/martin-friedrich
Dr. Martin Friedrich is head of Product Tracking and Authentication with Bayer Technology Services and has been employed with Bayer since 1992.
Summerpal Kahlon, MD
/persons/summerpal-kahlon
Dr. Summerpal S. Kahlon currently serves as a Vice President of Business Development for RelayHealth Pharmacy Solutions.
/persons/summerpal-kahlon
Dr. Summerpal S. Kahlon currently serves as a Vice President of Business Development for RelayHealth Pharmacy Solutions.
Thomas Ehman
/persons/thomas-ehmann
Thomas Ehmann has been the Senior Vice President of the PHOENIX group since 2012, responsible for Pharma Services and Corporate Communications.
/persons/thomas-ehmann
Thomas Ehmann has been the Senior Vice President of the PHOENIX group since 2012, responsible for Pharma Services and Corporate Communications.
Jon Giacomin
/persons/jon-giacomin-2
Jon Giacomin is the chief executive officer of the Pharmaceutical Segment of Cardinal Health, Inc.
/persons/jon-giacomin-2
Jon Giacomin is the chief executive officer of the Pharmaceutical Segment of Cardinal Health, Inc.
Peyton Howell
/persons/peyton-howell
Peyton Howell is Executive Vice President and President, Global Sourcing and Manufacturer Relations for AmerisourceBergen, where she leads manufacturer strategy and sourcing including brand, generic, specialty and consumer product purchasing of nearly $100 Billion.
/persons/peyton-howell
Peyton Howell is Executive Vice President and President, Global Sourcing and Manufacturer Relations for AmerisourceBergen, where she leads manufacturer strategy and sourcing including brand, generic, specialty and consumer product purchasing of nearly $100 Billion.
Tim Stearns
/persons/tim-stearns
Tim Stearns is a Senior E-Commerce Analyst with Baxter HealthCare, focusing primarily on the distributor customer base.
/persons/tim-stearns
Tim Stearns is a Senior E-Commerce Analyst with Baxter HealthCare, focusing primarily on the distributor customer base.
Lisa Gill
/persons/lisa-gill
Lisa Gill has been a leading member of the healthcare equity research team at J.P. Morgan for 16 years.
/persons/lisa-gill
Lisa Gill has been a leading member of the healthcare equity research team at J.P. Morgan for 16 years.
Doug Long
/persons/doug-long
Tuesday afternoon general session features Doug Long of IMS Health, Inc.
/persons/doug-long
Tuesday afternoon general session features Doug Long of IMS Health, Inc.
Rene Jenny
/persons/rene-jenny
Mr. René Jenny was elected the President of the European Association of Pharmaceutical Full-line Wholesalers (GIRP) in 2005 and has held this position ever since
/persons/rene-jenny
Mr. René Jenny was elected the President of the European Association of Pharmaceutical Full-line Wholesalers (GIRP) in 2005 and has held this position ever since
Scott Mooney
/persons/scott-mooney
Scott Mooney is Vice President of Distribution Operations at McKesson Corporation. His primary responsibilities are assuring product integrity through regulatory compliance and traceability.
/persons/scott-mooney
Scott Mooney is Vice President of Distribution Operations at McKesson Corporation. His primary responsibilities are assuring product integrity through regulatory compliance and traceability.
Rob Cockman
/persons/rob-cockman
Rob Cockman opened Midtown Pharmacy in 2003, originally located in the Stoney Creek Village Shopping Center.
/persons/rob-cockman
Rob Cockman opened Midtown Pharmacy in 2003, originally located in the Stoney Creek Village Shopping Center.
Raymond Lake
/persons/raymond-lake
Ray is the Corporate Director of Pharmacy Operations with MedStar Health, a 10-hospital system in the Mid-Atlantic, where he has worked for 10 years.
/persons/raymond-lake
Ray is the Corporate Director of Pharmacy Operations with MedStar Health, a 10-hospital system in the Mid-Atlantic, where he has worked for 10 years.
Paul Hamby
/persons/paul-hamby
Paul Hamby holds the position of Senior Director, Compliance Solutions with BuzzeoPDMA, A Cegedim company.
/persons/paul-hamby
Paul Hamby holds the position of Senior Director, Compliance Solutions with BuzzeoPDMA, A Cegedim company.
Robert Belknap
/persons/robert-belknap
Bob Belknap is the Executive Director, Trade & Specialty Sales & Operations at Boehringer Ingelheim Pharmaceuticals
/persons/robert-belknap
Bob Belknap is the Executive Director, Trade & Specialty Sales & Operations at Boehringer Ingelheim Pharmaceuticals
Andy Meyer
/persons/andy-meyer
Andrew Meyer is a Senior Systems Analyst at the Mutual Wholesale Drug Company where he coordinates their traceability efforts as the team lead.
/persons/andy-meyer
Andrew Meyer is a Senior Systems Analyst at the Mutual Wholesale Drug Company where he coordinates their traceability efforts as the team lead.
Steve Wilhelm
/persons/steve-wilhelm
Steve Wilhelm is the Vice President of Operations at R&S Northeast and offers a diverse blend of over 25 years’ experience in wholesale drug distribution.
/persons/steve-wilhelm
Steve Wilhelm is the Vice President of Operations at R&S Northeast and offers a diverse blend of over 25 years’ experience in wholesale drug distribution.
Louis Milione
/persons/louis-milione
Special Agent Louis J. Milione was appointed to lead DEA’s Office of Diversion Control as Deputy Assistant Administrator in October 2015.
/persons/louis-milione
Special Agent Louis J. Milione was appointed to lead DEA’s Office of Diversion Control as Deputy Assistant Administrator in October 2015.
Akin Odutola
/persons/akin-odutola
Akin Odutola is Vice President, Global Branded Rx Sourcing for AmerisourceBergen Corporation. In his role, Akin and his team manages the sourcing activities for Branded and Specialty pharmaceuticals across the AmerisourceBergen enterprise.
/persons/akin-odutola
Akin Odutola is Vice President, Global Branded Rx Sourcing for AmerisourceBergen Corporation. In his role, Akin and his team manages the sourcing activities for Branded and Specialty pharmaceuticals across the AmerisourceBergen enterprise.
Kathy Lang
/persons/kathy-lang
Kathy Lang is a Senior Director, Trade Relations at Valeritas, Inc. Her expert knowledge of the pharmaceutical industry, relationships and excellent reputation ensured the successful launch of V-Go® into the diabetes market.
/persons/kathy-lang
Kathy Lang is a Senior Director, Trade Relations at Valeritas, Inc. Her expert knowledge of the pharmaceutical industry, relationships and excellent reputation ensured the successful launch of V-Go® into the diabetes market.
Jim Cline
/persons/jim-cline
Jim is a member of the Cardinal Health Corporate EHS leadership team with responsibilities for all aspects of environmental, health & safety (EHS) and loss prevention for various Cardinal Health businesses.
/persons/jim-cline
Jim is a member of the Cardinal Health Corporate EHS leadership team with responsibilities for all aspects of environmental, health & safety (EHS) and loss prevention for various Cardinal Health businesses.
Sarah Krueger
/persons/sarah-krueger
Sarah joined Cardinal Health in 2013 as Category Sourcing Manager of Consumer Health where she is responsible for driving business growth for seven Wellness categories through assortment management, marketing initiatives and product promotion.
/persons/sarah-krueger
Sarah joined Cardinal Health in 2013 as Category Sourcing Manager of Consumer Health where she is responsible for driving business growth for seven Wellness categories through assortment management, marketing initiatives and product promotion.
David MacFarlane
/persons/david-macfarlane
David MacFarlane is a member of the HDA Board of Directors.
/persons/david-macfarlane
David MacFarlane is a member of the HDA Board of Directors.
Charles Phillips
/persons/charles-phillips
Charles Phillips is a member of HDA's Board of Directors.
/persons/charles-phillips
Charles Phillips is a member of HDA's Board of Directors.
Edward J. Pezzullo
/persons/edward-pezzullo
Vice President, Information Technology Systems and Facilities Management
/persons/edward-pezzullo
Vice President, Information Technology Systems and Facilities Management
Leah Lindahl
/persons/leah-lindahl
Leah Lindahl is Senior Director, State Government Affairs, Western Region, for HDA.
/persons/leah-lindahl
Leah Lindahl is Senior Director, State Government Affairs, Western Region, for HDA.
Roxolana Kozyckyj
/persons/roxolana-kozyckyj
Roxolana Kozyckyj is Director, State Government Affairs, for HDA.
/persons/roxolana-kozyckyj
Roxolana Kozyckyj is Director, State Government Affairs, for HDA.
Lisa Anderson
/persons/lisa-anderson
Lisa Anderson is HDA's Associate Manager, Registration, Meetings & Conferences.
/persons/lisa-anderson
Lisa Anderson is HDA's Associate Manager, Registration, Meetings & Conferences.
FDA
//www.hda.org/news/hda-blog/categories/fda
HDA blog entries that cover the Food and Drug Administration (FDA).
//www.hda.org/news/hda-blog/categories/fda
HDA blog entries that cover the Food and Drug Administration (FDA).
Supply Chain
//www.hda.org/news/hda-blog/categories/supply-chain
HDA blog entries that cover supply chain.
//www.hda.org/news/hda-blog/categories/supply-chain
HDA blog entries that cover supply chain.
//www.hda.org/news/hda-blog/categories/vrs
HDA blog entries that cover the Verification Router Service (VRS).
//www.hda.org/news/hda-blog/categories/rx-drug-abuse
HDA blog entries that cover prescription drug abuse.
Emergency Preparedness
//www.hda.org/news/hda-blog/categories/emergency-preparedness
HDA blog entries that cover emergency preparedness.
//www.hda.org/news/hda-blog/categories/emergency-preparedness
HDA blog entries that cover emergency preparedness.
Professional Development
//www.hda.org/news/hda-blog/categories/professional-development
HDA blog entries that cover professional development topics.
//www.hda.org/news/hda-blog/categories/professional-development
HDA blog entries that cover professional development topics.
DEA
//www.hda.org/news/hda-blog/categories/dea
HDA blog entries that cover the Drug Enforcement Administration (DEA).
//www.hda.org/news/hda-blog/categories/dea
HDA blog entries that cover the Drug Enforcement Administration (DEA).
AAOA
//www.hda.org/news/hda-blog/categories/aaoa
HDA blog entries that cover AAOA (Allied Against Opioid Abuse).
//www.hda.org/news/hda-blog/categories/aaoa
HDA blog entries that cover AAOA (Allied Against Opioid Abuse).
HDA Research Foundation
//www.hda.org/news/hda-blog/categories/hda-research-foundation
HDA blog topics that cover the HDA Research Foundation.
//www.hda.org/news/hda-blog/categories/hda-research-foundation
HDA blog topics that cover the HDA Research Foundation.
Rx Safety and Healthcare Leadership Award
//www.hda.org/about/industry-recognition/rx-safety-and-healthcare-leadership-award
HDA's Rx Safety and Healthcare Leadership Award recognizes public officials for their leadership and ongoing commitment to public policies that support and promote the safe, efficient and reliable delivery of lifesaving medicines to patients nationwide.
//www.hda.org/about/industry-recognition/rx-safety-and-healthcare-leadership-award
HDA's Rx Safety and Healthcare Leadership Award recognizes public officials for their leadership and ongoing commitment to public policies that support and promote the safe, efficient and reliable delivery of lifesaving medicines to patients nationwide.
DMA for Industry Leadership
//www.hda.org/about/industry-recognition/dma-industry-leadership
The Distribution Management Award for Industry Leadership (DMA) recognizes an individual for his/her extraordinary contributions to the pharmaceutical distribution industry.
//www.hda.org/about/industry-recognition/dma-industry-leadership
The Distribution Management Award for Industry Leadership (DMA) recognizes an individual for his/her extraordinary contributions to the pharmaceutical distribution industry.
//www.hda.org/about/industry-recognition/power-of-partnership-award
The Power of Partnership Award was created by HDA and the non-profit Americares to honor Association members who have shown exceptional dedication and innovation to expanding access to healthcare for disadvantaged populations in the developing world.
Nexus Award
//www.hda.org/about/industry-recognition/nexus-award
Since 1956, the Nexus Award has been the pharmaceutical distribution industry's highest award recognizing lifetime achievement. It honors exceptional character; accomplishments; and leadership in HDA, the industry and the community.
//www.hda.org/about/industry-recognition/nexus-award
Since 1956, the Nexus Award has been the pharmaceutical distribution industry's highest award recognizing lifetime achievement. It honors exceptional character; accomplishments; and leadership in HDA, the industry and the community.
Nexus Award Winners
//www.hda.org/about/industry-recognition/nexus-award/nexus-award-winners
Since 1956, the Nexus Award has been the pharmaceutical distribution industry's highest award recognizing lifetime achievement. It honors exceptional character; accomplishments; and leadership in HDA, the industry and the community.
//www.hda.org/about/industry-recognition/nexus-award/nexus-award-winners
Since 1956, the Nexus Award has been the pharmaceutical distribution industry's highest award recognizing lifetime achievement. It honors exceptional character; accomplishments; and leadership in HDA, the industry and the community.
Government Affairs
//www.hda.org/about/staff-directory/government-affairs
HDA’s Government Affairs department addresses legislative and regulatory issues at the federal and state levels. It advocates for the industry of healthcare distribution as well as for the larger interests of supply chain stakeholders.
//www.hda.org/about/staff-directory/government-affairs
HDA’s Government Affairs department addresses legislative and regulatory issues at the federal and state levels. It advocates for the industry of healthcare distribution as well as for the larger interests of supply chain stakeholders.
Executive Office
//www.hda.org/about/staff-directory/executive-office
The Executive Office provides strategic leadership for the Alliance by working with the Executive Committee and Board of Directors to establish long-range goals, strategies, plans and policies that advance the wholesale distribution industry.
//www.hda.org/about/staff-directory/executive-office
The Executive Office provides strategic leadership for the Alliance by working with the Executive Committee and Board of Directors to establish long-range goals, strategies, plans and policies that advance the wholesale distribution industry.
Meetings and Conferences
//www.hda.org/about/staff-directory/meetings-and-conferences
HDA’s Meetings and Conferences department plans and executes meetings, conferences and webinars that enable members and other constituents to increase their knowledge about the healthcare distribution industry and other pertinent healthcare supply chain topics.
//www.hda.org/about/staff-directory/meetings-and-conferences
HDA’s Meetings and Conferences department plans and executes meetings, conferences and webinars that enable members and other constituents to increase their knowledge about the healthcare distribution industry and other pertinent healthcare supply chain topics.
Industry Relations, Membership and Education
//www.hda.org/about/staff-directory/industry-relations-membership-and-education
HDA’s Industry Relations, Membership and Education department helps to maintain the effectiveness and efficiency of the distribution industry’s operations by bringing together distribution and manufacturer stakeholders to recommend “best practices,” drafting guidelines on the appropriate use of information processing, materials handling and other technologies, such as e-commerce.
//www.hda.org/about/staff-directory/industry-relations-membership-and-education
HDA’s Industry Relations, Membership and Education department helps to maintain the effectiveness and efficiency of the distribution industry’s operations by bringing together distribution and manufacturer stakeholders to recommend “best practices,” drafting guidelines on the appropriate use of information processing, materials handling and other technologies, such as e-commerce.
Finance, Administration and IT
//www.hda.org/about/staff-directory/finance-administration-and-it
HDA’s Finance, Administration and Information Technology Services department administers and manages internal Alliance operations, including financial management; office operations; human resources; information technology and facilities.
//www.hda.org/about/staff-directory/finance-administration-and-it
HDA’s Finance, Administration and Information Technology Services department administers and manages internal Alliance operations, including financial management; office operations; human resources; information technology and facilities.
Pharmaceutical Cargo Security Coalition
//www.hda.org/about/staff-directory/pharmaceutical-cargo-security-coalition
HDA's Pharmaceutical Cargo Security Coalition offers supply chain security intelligence; access to contacts from industry, government and vendor trade disciplines; physical and supply chain security assessments; a reference library of supply chain security publications, articles and related documents; as well as opportunities to attend educational events.
//www.hda.org/about/staff-directory/pharmaceutical-cargo-security-coalition
HDA's Pharmaceutical Cargo Security Coalition offers supply chain security intelligence; access to contacts from industry, government and vendor trade disciplines; physical and supply chain security assessments; a reference library of supply chain security publications, articles and related documents; as well as opportunities to attend educational events.
Communications and Marketing
//www.hda.org/about/staff-directory/communications-and-marketing
HDA’s Communications and Marketing department creates and disseminates information that promotes the Alliance's educational offerings, services and resources, and communicates the organization’s perspectives on key issues of interest to pharmaceutical distributors and the healthcare supply chain.
//www.hda.org/about/staff-directory/communications-and-marketing
HDA’s Communications and Marketing department creates and disseminates information that promotes the Alliance's educational offerings, services and resources, and communicates the organization’s perspectives on key issues of interest to pharmaceutical distributors and the healthcare supply chain.
HDA Research Foundation
//www.hda.org/about/staff-directory/hda-research-foundation
The HDA Research Foundation is the 501(c)(3) non-profit charitable organization that serves as the knowledge partner of HDA.
//www.hda.org/about/staff-directory/hda-research-foundation
The HDA Research Foundation is the 501(c)(3) non-profit charitable organization that serves as the knowledge partner of HDA.
Industry Initiatives
//www.hda.org/issues/prescription-drug-abuse-and-diversion/industry-initiatives
The Healthcare Distribution Alliance (HDA) and its members are committed to stopping opioid abuse and misuse before it occurs.
//www.hda.org/issues/prescription-drug-abuse-and-diversion/industry-initiatives
The Healthcare Distribution Alliance (HDA) and its members are committed to stopping opioid abuse and misuse before it occurs.
Daily Schedule
//www.hda.org/events/2019-traceability-seminar/daily-schedule
Program agenda for the Traceability Seminar held at the Marriott Wardman Park Hotel in Washington DC on October 21-23, 2019
//www.hda.org/events/2019-traceability-seminar/daily-schedule
Program agenda for the Traceability Seminar held at the Marriott Wardman Park Hotel in Washington DC on October 21-23, 2019
Speakers
//www.hda.org/events/2019-traceability-seminar/speakers
Speaker information for the 2019 Traceability Seminar to be held at the Marriott Wardman Park Hotel in Washington DC on October 21-23, 2019
//www.hda.org/events/2019-traceability-seminar/speakers
Speaker information for the 2019 Traceability Seminar to be held at the Marriott Wardman Park Hotel in Washington DC on October 21-23, 2019
Table-Top Sponsorship
//www.hda.org/events/2019-traceability-seminar/table-top-sponsorship
Sponsoring the Traceability Seminar provides an opportunity to increase exposure and build relationships.
//www.hda.org/events/2019-traceability-seminar/table-top-sponsorship
Sponsoring the Traceability Seminar provides an opportunity to increase exposure and build relationships.
Hotel and Travel
//www.hda.org/events/2020-distribution-management-conference-and-expo/hotel-and-travel
The Distribution Management Conference and Expo is HDA's largest supply chain education event, attended by more than 500 manufacturers, distributors, consultants and third parties who keep the pharmaceutical distribution industry moving.
//www.hda.org/events/2020-distribution-management-conference-and-expo/hotel-and-travel
The Distribution Management Conference and Expo is HDA's largest supply chain education event, attended by more than 500 manufacturers, distributors, consultants and third parties who keep the pharmaceutical distribution industry moving.
Contact Us
//www.hda.org/events/2020-distribution-management-conference-and-expo/contact-us
The Distribution Management Conference and Expo is HDA's largest supply chain education event, attended by more than 500 manufacturers, distributors, consultants and third parties who keep the pharmaceutical distribution industry moving.
//www.hda.org/events/2020-distribution-management-conference-and-expo/contact-us
The Distribution Management Conference and Expo is HDA's largest supply chain education event, attended by more than 500 manufacturers, distributors, consultants and third parties who keep the pharmaceutical distribution industry moving.
Exhibit
//www.hda.org/events/2020-distribution-management-conference-and-expo/plan-your-exhibit
The Distribution Management Conference and Expo is HDA's largest supply chain education event, attended by more than 500 manufacturers, distributors, consultants and third parties who keep the pharmaceutical distribution industry moving.
//www.hda.org/events/2020-distribution-management-conference-and-expo/plan-your-exhibit
The Distribution Management Conference and Expo is HDA's largest supply chain education event, attended by more than 500 manufacturers, distributors, consultants and third parties who keep the pharmaceutical distribution industry moving.
Past Exhibitors
//www.hda.org/events/2020-distribution-management-conference-and-expo/plan-your-exhibit/past-exhibitors
The Distribution Management Conference and Expo is HDA's largest supply chain education event, attended by more than 500 manufacturers, distributors, consultants and third parties who keep the pharmaceutical distribution industry moving.
//www.hda.org/events/2020-distribution-management-conference-and-expo/plan-your-exhibit/past-exhibitors
The Distribution Management Conference and Expo is HDA's largest supply chain education event, attended by more than 500 manufacturers, distributors, consultants and third parties who keep the pharmaceutical distribution industry moving.
//www.hda.org/events/2019-distribution-management-conference-and-expo/expo-information/current-exhibitors
Contact Us
//www.hda.org/events/2019-distribution-management-conference-and-expo/contact-us
The Distribution Management Conference and Expo is HDA's largest supply chain education event, attended by more than 500 manufacturers, distributors, consultants and third parties who keep the pharmaceutical distribution industry moving.
//www.hda.org/events/2019-distribution-management-conference-and-expo/contact-us
The Distribution Management Conference and Expo is HDA's largest supply chain education event, attended by more than 500 manufacturers, distributors, consultants and third parties who keep the pharmaceutical distribution industry moving.
Speakers
//www.hda.org/events/2019-hda-pcsc-educational-seminar/speakers
The HDA Pharmaceutical Cargo Security Coalition (PCSC) Educational Seminar brings together those within healthcare, as well as many other industries, that ship and store sensitive, high-risk/high-value products — anywhere in the world.
//www.hda.org/events/2019-hda-pcsc-educational-seminar/speakers
The HDA Pharmaceutical Cargo Security Coalition (PCSC) Educational Seminar brings together those within healthcare, as well as many other industries, that ship and store sensitive, high-risk/high-value products — anywhere in the world.
Sponsorship and Exhibits
//www.hda.org/events/2019-hda-pcsc-educational-seminar/sponsorship-and-exhibits
Sponsoring the 2019 PCSC Educational Seminar is an effective way to enhance your company's exposure, build relationships with decision makers and boost your brand.
//www.hda.org/events/2019-hda-pcsc-educational-seminar/sponsorship-and-exhibits
Sponsoring the 2019 PCSC Educational Seminar is an effective way to enhance your company's exposure, build relationships with decision makers and boost your brand.
Current Exhibitors
//www.hda.org/events/2019-hda-pcsc-educational-seminar/sponsorship-and-exhibits/current-exhibitors
//www.hda.org/events/2019-hda-pcsc-educational-seminar/sponsorship-and-exhibits/current-exhibitors
Daily Schedule
//www.hda.org/events/2019-hda-pcsc-educational-seminar/daily-schedule
Program agenda for PCSC Educational Seminar to be held at Norvartis Corporate Headquarters on May 8-9, 2019.
//www.hda.org/events/2019-hda-pcsc-educational-seminar/daily-schedule
Program agenda for PCSC Educational Seminar to be held at Norvartis Corporate Headquarters on May 8-9, 2019.
Speaker Tips and Guidelines
//www.hda.org/events/speaker-resource-center/speaker-tips-and-guidelines
Every year, thousands of individuals attend HDA events. In addition to the many networking opportunities available at these meetings, attendees appreciate and expect that the sessions they attend will be well planned and thought-provoking, with significant take-home value. This guide has been compiled to help you plan, prepare and deliver a professional presentation. Even if you are a seasoned speaker or facilitator, we recommend you taking a few moments to review the contents on this page.
//www.hda.org/events/speaker-resource-center/speaker-tips-and-guidelines
Every year, thousands of individuals attend HDA events. In addition to the many networking opportunities available at these meetings, attendees appreciate and expect that the sessions they attend will be well planned and thought-provoking, with significant take-home value. This guide has been compiled to help you plan, prepare and deliver a professional presentation. Even if you are a seasoned speaker or facilitator, we recommend you taking a few moments to review the contents on this page.
Attendee Materials
//www.hda.org/events/2017-international-pharmaceutical-distribution-conference/attendee-materials
//www.hda.org/events/2017-international-pharmaceutical-distribution-conference/attendee-materials
Table-Top Sponsorship
//www.hda.org/events/2017-traceability-seminar/table-top-sponsorship
Sponsoring at the HDA Traceability seminar provides organizations a cost-efficient opportunity to increase exposure and build relationships.
//www.hda.org/events/2017-traceability-seminar/table-top-sponsorship
Sponsoring at the HDA Traceability seminar provides organizations a cost-efficient opportunity to increase exposure and build relationships.
Current Table-Top Sponsors
//www.hda.org/events/2017-traceability-seminar/table-top-sponsorship/current-table-top-sponsors
Sponsoring at the HDA Traceability seminar provides organizations a cost-efficient opportunity to increase exposure and build relationships.
//www.hda.org/events/2017-traceability-seminar/table-top-sponsorship/current-table-top-sponsors
Sponsoring at the HDA Traceability seminar provides organizations a cost-efficient opportunity to increase exposure and build relationships.
Speakers
//www.hda.org/events/2017-traceability-seminar/speakers
Speaker information for 2017 Traceability Seminar to be held at the Renaissance Washington, DC Downtown Hotel on November 8-10.
//www.hda.org/events/2017-traceability-seminar/speakers
Speaker information for 2017 Traceability Seminar to be held at the Renaissance Washington, DC Downtown Hotel on November 8-10.
Daily Schedule
//www.hda.org/events/2017-traceability-seminar/daily-schedule
Program agenda for Traceability Seminar to be held at the Renaissance Washington DC Downtown Hotel on November 8-10, 2017
//www.hda.org/events/2017-traceability-seminar/daily-schedule
Program agenda for Traceability Seminar to be held at the Renaissance Washington DC Downtown Hotel on November 8-10, 2017
Daily Schedule
//www.hda.org/events/2019-business-and-leadership-conference/daily-schedule
HDA’s Business and Leadership Conference (BLC) is the healthcare distribution industry’s signature annual conference, developed by and for healthcare supply chain leaders and innovators. Exclusive to HDA member companies, the conference brings together high-level executives, thought leaders and influential managers from across the healthcare supply chain to hold strategic business discussions on the most pressing industry issues.
//www.hda.org/events/2019-business-and-leadership-conference/daily-schedule
HDA’s Business and Leadership Conference (BLC) is the healthcare distribution industry’s signature annual conference, developed by and for healthcare supply chain leaders and innovators. Exclusive to HDA member companies, the conference brings together high-level executives, thought leaders and influential managers from across the healthcare supply chain to hold strategic business discussions on the most pressing industry issues.
Business Appointments
//www.hda.org/events/2019-business-and-leadership-conference/business-appointments
HDA’s Business and Leadership Conference (BLC) is the healthcare distribution industry’s signature annual conference, developed by and for healthcare supply chain leaders and innovators. Exclusive to HDA member companies, the conference brings together high-level executives, thought leaders and influential managers from across the healthcare supply chain to hold strategic business discussions on the most pressing industry issues.
//www.hda.org/events/2019-business-and-leadership-conference/business-appointments
HDA’s Business and Leadership Conference (BLC) is the healthcare distribution industry’s signature annual conference, developed by and for healthcare supply chain leaders and innovators. Exclusive to HDA member companies, the conference brings together high-level executives, thought leaders and influential managers from across the healthcare supply chain to hold strategic business discussions on the most pressing industry issues.
PartnerLinx
//www.hda.org/events/2019-business-and-leadership-conference/business-appointments/partnerlinx
HDA’s Business and Leadership Conference (BLC) is the healthcare distribution industry’s signature annual conference, developed by and for healthcare supply chain leaders and innovators. Exclusive to HDA member companies, the conference brings together high-level executives, thought leaders and influential managers from across the healthcare supply chain to hold strategic business discussions on the most pressing industry issues.
//www.hda.org/events/2019-business-and-leadership-conference/business-appointments/partnerlinx
HDA’s Business and Leadership Conference (BLC) is the healthcare distribution industry’s signature annual conference, developed by and for healthcare supply chain leaders and innovators. Exclusive to HDA member companies, the conference brings together high-level executives, thought leaders and influential managers from across the healthcare supply chain to hold strategic business discussions on the most pressing industry issues.
Conference Coordinators
//www.hda.org/events/2019-business-and-leadership-conference/business-appointments/conference-coordinators
HDA’s Business and Leadership Conference (BLC) is the healthcare distribution industry’s signature annual conference, developed by and for healthcare supply chain leaders and innovators. Exclusive to HDA member companies, the conference brings together high-level executives, thought leaders and influential managers from across the healthcare supply chain to hold strategic business discussions on the most pressing industry issues.
//www.hda.org/events/2019-business-and-leadership-conference/business-appointments/conference-coordinators
HDA’s Business and Leadership Conference (BLC) is the healthcare distribution industry’s signature annual conference, developed by and for healthcare supply chain leaders and innovators. Exclusive to HDA member companies, the conference brings together high-level executives, thought leaders and influential managers from across the healthcare supply chain to hold strategic business discussions on the most pressing industry issues.
Service Provider Pavilion
//www.hda.org/events/2019-business-and-leadership-conference/service-provider-pavilion
HDA’s Business and Leadership Conference (BLC) is the healthcare distribution industry’s signature annual conference, developed by and for healthcare supply chain leaders and innovators. Exclusive to HDA member companies, the conference brings together high-level executives, thought leaders and influential managers from across the healthcare supply chain to hold strategic business discussions on the most pressing industry issues.
//www.hda.org/events/2019-business-and-leadership-conference/service-provider-pavilion
HDA’s Business and Leadership Conference (BLC) is the healthcare distribution industry’s signature annual conference, developed by and for healthcare supply chain leaders and innovators. Exclusive to HDA member companies, the conference brings together high-level executives, thought leaders and influential managers from across the healthcare supply chain to hold strategic business discussions on the most pressing industry issues.
Current Exhibitors
//www.hda.org/events/2019-business-and-leadership-conference/service-provider-pavilion/current-exhibitors
//www.hda.org/events/2019-business-and-leadership-conference/service-provider-pavilion/current-exhibitors
Benefits
//www.hda.org/events/2019-business-and-leadership-conference/service-provider-pavilion/benefits
HDA’s Business and Leadership Conference (BLC) is the healthcare distribution industry’s signature annual conference, developed by and for healthcare supply chain leaders and innovators. Exclusive to HDA member companies, the conference brings together high-level executives, thought leaders and influential managers from across the healthcare supply chain to hold strategic business discussions on the most pressing industry issues.
//www.hda.org/events/2019-business-and-leadership-conference/service-provider-pavilion/benefits
HDA’s Business and Leadership Conference (BLC) is the healthcare distribution industry’s signature annual conference, developed by and for healthcare supply chain leaders and innovators. Exclusive to HDA member companies, the conference brings together high-level executives, thought leaders and influential managers from across the healthcare supply chain to hold strategic business discussions on the most pressing industry issues.
Cancellation Policies
//www.hda.org/events/2019-business-and-leadership-conference/cancellation-policies
HDA’s Business and Leadership Conference (BLC) is the healthcare distribution industry’s signature annual conference, developed by and for healthcare supply chain leaders and innovators. Exclusive to HDA member companies, the conference brings together high-level executives, thought leaders and influential managers from across the healthcare supply chain to hold strategic business discussions on the most pressing industry issues.
//www.hda.org/events/2019-business-and-leadership-conference/cancellation-policies
HDA’s Business and Leadership Conference (BLC) is the healthcare distribution industry’s signature annual conference, developed by and for healthcare supply chain leaders and innovators. Exclusive to HDA member companies, the conference brings together high-level executives, thought leaders and influential managers from across the healthcare supply chain to hold strategic business discussions on the most pressing industry issues.
Sponsorship
//www.hda.org/events/2019-business-and-leadership-conference/sponsorship
HDA’s Business and Leadership Conference (BLC) is the healthcare distribution industry’s signature annual conference, developed by and for healthcare supply chain leaders and innovators. Exclusive to HDA member companies, the conference brings together high-level executives, thought leaders and influential managers from across the healthcare supply chain to hold strategic business discussions on the most pressing industry issues.
//www.hda.org/events/2019-business-and-leadership-conference/sponsorship
HDA’s Business and Leadership Conference (BLC) is the healthcare distribution industry’s signature annual conference, developed by and for healthcare supply chain leaders and innovators. Exclusive to HDA member companies, the conference brings together high-level executives, thought leaders and influential managers from across the healthcare supply chain to hold strategic business discussions on the most pressing industry issues.
Contact Us
//www.hda.org/events/2019-business-and-leadership-conference/contact-us
HDA’s Business and Leadership Conference (BLC) is the healthcare distribution industry’s signature annual conference, developed by and for healthcare supply chain leaders and innovators. Exclusive to HDA member companies, the conference brings together high-level executives, thought leaders and influential managers from across the healthcare supply chain to hold strategic business discussions on the most pressing industry issues.
//www.hda.org/events/2019-business-and-leadership-conference/contact-us
HDA’s Business and Leadership Conference (BLC) is the healthcare distribution industry’s signature annual conference, developed by and for healthcare supply chain leaders and innovators. Exclusive to HDA member companies, the conference brings together high-level executives, thought leaders and influential managers from across the healthcare supply chain to hold strategic business discussions on the most pressing industry issues.
Contact Us
//www.hda.org/events/2020-blc-online/contact-us
We are pleased to announce that the 2020 Business and Leadership Conference has been moved to an online format. Building on the strong attributes associated with HDA's annual member conference, the HDA BLC Online will now provide an opportunity to connect with your supply chain partners though a virtual setting.
//www.hda.org/events/2020-blc-online/contact-us
We are pleased to announce that the 2020 Business and Leadership Conference has been moved to an online format. Building on the strong attributes associated with HDA's annual member conference, the HDA BLC Online will now provide an opportunity to connect with your supply chain partners though a virtual setting.
DIANA Award
//www.hda.org/about/industry-recognition/diana
HDA's DIANA awards honor pharmaceutical and consumer manufacturers for launching successful product introductions and promotions as well as building stronger business practices with HDA distributor members.
//www.hda.org/about/industry-recognition/diana
HDA's DIANA awards honor pharmaceutical and consumer manufacturers for launching successful product introductions and promotions as well as building stronger business practices with HDA distributor members.
Nexus Award
//www.hda.org/foundation/events-and-awards/nexus-award
Since 1956, the Nexus Award has been the pharmaceutical distribution industry's highest award recognizing lifetime achievement. It honors exceptional character; accomplishments; and leadership in HDA, the industry and the community.
//www.hda.org/foundation/events-and-awards/nexus-award
Since 1956, the Nexus Award has been the pharmaceutical distribution industry's highest award recognizing lifetime achievement. It honors exceptional character; accomplishments; and leadership in HDA, the industry and the community.
Nexus Award Winners
//www.hda.org/foundation/events-and-awards/nexus-award/nexus-award-winners
Since 1956, the Nexus Award has been the pharmaceutical distribution industry's highest award recognizing lifetime achievement. It honors exceptional character; accomplishments; and leadership in HDA, the industry and the community.
//www.hda.org/foundation/events-and-awards/nexus-award/nexus-award-winners
Since 1956, the Nexus Award has been the pharmaceutical distribution industry's highest award recognizing lifetime achievement. It honors exceptional character; accomplishments; and leadership in HDA, the industry and the community.
Event Details and Due Dates
//www.hda.org/events/speaker-resource-center/event-details-and-due-dates
//www.hda.org/events/speaker-resource-center/event-details-and-due-dates
Contact Us
//www.hda.org/events/2020-hda-pcsc-educational-seminar/contact-us
HDA's 2020 Pharmaceutical Cargo Security Coalition (PCSC) Educational Seminar will now take place virtually. The Pharmaceutical Cargo Security Coalition (PCSC) Online Seminar will bring together those within healthcare, as well as many other industries, that ship and store sensitive, high-risk/high-value products — anywhere in the world.
//www.hda.org/events/2020-hda-pcsc-educational-seminar/contact-us
HDA's 2020 Pharmaceutical Cargo Security Coalition (PCSC) Educational Seminar will now take place virtually. The Pharmaceutical Cargo Security Coalition (PCSC) Online Seminar will bring together those within healthcare, as well as many other industries, that ship and store sensitive, high-risk/high-value products — anywhere in the world.
Speakers
//www.hda.org/events/2020-traceability-seminar/speakers
Speaker information for the 2020 Traceability Seminar.
//www.hda.org/events/2020-traceability-seminar/speakers
Speaker information for the 2020 Traceability Seminar.
Speakers
//www.hda.org/events/distribution-management-webinar-series/speakers
Through the Distribution Management Webinar Series, HDA is bringing DMC 2020 programming directly to your screens. In this complimentary webinar series, HDA has curated its timeliest educational sessions to present in a virtual format.
//www.hda.org/events/distribution-management-webinar-series/speakers
Through the Distribution Management Webinar Series, HDA is bringing DMC 2020 programming directly to your screens. In this complimentary webinar series, HDA has curated its timeliest educational sessions to present in a virtual format.
Contact Us
//www.hda.org/events/distribution-management-webinar-series/contact-us
Through the Distribution Management Webinar Series, HDA is bringing DMC 2020 programming directly to your screens. In this complimentary webinar series, HDA has curated its timeliest educational sessions to present in a virtual format.
//www.hda.org/events/distribution-management-webinar-series/contact-us
Through the Distribution Management Webinar Series, HDA is bringing DMC 2020 programming directly to your screens. In this complimentary webinar series, HDA has curated its timeliest educational sessions to present in a virtual format.
Daily Schedule
//www.hda.org/events/distribution-management-webinar-series/daily-schedule
Through the Distribution Management Webinar Series, HDA is bringing DMC 2020 programming directly to your screens. In this complimentary webinar series, HDA has curated its timeliest educational sessions to present in a virtual format.
//www.hda.org/events/distribution-management-webinar-series/daily-schedule
Through the Distribution Management Webinar Series, HDA is bringing DMC 2020 programming directly to your screens. In this complimentary webinar series, HDA has curated its timeliest educational sessions to present in a virtual format.
How to Apply
//www.hda.org/professional-development/emerging-leaders/how-to-apply
To develop the next generation of supply chain leaders, the Healthcare Distribution Alliance (HDA) is further expanding its professional development program, Convene, to include the Emerging Leaders program.
//www.hda.org/professional-development/emerging-leaders/how-to-apply
To develop the next generation of supply chain leaders, the Healthcare Distribution Alliance (HDA) is further expanding its professional development program, Convene, to include the Emerging Leaders program.
Benefits
//www.hda.org/professional-development/emerging-leaders/benefits
To develop the next generation of supply chain leaders, the Healthcare Distribution Alliance (HDA) is further expanding its professional development program, Convene, to include the Emerging Leaders program.
//www.hda.org/professional-development/emerging-leaders/benefits
To develop the next generation of supply chain leaders, the Healthcare Distribution Alliance (HDA) is further expanding its professional development program, Convene, to include the Emerging Leaders program.
Mentoring Resources
//www.hda.org/professional-development/mentoring/mentoring-resources
Mentoring resources provided include tips for HDA Mentors and Mentees, suggestions to help build a strong foundation with your mentor/mentee, and other resources including articles and links.
//www.hda.org/professional-development/mentoring/mentoring-resources
Mentoring resources provided include tips for HDA Mentors and Mentees, suggestions to help build a strong foundation with your mentor/mentee, and other resources including articles and links.
How to Participate
//www.hda.org/professional-development/mentoring/how-to-participate
The level of participation and type of relationship is up to you. Some participants may want to focus on a specific project or aspect of their current jobs; others may want guidance on navigating the industry or preparing for a new role or promotion. Accordingly, some mentor/mentee relationships will be long-term and others will be short-term; some will be structured and others will be more fluid. One size does not fit all!
//www.hda.org/professional-development/mentoring/how-to-participate
The level of participation and type of relationship is up to you. Some participants may want to focus on a specific project or aspect of their current jobs; others may want guidance on navigating the industry or preparing for a new role or promotion. Accordingly, some mentor/mentee relationships will be long-term and others will be short-term; some will be structured and others will be more fluid. One size does not fit all!
Benefits of Mentoring
//www.hda.org/professional-development/mentoring/benefits-of-mentoring
According to Fortune's Anne Fisher, the HR department of Sun Microsystems found a variety of mentoring benefits by analyzing 1,000 employees over five years.
//www.hda.org/professional-development/mentoring/benefits-of-mentoring
According to Fortune's Anne Fisher, the HR department of Sun Microsystems found a variety of mentoring benefits by analyzing 1,000 employees over five years.
Matthew DiLoreto
/persons/matthew-diloreto
Matthew DiLoreto is Vice President, State Government Affairs, for HDA.
/persons/matthew-diloreto
Matthew DiLoreto is Vice President, State Government Affairs, for HDA.
Elizabeth A. Gallenagh, Esq.
/persons/elizabeth-gallenagh
Elizabeth A. Gallenagh, Esq., is the General Counsel and Senior Vice President, Supply Chain Integrity for HDA.
/persons/elizabeth-gallenagh
Elizabeth A. Gallenagh, Esq., is the General Counsel and Senior Vice President, Supply Chain Integrity for HDA.
Service Provider
//www.hda.org/about/membership/service-provider
HDA service providers provide goods and services to distributors and manufacturers that are not intended for resale. These companies may include, but are not limited to, advertisers and consultants, public relations firms, media companies, brokers, hardware/software suppliers and publishers.
//www.hda.org/about/membership/service-provider
HDA service providers provide goods and services to distributors and manufacturers that are not intended for resale. These companies may include, but are not limited to, advertisers and consultants, public relations firms, media companies, brokers, hardware/software suppliers and publishers.
International
//www.hda.org/about/membership/international
HDA international distributors must operate as a full-service, healthcare-related product wholesaler in a geographical territory outside the United States and its territories.
//www.hda.org/about/membership/international
HDA international distributors must operate as a full-service, healthcare-related product wholesaler in a geographical territory outside the United States and its territories.
Health, Beauty and Wellness/Consumer Manufacturers
//www.hda.org/about/membership/hbw
Health, beauty and wellness or consumer manufacturers considering HDA membership are primarily engaged in developing, manufacturing or labeling beauty care or consumer products.
//www.hda.org/about/membership/hbw
Health, beauty and wellness or consumer manufacturers considering HDA membership are primarily engaged in developing, manufacturing or labeling beauty care or consumer products.
Manufacturer
//www.hda.org/about/membership/manufacturer
HDA Manufacturers are primarily engaged in developing, manufacturing or labeling healthcare products.
//www.hda.org/about/membership/manufacturer
HDA Manufacturers are primarily engaged in developing, manufacturing or labeling healthcare products.
Distributor
//www.hda.org/about/membership/distributor
Distributors considering an HDA membership must purchase or receive pharmaceutical and health-related products in bulk quantities, inventory these products, distribute them in individual package quantities and provide other value-added services to its suppliers and healthcare providers.
//www.hda.org/about/membership/distributor
Distributors considering an HDA membership must purchase or receive pharmaceutical and health-related products in bulk quantities, inventory these products, distribute them in individual package quantities and provide other value-added services to its suppliers and healthcare providers.
How to Apply
//www.hda.org/professional-development/scholarship-program/how-to-apply
As part of its mission to foster industry knowledge, the HDA Research Foundation is expanding its offerings, via a graduate scholarship program, to help cultivate the next generation of supply chain leaders.
//www.hda.org/professional-development/scholarship-program/how-to-apply
As part of its mission to foster industry knowledge, the HDA Research Foundation is expanding its offerings, via a graduate scholarship program, to help cultivate the next generation of supply chain leaders.
How to Apply
//www.hda.org/foundation/scholarship-program/how-to-apply
As part of its mission to foster industry knowledge, the HDA Research Foundation is expanding its offerings, via a graduate scholarship program, to help cultivate the next generation of supply chain leaders.
//www.hda.org/foundation/scholarship-program/how-to-apply
As part of its mission to foster industry knowledge, the HDA Research Foundation is expanding its offerings, via a graduate scholarship program, to help cultivate the next generation of supply chain leaders.
The Vital Link in Healthcare
//www.hda.org/foundation/resources/the-vital-link
HDA's "Vital Link Toolkit" was created to inform and educate the public on the role of pharmaceutical distributors in the healthcare industry.
//www.hda.org/foundation/resources/the-vital-link
HDA's "Vital Link Toolkit" was created to inform and educate the public on the role of pharmaceutical distributors in the healthcare industry.
Nominations
//www.hda.org/about/industry-recognition/diana/nominations
The DIANA Best Overall Manufacturer Award is a distributor-driven nomination process. HDA distributor members are asked to nominate their top five manufacturer partners in each of the categories. The nomination process for the DIANA Best New Product or Promotion Awards is primarily manufacturer-driven, with manufacturer members asked to submit nomination materials in the applicable five categories. HDA distributor members also may nominate a trading partner for the awards.
//www.hda.org/about/industry-recognition/diana/nominations
The DIANA Best Overall Manufacturer Award is a distributor-driven nomination process. HDA distributor members are asked to nominate their top five manufacturer partners in each of the categories. The nomination process for the DIANA Best New Product or Promotion Awards is primarily manufacturer-driven, with manufacturer members asked to submit nomination materials in the applicable five categories. HDA distributor members also may nominate a trading partner for the awards.
DMA
//www.hda.org/about/industry-recognition/dma
The Distribution Management Award honors HDA member companies’ efforts to improve the efficiency, effectiveness and safety of the healthcare supply chain through successful trading partner initiatives that enhance processes, reduce costs and leverage advanced technologies or logistical practices.
//www.hda.org/about/industry-recognition/dma
The Distribution Management Award honors HDA member companies’ efforts to improve the efficiency, effectiveness and safety of the healthcare supply chain through successful trading partner initiatives that enhance processes, reduce costs and leverage advanced technologies or logistical practices.
Contact Us
//www.hda.org/events/2021-business-and-leadership-conference/contact-us
HDA’s Business and Leadership Conference (BLC) is the healthcare distribution industry’s signature annual conference, developed by and for healthcare supply chain leaders and innovators. Exclusive to HDA member companies, the conference brings together high-level executives, thought leaders and influential managers from across the healthcare supply chain to hold strategic business discussions on the most pressing industry issues.
//www.hda.org/events/2021-business-and-leadership-conference/contact-us
HDA’s Business and Leadership Conference (BLC) is the healthcare distribution industry’s signature annual conference, developed by and for healthcare supply chain leaders and innovators. Exclusive to HDA member companies, the conference brings together high-level executives, thought leaders and influential managers from across the healthcare supply chain to hold strategic business discussions on the most pressing industry issues.
Speakers
//www.hda.org/events/2021-traceability-seminar/speakers
Speaker information for the 2019 Traceability Seminar to be held at the Marriott Wardman Park Hotel in Washington DC on October 21-23, 2019
//www.hda.org/events/2021-traceability-seminar/speakers
Speaker information for the 2019 Traceability Seminar to be held at the Marriott Wardman Park Hotel in Washington DC on October 21-23, 2019
Daily Schedule
//www.hda.org/events/2021-traceability-seminar/daily-schedule
Program agenda for the Traceability Seminar held at the Marriott Wardman Park Hotel in Washington DC on October 21-23, 2019
//www.hda.org/events/2021-traceability-seminar/daily-schedule
Program agenda for the Traceability Seminar held at the Marriott Wardman Park Hotel in Washington DC on October 21-23, 2019
Previous Attendees
//www.hda.org/events/2021-traceability-seminar/previous-attendees
Companies that previously attended the HDA 2020 Traceability Seminar
//www.hda.org/events/2021-traceability-seminar/previous-attendees
Companies that previously attended the HDA 2020 Traceability Seminar
COVID-19 Information
//www.hda.org/events/2021-distribution-management-conference-and-expo/covid19-info
The safety and well-being of our members is paramount, and HDA is working closely with the hotel on the health safeguards they have put in place to host our in-person meeting.
//www.hda.org/events/2021-distribution-management-conference-and-expo/covid19-info
The safety and well-being of our members is paramount, and HDA is working closely with the hotel on the health safeguards they have put in place to host our in-person meeting.
Awards
//www.hda.org/events/2021-distribution-management-conference-and-expo/award
The Distribution Management Conference and Expo is HDA's largest supply chain education event, attended by more than 500 manufacturers, distributors, consultants and third parties who keep the pharmaceutical distribution industry moving.
//www.hda.org/events/2021-distribution-management-conference-and-expo/award
The Distribution Management Conference and Expo is HDA's largest supply chain education event, attended by more than 500 manufacturers, distributors, consultants and third parties who keep the pharmaceutical distribution industry moving.
Registration
//www.hda.org/events/2021-distribution-management-conference-and-expo/registration
The Distribution Management Conference and Expo is HDA's largest supply chain education event, attended by more than 500 manufacturers, distributors, consultants and third parties who keep the pharmaceutical distribution industry moving.
//www.hda.org/events/2021-distribution-management-conference-and-expo/registration
The Distribution Management Conference and Expo is HDA's largest supply chain education event, attended by more than 500 manufacturers, distributors, consultants and third parties who keep the pharmaceutical distribution industry moving.
Contact Us
//www.hda.org/events/2021-distribution-management-conference-and-expo/contact-us
The Distribution Management Conference and Expo is HDA's largest supply chain education event, attended by more than 500 manufacturers, distributors, consultants and third parties who keep the pharmaceutical distribution industry moving.
//www.hda.org/events/2021-distribution-management-conference-and-expo/contact-us
The Distribution Management Conference and Expo is HDA's largest supply chain education event, attended by more than 500 manufacturers, distributors, consultants and third parties who keep the pharmaceutical distribution industry moving.
Hotel and Travel
//www.hda.org/events/2021-distribution-management-conference-and-expo/hotel-and-travel
The Distribution Management Conference and Expo is HDA's largest supply chain education event, attended by more than 500 manufacturers, distributors, consultants and third parties who keep the pharmaceutical distribution industry moving.
//www.hda.org/events/2021-distribution-management-conference-and-expo/hotel-and-travel
The Distribution Management Conference and Expo is HDA's largest supply chain education event, attended by more than 500 manufacturers, distributors, consultants and third parties who keep the pharmaceutical distribution industry moving.
Hotel and Travel
//www.hda.org/events/2021-business-and-leadership-conference/hotel-and-travel
HDA’s Business and Leadership Conference (BLC) is the healthcare distribution industry’s signature annual conference, developed by and for healthcare supply chain leaders and innovators. Exclusive to HDA member companies, the conference brings together high-level executives, thought leaders and influential managers from across the healthcare supply chain to hold strategic business discussions on the most pressing industry issues.
//www.hda.org/events/2021-business-and-leadership-conference/hotel-and-travel
HDA’s Business and Leadership Conference (BLC) is the healthcare distribution industry’s signature annual conference, developed by and for healthcare supply chain leaders and innovators. Exclusive to HDA member companies, the conference brings together high-level executives, thought leaders and influential managers from across the healthcare supply chain to hold strategic business discussions on the most pressing industry issues.
CEO Roundtable
//www.hda.org/foundation/events-and-awards/ceo-roundtable
The CEO Roundtable is the HDA Research Foundation’s annual fundraiser and helps to support the Foundation’s mission to increase supply chain efficiency and effectiveness as well as to enhance patient safety.
//www.hda.org/foundation/events-and-awards/ceo-roundtable
The CEO Roundtable is the HDA Research Foundation’s annual fundraiser and helps to support the Foundation’s mission to increase supply chain efficiency and effectiveness as well as to enhance patient safety.
The SUPPORT for Patients and Communities Act: One Year Later
//www.hda.org/news/hda-blog/2019/12/17/11/08/2019-12-17-support-act-one-year-later
In October 2018, the SUPPORT for Patients and Communities Act was signed into law. This bipartisan legislation offered a comprehensive response to the prescription opioid abuse epidemic — its enactment marked a significant step towards advancing meaningful solutions to address this public health crisis.
//www.hda.org/news/hda-blog/2019/12/17/11/08/2019-12-17-support-act-one-year-later
In October 2018, the SUPPORT for Patients and Communities Act was signed into law. This bipartisan legislation offered a comprehensive response to the prescription opioid abuse epidemic — its enactment marked a significant step towards advancing meaningful solutions to address this public health crisis.
The Future Role of Distributors
//www.hda.org/news/hda-blog/2019/12/18/09/16/2019-12-19-the-future-role-of-distributors
Distributors sit at the heart of the pharmaceutical supply chain, connecting 180,000 healthcare providers and pharmacies with 1,300 drug manufacturers. Through their partnerships across the industry, pharmaceutical distributors provide the more than 180 million patients who regularly take prescription medicines with safe, quick and low-cost access to more than 4 billion prescription medicines each year.
//www.hda.org/news/hda-blog/2019/12/18/09/16/2019-12-19-the-future-role-of-distributors
Distributors sit at the heart of the pharmaceutical supply chain, connecting 180,000 healthcare providers and pharmacies with 1,300 drug manufacturers. Through their partnerships across the industry, pharmaceutical distributors provide the more than 180 million patients who regularly take prescription medicines with safe, quick and low-cost access to more than 4 billion prescription medicines each year.
Helping Independent Pharmacies Navigate the Changing Healthcare Landscape
//www.hda.org/news/hda-blog/2019/10/29/13/53/2019-10-29-helping-independent-pharmacies
//www.hda.org/news/hda-blog/2019/10/29/13/53/2019-10-29-helping-independent-pharmacies
Member Spotlight: Tropical Storm Barry Highlights Distributors’ Crucial Role
//www.hda.org/news/hda-blog/2019/08/07/13/26/2019-08-06-member-spotlight
Most days, pharmaceutical distributors fulfill their vital role largely unnoticed. Patients take for granted their medications will reach them safely and quickly. They don’t think about the systems, protocols, professionalism and technology required to make delivery seamless from manufacturer to pharmacy and, ultimately, to them.
//www.hda.org/news/hda-blog/2019/08/07/13/26/2019-08-06-member-spotlight
Most days, pharmaceutical distributors fulfill their vital role largely unnoticed. Patients take for granted their medications will reach them safely and quickly. They don’t think about the systems, protocols, professionalism and technology required to make delivery seamless from manufacturer to pharmacy and, ultimately, to them.
Convening Healthcare Stakeholders to Address the Opioid Epidemic
//www.hda.org/news/hda-blog/2019/03/19/10/15/2019-03-19-convening-healthcare-stakeholders-to-address-the-opioid-epidemic
Last week, Allied Against Opioid Abuse (AAOA) partners, the National Community Pharmacists Association (NCPA) and the PA Foundation, joined HDA at the Distribution Management Conference and Expo (DMC) for a discussion about how we are working together to educate and raise awareness about the rights, risks and responsibilities associated with prescription opioids.
//www.hda.org/news/hda-blog/2019/03/19/10/15/2019-03-19-convening-healthcare-stakeholders-to-address-the-opioid-epidemic
Last week, Allied Against Opioid Abuse (AAOA) partners, the National Community Pharmacists Association (NCPA) and the PA Foundation, joined HDA at the Distribution Management Conference and Expo (DMC) for a discussion about how we are working together to educate and raise awareness about the rights, risks and responsibilities associated with prescription opioids.
Safe and Secure, Every Step of the Way
//www.hda.org/news/hda-blog/2019/06/18/09/47/2019-06-19-safe-and-secure
Patients often have many questions when they are prescribed a medication by their healthcare provider for the first time. What they typically do not need to worry about, however, is how their prescription medicine got to the pharmacy, whether anything happened to it along its journey, if it was handled with care or if it was potentially compromised by illegitimate products that may have entered the pharmaceutical supply chain.
//www.hda.org/news/hda-blog/2019/06/18/09/47/2019-06-19-safe-and-secure
Patients often have many questions when they are prescribed a medication by their healthcare provider for the first time. What they typically do not need to worry about, however, is how their prescription medicine got to the pharmacy, whether anything happened to it along its journey, if it was handled with care or if it was potentially compromised by illegitimate products that may have entered the pharmaceutical supply chain.
Introducing a Hero of the Supply Chain
//www.hda.org/news/hda-blog/2019/06/19/10/46/2019-06-10-introducing-a-hero-of-the-supply-chain
HDA is proud to partner with and support Healthcare Ready’s Heroes of the Supply Chain campaign, which highlights the unsung heroes who keep critical healthcare supply chains intact all year long.
//www.hda.org/news/hda-blog/2019/06/19/10/46/2019-06-10-introducing-a-hero-of-the-supply-chain
HDA is proud to partner with and support Healthcare Ready’s Heroes of the Supply Chain campaign, which highlights the unsung heroes who keep critical healthcare supply chains intact all year long.
HDA Research Foundation Announces its First Scholarship Recipients
//www.hda.org/news/hda-blog/2019/02/22/10/35/2019-02-22-hda-research-foundation-announces-its-first-scholarship-recipients
The HDA Research Foundation recently announced the selection of four inaugural recipients for its graduate-level scholarship. Established in conjunction with HDA’s Convene, the scholarship, sponsored by Teva Pharmaceuticals, is available annually to individuals with at least two years of service working within HDA-member distributor and manufacturer companies. The recipients include:
//www.hda.org/news/hda-blog/2019/02/22/10/35/2019-02-22-hda-research-foundation-announces-its-first-scholarship-recipients
The HDA Research Foundation recently announced the selection of four inaugural recipients for its graduate-level scholarship. Established in conjunction with HDA’s Convene, the scholarship, sponsored by Teva Pharmaceuticals, is available annually to individuals with at least two years of service working within HDA-member distributor and manufacturer companies. The recipients include:
Healthcare Distribution: Rain, Snow or Shine
//www.hda.org/news/hda-blog/2019/02/01/10/00/2019-02-01-healthcare-distribution-rain-snow-or-shine
Pharmaceutical distributors deliver millions of medicines and healthcare products to providers nationwide — rain, snow or shine. Every day, hundreds of thousands of patients across the country depend on the uninterrupted delivery of prescription medicines, and pharmaceutical distributors work around the clock to ensure these products get to where they need to be, safely and efficiently. As winter marches on, with snowstorms and sub-zero temperatures in parts of the country, HDA member companies rise to the challenge of making sure vital medicines reach the people who need them, no matter what it takes.
//www.hda.org/news/hda-blog/2019/02/01/10/00/2019-02-01-healthcare-distribution-rain-snow-or-shine
Pharmaceutical distributors deliver millions of medicines and healthcare products to providers nationwide — rain, snow or shine. Every day, hundreds of thousands of patients across the country depend on the uninterrupted delivery of prescription medicines, and pharmaceutical distributors work around the clock to ensure these products get to where they need to be, safely and efficiently. As winter marches on, with snowstorms and sub-zero temperatures in parts of the country, HDA member companies rise to the challenge of making sure vital medicines reach the people who need them, no matter what it takes.
That's A Great Question
//www.hda.org/news/hda-blog/2019/05/16/09/44/2019-05-16-a-great-question
Most Americans take for granted the complex pharmaceutical supply chain that ensures their medication arrives safely, reliably and efficiently at the pharmacy, doctor’s office or hospital. Have you ever wondered how pharmacies and healthcare providers keep these vital medicines in stock so that patients have access to medicines when they need them, even during weather emergencies?
//www.hda.org/news/hda-blog/2019/05/16/09/44/2019-05-16-a-great-question
Most Americans take for granted the complex pharmaceutical supply chain that ensures their medication arrives safely, reliably and efficiently at the pharmacy, doctor’s office or hospital. Have you ever wondered how pharmacies and healthcare providers keep these vital medicines in stock so that patients have access to medicines when they need them, even during weather emergencies?
Ten Things to Know About the Opioid Abuse Epidemic
//www.hda.org/news/hda-blog/2019/04/16/10/56/2019-04-16-ten-things-to-know-about-the-opioid-abuse-epidemic
//www.hda.org/news/hda-blog/2019/04/16/10/56/2019-04-16-ten-things-to-know-about-the-opioid-abuse-epidemic
More Than Just Delivery
//www.hda.org/news/hda-blog/2019/04/25/15/38/2019-04-26-more-than-just-delivery
As the logistics experts of healthcare, distributors deliver millions of prescription medicines and healthcare products to hundreds of thousands of providers, including pharmacies, hospitals and healthcare facilities, across the country. But their relationships with these customers is about more than just delivery — distributors offer additional services that allow their customers to focus on patients and remain competitive in the marketplace.
//www.hda.org/news/hda-blog/2019/04/25/15/38/2019-04-26-more-than-just-delivery
As the logistics experts of healthcare, distributors deliver millions of prescription medicines and healthcare products to hundreds of thousands of providers, including pharmacies, hospitals and healthcare facilities, across the country. But their relationships with these customers is about more than just delivery — distributors offer additional services that allow their customers to focus on patients and remain competitive in the marketplace.
A Day in the Life at a Distribution Center
//www.hda.org/news/hda-blog/2019/07/15/14/03/2019-07-15-a-day-in-the-life-distribution-center
Step into a pharmaceutical distribution center, and you will find a modern facility bustling with activity. In today’s state-of-the-art facilities, passionate employees, supported by sophisticated new technology, work around the clock to fulfill shipments to hundreds of thousands of pharmacies, hospitals and other healthcare facilities across the country.
//www.hda.org/news/hda-blog/2019/07/15/14/03/2019-07-15-a-day-in-the-life-distribution-center
Step into a pharmaceutical distribution center, and you will find a modern facility bustling with activity. In today’s state-of-the-art facilities, passionate employees, supported by sophisticated new technology, work around the clock to fulfill shipments to hundreds of thousands of pharmacies, hospitals and other healthcare facilities across the country.
Minimizing Risk Within the Pharmaceutical Supply Chain
//www.hda.org/news/hda-blog/2019/11/18/14/55/2019-11-19-minimizing-risk-within-the-pharmaceutical-supply-chain
The U.S. pharmaceutical supply chain is responsible for providing patients safe, secure and timely access to more than 4 billion prescription medicines every year. Sustaining this complex supply chain requires the collaboration between a diverse group of partners, including manufacturers, distributors, pharmacies as well as other healthcare facilities and providers.
//www.hda.org/news/hda-blog/2019/11/18/14/55/2019-11-19-minimizing-risk-within-the-pharmaceutical-supply-chain
The U.S. pharmaceutical supply chain is responsible for providing patients safe, secure and timely access to more than 4 billion prescription medicines every year. Sustaining this complex supply chain requires the collaboration between a diverse group of partners, including manufacturers, distributors, pharmacies as well as other healthcare facilities and providers.
Leveraging Efficiency Across the Pharmaceutical Supply Chain
//www.hda.org/news/hda-blog/2019/09/03/14/36/2019-09-09-leveraging-efficiency-across-the-pharmaceutical-supply-chain
//www.hda.org/news/hda-blog/2019/09/03/14/36/2019-09-09-leveraging-efficiency-across-the-pharmaceutical-supply-chain
Distributors Leading Efforts to Maintain Supply Chain Integrity
//www.hda.org/news/hda-blog/2020/03/27/14/35/2020-03-27-distributors-leading-efforts-to-maintain-supply-chain-integrity
While the impact of the COVID-19 pandemic continues to unfold, distributors are taking proactive steps and working closely with the broader healthcare community to respond to the crisis and prevent disruptions to the pharmaceutical supply chain. As the logistics experts of healthcare, our commitment is to ensure that providers, pharmacies and the patients they serve have access to the vital medicines and supplies they need during these challenging times.
//www.hda.org/news/hda-blog/2020/03/27/14/35/2020-03-27-distributors-leading-efforts-to-maintain-supply-chain-integrity
While the impact of the COVID-19 pandemic continues to unfold, distributors are taking proactive steps and working closely with the broader healthcare community to respond to the crisis and prevent disruptions to the pharmaceutical supply chain. As the logistics experts of healthcare, our commitment is to ensure that providers, pharmacies and the patients they serve have access to the vital medicines and supplies they need during these challenging times.
Beyond Distribution: The Role of Hub Services
//www.hda.org/news/hda-blog/2020/01/29/15/05/2020-01-30-beyond-distribution-hub-services
The core mission of pharmaceutical distribution — secure, efficient and reliable healthcare delivery — provides more than 180 million patients across the United States with efficient and low-cost access to more than 4 billion prescription medicines each year. But distributors’ work does not end there.
//www.hda.org/news/hda-blog/2020/01/29/15/05/2020-01-30-beyond-distribution-hub-services
The core mission of pharmaceutical distribution — secure, efficient and reliable healthcare delivery — provides more than 180 million patients across the United States with efficient and low-cost access to more than 4 billion prescription medicines each year. But distributors’ work does not end there.
HDA Spotlights 2019 Accomplishments
//www.hda.org/news/hda-blog/2020/01/23/15/31/2020-01-29-hda-highlights-2019-accomplishments
HDA has published “A Year in Review,” which chronicles the Alliance’s 2019 activities.
//www.hda.org/news/hda-blog/2020/01/23/15/31/2020-01-29-hda-highlights-2019-accomplishments
HDA has published “A Year in Review,” which chronicles the Alliance’s 2019 activities.
Value Drug Helps Pharmacies During COVID-19
//www.hda.org/news/hda-blog/2020/05/18/17/37/2020-05-18-helping-local-pharmacies-navigate-covid19
//www.hda.org/news/hda-blog/2020/05/18/17/37/2020-05-18-helping-local-pharmacies-navigate-covid19
TopRx Responding to COVID-19, Strengthening the Community
//www.hda.org/news/hda-blog/2020/04/30/13/21/2020-04-30-toprx-responding-to-covid-19-strengthening-the-community
The COVID-19 pandemic has upended the lives of almost every American. Businesses have closed, families have been forced apart temporarily and community events across the country have been put on hold. While the crisis has impacted each one of us differently, it has become clear that by joining together with our communities and families, we can all do our part to support each other through this crisis.
//www.hda.org/news/hda-blog/2020/04/30/13/21/2020-04-30-toprx-responding-to-covid-19-strengthening-the-community
The COVID-19 pandemic has upended the lives of almost every American. Businesses have closed, families have been forced apart temporarily and community events across the country have been put on hold. While the crisis has impacted each one of us differently, it has become clear that by joining together with our communities and families, we can all do our part to support each other through this crisis.
Partnering in Response to COVID-19
//www.hda.org/news/hda-blog/2020/04/08/15/18/2020-04-08-partnering-in-response-to-covid19
//www.hda.org/news/hda-blog/2020/04/08/15/18/2020-04-08-partnering-in-response-to-covid19
Logistics Will Help Win the Battle Against COVID-19
//www.hda.org/news/hda-blog/2020/04/17/14/22/2020-04-17-logistics-will-help-win-battle-against-covid19
Across the country, brave, frontline healthcare professionals are working around the clock as our nation grapples with the COVID-19 pandemic. These workers — the true heroes of the pandemic — are treating patients, maintaining vital healthcare operations and serving as emergency responders.
//www.hda.org/news/hda-blog/2020/04/17/14/22/2020-04-17-logistics-will-help-win-battle-against-covid19
Across the country, brave, frontline healthcare professionals are working around the clock as our nation grapples with the COVID-19 pandemic. These workers — the true heroes of the pandemic — are treating patients, maintaining vital healthcare operations and serving as emergency responders.
Understanding the Origins of the Opioid Abuse Epidemic to Advance Solutions
//www.hda.org/news/hda-blog/2018/12/06/07/59/2018-12-06-understanding-the-origins-of-the-opioid-abuse-epidemic
A new report by Avalere Health, "Trends in Opioid Use: History, Background, and Origins of the Epidemic," comes at a critical point in the broader discussion about opioid abuse and misuse, and provides important context around the clinical, regulatory and policy milestones that contributed to the public health epidemic and impacted the national response to the crisis.
//www.hda.org/news/hda-blog/2018/12/06/07/59/2018-12-06-understanding-the-origins-of-the-opioid-abuse-epidemic
A new report by Avalere Health, "Trends in Opioid Use: History, Background, and Origins of the Epidemic," comes at a critical point in the broader discussion about opioid abuse and misuse, and provides important context around the clinical, regulatory and policy milestones that contributed to the public health epidemic and impacted the national response to the crisis.
HDA Featured in Chain Drug Review's 2019 "Pharmacy Outlook"
//www.hda.org/news/hda-blog/2018/12/17/13/30/2019-01-07-hda-featured-in-chain-drug-review-outlook
With a new year in full swing, HDA President and CEO John M. Gray looked ahead to the organization’s 2019 priorities (along with other industry association executives) as part of the Chain Drug Review "Pharmacy Outlook" feature.
//www.hda.org/news/hda-blog/2018/12/17/13/30/2019-01-07-hda-featured-in-chain-drug-review-outlook
With a new year in full swing, HDA President and CEO John M. Gray looked ahead to the organization’s 2019 priorities (along with other industry association executives) as part of the Chain Drug Review "Pharmacy Outlook" feature.
VRS Update: Past, Present, Future
//www.hda.org/news/hda-blog/2018/12/07/14/44/2018-12-12-vrs-update-past-present-future
The Verification Router Service (VRS) started off as an idea in 2015. In 2016, it was identified as a preferred option for compliance with the 2019 saleable returns requirement (along with sending data via EPCIS). Since 2017, HDA has been convening industry stakeholders to write business requirements for the VRS, later pulling in solution providers to help with the technical details and then facilitating the group that developed the documentation that exists today.
//www.hda.org/news/hda-blog/2018/12/07/14/44/2018-12-12-vrs-update-past-present-future
The Verification Router Service (VRS) started off as an idea in 2015. In 2016, it was identified as a preferred option for compliance with the 2019 saleable returns requirement (along with sending data via EPCIS). Since 2017, HDA has been convening industry stakeholders to write business requirements for the VRS, later pulling in solution providers to help with the technical details and then facilitating the group that developed the documentation that exists today.
The Opioid Epidemic Requires A Greater Focus on Education and Awareness
//www.hda.org/news/hda-blog/2018/07/25/08/22/the-opioid-epidemic-requires-a-greater-focus-on-education-and-awareness
As the country looks to reverse the harmful trend of opioid addiction, the need for education and awareness around the safe use of pain treatments has never been clearer.
//www.hda.org/news/hda-blog/2018/07/25/08/22/the-opioid-epidemic-requires-a-greater-focus-on-education-and-awareness
As the country looks to reverse the harmful trend of opioid addiction, the need for education and awareness around the safe use of pain treatments has never been clearer.
2018 HDA Priorities in Chain Drug Review
//www.hda.org/news/hda-blog/2018/07/25/08/09/2018-hda-priorities-in-chain-drug-review
Efforts to mitigate the prescription drug abuse epidemic and activities surrounding DSCSA implementation once again top the list of priorities HDA will be addressing in the year ahead, according to HDA President and CEO John M. Gray. Mr. Gray provided his perspective, along with other healthcare supply chain leaders, as part of Chain Drug Review’s annual “Pharmacy Outlook” feature, published in the January 1 issue.
//www.hda.org/news/hda-blog/2018/07/25/08/09/2018-hda-priorities-in-chain-drug-review
Efforts to mitigate the prescription drug abuse epidemic and activities surrounding DSCSA implementation once again top the list of priorities HDA will be addressing in the year ahead, according to HDA President and CEO John M. Gray. Mr. Gray provided his perspective, along with other healthcare supply chain leaders, as part of Chain Drug Review’s annual “Pharmacy Outlook” feature, published in the January 1 issue.
HDA, Georgia Extend Efforts to Combat the Opioid Epidemic
//www.hda.org/news/hda-blog/2018/07/25/08/38/hda-and-georgia-extend-efforts-to-combat-the-opioid-epidemic
HDA and its member companies are committed to reversing our nation’s opioid abuse epidemic. That is why the Alliance is working with stakeholders in communities nationwide to educate and raise awareness about the dangers associated with opioid abuse and misuse.
//www.hda.org/news/hda-blog/2018/07/25/08/38/hda-and-georgia-extend-efforts-to-combat-the-opioid-epidemic
HDA and its member companies are committed to reversing our nation’s opioid abuse epidemic. That is why the Alliance is working with stakeholders in communities nationwide to educate and raise awareness about the dangers associated with opioid abuse and misuse.
HDA Launches Allied Against Opioid Abuse
//www.hda.org/news/hda-blog/2018/07/25/08/26/hda-launches-allied-against-opioid-abuse
As the logistics experts of healthcare, pharmaceutical distributors play a critical role in the day-to-day operations of the supply chain, but also when health challenges arise, such as a natural disaster or shortages in critical medicines.
//www.hda.org/news/hda-blog/2018/07/25/08/26/hda-launches-allied-against-opioid-abuse
As the logistics experts of healthcare, pharmaceutical distributors play a critical role in the day-to-day operations of the supply chain, but also when health challenges arise, such as a natural disaster or shortages in critical medicines.
Verification Router Service Progress Update
//www.hda.org/news/hda-blog/2018/07/25/08/42/verification-router-service-progress-update
As mentioned in our February 16 blog post, HDA and industry participants continue to make progress working with solution providers as Verification Router Service (VRS) solutions are developed for the 2019 DSCSA saleable returns requirement. This work has taken three paths: establishing governance processes; creating testing scenarios; and launching the testing phase.
//www.hda.org/news/hda-blog/2018/07/25/08/42/verification-router-service-progress-update
As mentioned in our February 16 blog post, HDA and industry participants continue to make progress working with solution providers as Verification Router Service (VRS) solutions are developed for the 2019 DSCSA saleable returns requirement. This work has taken three paths: establishing governance processes; creating testing scenarios; and launching the testing phase.
Three Takeaways from the FDA Public Meetings on DSCSA
//www.hda.org/news/hda-blog/2018/07/25/08/29/three-takeaways-from-the-fda-public-meetings-on-dscsa
On February 28, FDA hosted its third and final public meeting in a series focused on "Enhanced Drug Distribution Security Under the Drug Supply Chain Security Act [DSCSA],” bringing together a broad group of stakeholders, including manufacturers, distributors, dispensers, hospitals and service providers.
//www.hda.org/news/hda-blog/2018/07/25/08/29/three-takeaways-from-the-fda-public-meetings-on-dscsa
On February 28, FDA hosted its third and final public meeting in a series focused on "Enhanced Drug Distribution Security Under the Drug Supply Chain Security Act [DSCSA],” bringing together a broad group of stakeholders, including manufacturers, distributors, dispensers, hospitals and service providers.
Transitioning to Traceability
//www.hda.org/news/hda-blog/2018/07/25/08/18/transitioning-to-traceability-and-a-verification-router-service-update
The HDA blog is expanding to feature traceability/Drug Supply Chain Security Act (DSCSA) updates as well as HDA perspectives on a variety of related issues throughout the year.
//www.hda.org/news/hda-blog/2018/07/25/08/18/transitioning-to-traceability-and-a-verification-router-service-update
The HDA blog is expanding to feature traceability/Drug Supply Chain Security Act (DSCSA) updates as well as HDA perspectives on a variety of related issues throughout the year.
Prepare for DSCSA Serialization with HDA Origin
//www.hda.org/news/hda-blog/2018/07/25/08/35/prepare-for-dscsa-serialization-with-hda-origin
Last year, FDA announced a period of “enforcement discretion” related to the deadline for manufacturers to serialize products under the Drug Supply Chain Security Act (DSCSA). As the industry quickly approaches the November 2018 deadline, it is essential for companies to prepare now for the reality of conducting business in a serialized environment. Is your company ready to meet the new requirements?
//www.hda.org/news/hda-blog/2018/07/25/08/35/prepare-for-dscsa-serialization-with-hda-origin
Last year, FDA announced a period of “enforcement discretion” related to the deadline for manufacturers to serialize products under the Drug Supply Chain Security Act (DSCSA). As the industry quickly approaches the November 2018 deadline, it is essential for companies to prepare now for the reality of conducting business in a serialized environment. Is your company ready to meet the new requirements?
Preparing for National Prescription Drug Take Back Day
//www.hda.org/news/hda-blog/2018/07/25/08/32/preparing-for-national-prescription-drug-take-back-day
Disposing of unused prescription opioids safely and as soon as they are no longer needed can help prevent these medicines from falling into the wrong hands. Data show that opioid misuse often starts in the home, with more than 40 percent of those who misused prescription pain relievers obtaining the medication from a friend or relative for free.
//www.hda.org/news/hda-blog/2018/07/25/08/32/preparing-for-national-prescription-drug-take-back-day
Disposing of unused prescription opioids safely and as soon as they are no longer needed can help prevent these medicines from falling into the wrong hands. Data show that opioid misuse often starts in the home, with more than 40 percent of those who misused prescription pain relievers obtaining the medication from a friend or relative for free.
Pharmaceutical Distributors: Understanding Our Role in the Supply Chain
//www.hda.org/news/hda-blog/2018/09/27/15/32/2018-09-27-understanding-our-role-in-the-supply-chain
Few people understand exactly what role wholesale distributors play in the pharmaceutical supply chain, often confusing them with manufacturers, pharmacy benefit managers or even pharmacists. Just like the wholesale distributor who helps keep your grocery store shelves stocked with many different food brands, pharmaceutical distributors work with large numbers of suppliers (in this case pharmaceutical manufacturers) to ensure that their products (medicines) are safely, securely and reliably delivered to their ultimate destination — such as a state and federally licensed pharmacy, hospital or long-term care facility.
//www.hda.org/news/hda-blog/2018/09/27/15/32/2018-09-27-understanding-our-role-in-the-supply-chain
Few people understand exactly what role wholesale distributors play in the pharmaceutical supply chain, often confusing them with manufacturers, pharmacy benefit managers or even pharmacists. Just like the wholesale distributor who helps keep your grocery store shelves stocked with many different food brands, pharmaceutical distributors work with large numbers of suppliers (in this case pharmaceutical manufacturers) to ensure that their products (medicines) are safely, securely and reliably delivered to their ultimate destination — such as a state and federally licensed pharmacy, hospital or long-term care facility.
HDA Partners with AAOA to Release Pharmacy Toolkit
//www.hda.org/news/hda-blog/2018/09/25/09/54/2018-09-26-aaoa-releases-pharmacy-toolkit
For the past several months, HDA has been collaborating with our pharmacy partners at Allied Against Opioid Abuse (AAOA), the National Community Pharmacists Association (NCPA) and the National Alliance of State Pharmacy Associations (NASPA), to develop a suite of resources specific to the pharmacy community. We are pleased that last week, those resources were mailed to thousands of pharmacists across the country and released online at www.AgainstOpioidAbuse.org/PharmacyToolkit.
//www.hda.org/news/hda-blog/2018/09/25/09/54/2018-09-26-aaoa-releases-pharmacy-toolkit
For the past several months, HDA has been collaborating with our pharmacy partners at Allied Against Opioid Abuse (AAOA), the National Community Pharmacists Association (NCPA) and the National Alliance of State Pharmacy Associations (NASPA), to develop a suite of resources specific to the pharmacy community. We are pleased that last week, those resources were mailed to thousands of pharmacists across the country and released online at www.AgainstOpioidAbuse.org/PharmacyToolkit.
HDA Traceability Seminar to Feature FDA Update, Discussions on DSCSA Milestones
//www.hda.org/news/hda-blog/2018/08/10/10/55/2018-08-10-traceability-seminar-to-feature-fda-update
As the summer winds down, HDA is hard at work planning our 2018 Traceability Seminar, which will take place three weeks earlier, on October 17–19 at the Renaissance Washington, DC Downtown Hotel. As the industry passes the halfway mark for DSCSA implementation, our 2018 agenda leverages HDA and our members’ unique expertise to help fellow stakeholders answer critical questions while planning for the multiple milestones ahead.
//www.hda.org/news/hda-blog/2018/08/10/10/55/2018-08-10-traceability-seminar-to-feature-fda-update
As the summer winds down, HDA is hard at work planning our 2018 Traceability Seminar, which will take place three weeks earlier, on October 17–19 at the Renaissance Washington, DC Downtown Hotel. As the industry passes the halfway mark for DSCSA implementation, our 2018 agenda leverages HDA and our members’ unique expertise to help fellow stakeholders answer critical questions while planning for the multiple milestones ahead.
Gray Forecasts 2017 Alliance Priorities
//www.hda.org/news/hda-blog/2018/08/14/15/10/2017-01-02-gray-forecasts-2017-alliance-priorities-in-chain-drug-review
HDA President and CEO John M. Gray has outlined the organization’s priorities for the upcoming year in his annual “Pharmacy Outlook” column, published in the January 2 issue of Chain Drug Review.
//www.hda.org/news/hda-blog/2018/08/14/15/10/2017-01-02-gray-forecasts-2017-alliance-priorities-in-chain-drug-review
HDA President and CEO John M. Gray has outlined the organization’s priorities for the upcoming year in his annual “Pharmacy Outlook” column, published in the January 2 issue of Chain Drug Review.
HDA and NACDS Call on Congress to Protect Patient Safety
//www.hda.org/news/hda-blog/2018/08/14/14/46/2017-05-08-hda-and-nacds-call-on-congress-to-protect-patient-safety
In an opinion piece published today in the Capitol Hill newspaper, The Hill, HDA and NACDS called on members of Congress to honor its commitment to protecting patients and the safety of the supply chain by rejecting any proposal that would call for the importation of prescription drugs from foreign markets.
//www.hda.org/news/hda-blog/2018/08/14/14/46/2017-05-08-hda-and-nacds-call-on-congress-to-protect-patient-safety
In an opinion piece published today in the Capitol Hill newspaper, The Hill, HDA and NACDS called on members of Congress to honor its commitment to protecting patients and the safety of the supply chain by rejecting any proposal that would call for the importation of prescription drugs from foreign markets.
Gray Highlights State of the Distribution Industry
//www.hda.org/news/hda-blog/2018/08/14/14/37/2017-06-05-gray-highlights-state-of-distribution-industry
Ahead of the HDA Business and Leadership Conference, President and CEO John M. Gray was interviewed by Chain Drug Review as part of the publication’s “Annual Report of Drug Wholesalers.”
//www.hda.org/news/hda-blog/2018/08/14/14/37/2017-06-05-gray-highlights-state-of-distribution-industry
Ahead of the HDA Business and Leadership Conference, President and CEO John M. Gray was interviewed by Chain Drug Review as part of the publication’s “Annual Report of Drug Wholesalers.”
Fri Highlights DSCSA Efforts
//www.hda.org/news/hda-blog/2018/08/14/14/52/2017-04-17-fri-highlights-dscsa-efforts-through-healthcare-ready-blog
Implementation of the Drug Supply Chain Security Act (DSCSA) and the critical work of pharmaceutical distributors are the subject of a guest post by HDA’s Perry Fri on the Healthcare Ready blog. Healthcare Ready is a non-profit supported by both public and private sector partners, including HDA, that works to ensure patient access to healthcare, including medicines, during times of disaster.
//www.hda.org/news/hda-blog/2018/08/14/14/52/2017-04-17-fri-highlights-dscsa-efforts-through-healthcare-ready-blog
Implementation of the Drug Supply Chain Security Act (DSCSA) and the critical work of pharmaceutical distributors are the subject of a guest post by HDA’s Perry Fri on the Healthcare Ready blog. Healthcare Ready is a non-profit supported by both public and private sector partners, including HDA, that works to ensure patient access to healthcare, including medicines, during times of disaster.
A Crisis of Misinformation
//www.hda.org/news/hda-blog/2018/08/14/11/35/2017-10-18-a-crisis-of-misinformation
The Washington Post and 60 Minutes have done a major disservice to the battle against opioid abuse with their biased and one-sided reporting, specifically related to the Ensuring Patient Access and Effective Drug Enforcement Act.
//www.hda.org/news/hda-blog/2018/08/14/11/35/2017-10-18-a-crisis-of-misinformation
The Washington Post and 60 Minutes have done a major disservice to the battle against opioid abuse with their biased and one-sided reporting, specifically related to the Ensuring Patient Access and Effective Drug Enforcement Act.
Gray Calls for Systemic Response to Opioid Abuse in Op-Ed
//www.hda.org/news/hda-blog/2018/08/14/11/56/2017-07-12-gray-calls-for-systemic-response-to-opioid-abuse-in-op-ed
In an op-ed published in the Capitol Hill newspaper, The Hill, HDA President and CEO John M. Gray noted that a commitment and robust effort from all supply chain stakeholders are necessary to help mitigate the nation’s opioid abuse epidemic.
//www.hda.org/news/hda-blog/2018/08/14/11/56/2017-07-12-gray-calls-for-systemic-response-to-opioid-abuse-in-op-ed
In an op-ed published in the Capitol Hill newspaper, The Hill, HDA President and CEO John M. Gray noted that a commitment and robust effort from all supply chain stakeholders are necessary to help mitigate the nation’s opioid abuse epidemic.
The Reality of the Opioid Epidemic
//www.hda.org/news/hda-blog/2018/08/14/11/49/2017-10-13-the-reality-of-the-opioid-epidemic
Two years ago, Congress approved bipartisan legislation to address the rapidly growing opioid epidemic. Yet today, that legislation — S.483: Ensuring Patient Access and Effective Drug Enforcement Act — is the subject of two upcoming media reports which mischaracterize the intent and outcome of the legislation.
//www.hda.org/news/hda-blog/2018/08/14/11/49/2017-10-13-the-reality-of-the-opioid-epidemic
Two years ago, Congress approved bipartisan legislation to address the rapidly growing opioid epidemic. Yet today, that legislation — S.483: Ensuring Patient Access and Effective Drug Enforcement Act — is the subject of two upcoming media reports which mischaracterize the intent and outcome of the legislation.
Overprescribing and the Opioid Epidemic
//www.hda.org/news/hda-blog/2018/08/09/16/03/2017-12-05-overprescribing-and-the-opioid-epidemic
As our country grapples with how to most effectively combat the misuse and abuse of prescription opioids, it’s helpful to look at how we got here.
//www.hda.org/news/hda-blog/2018/08/09/16/03/2017-12-05-overprescribing-and-the-opioid-epidemic
As our country grapples with how to most effectively combat the misuse and abuse of prescription opioids, it’s helpful to look at how we got here.
AmerisourceBergen and the Role of Local Philanthropy During COVID-19
//www.hda.org/news/hda-blog/2020/06/03/10/54/2020-06-04-amerisourcebergen-and-local-philanthropy-during-covid19
From the outset of COVID-19, HDA member AmerisourceBergen recognized the critical role that local philanthropic efforts can play in addressing global health emergencies.
//www.hda.org/news/hda-blog/2020/06/03/10/54/2020-06-04-amerisourcebergen-and-local-philanthropy-during-covid19
From the outset of COVID-19, HDA member AmerisourceBergen recognized the critical role that local philanthropic efforts can play in addressing global health emergencies.
For McKesson, COVID-19 Response Begins with Supporting Employees
//www.hda.org/news/hda-blog/2020/06/16/15/37/2020-06-17-mckesson-covid19-response-begins-with-supporting-employees
Across the country, frontline healthcare workers are leading COVID-19 response efforts. HDA member McKesson is taking care of its employees so they can continue to support these medical professionals every step of the way in their efforts to treat patients, maintain vital healthcare operations and support emergency responders.
//www.hda.org/news/hda-blog/2020/06/16/15/37/2020-06-17-mckesson-covid19-response-begins-with-supporting-employees
Across the country, frontline healthcare workers are leading COVID-19 response efforts. HDA member McKesson is taking care of its employees so they can continue to support these medical professionals every step of the way in their efforts to treat patients, maintain vital healthcare operations and support emergency responders.
COVID-19 Reinforces Distributors’ Commitment to Protecting Employees
//www.hda.org/news/hda-blog/2020/07/06/15/30/2020-07-07-covid19-reinforces-distributor-commitment-to-employees
Maintaining the integrity of the pharmaceutical supply chain in this unprecedented time would not be possible without the incredible efforts of distribution industry employees, who are working around-the-clock to move critical medicines and healthcare supplies.
//www.hda.org/news/hda-blog/2020/07/06/15/30/2020-07-07-covid19-reinforces-distributor-commitment-to-employees
Maintaining the integrity of the pharmaceutical supply chain in this unprecedented time would not be possible without the incredible efforts of distribution industry employees, who are working around-the-clock to move critical medicines and healthcare supplies.
COVID-19 Reinforces KeySource’s Commitment to Helping Those in Need
//www.hda.org/news/hda-blog/2020/07/15/11/48/2020-07-16-covid19-reinforces-keysource-commitment
Since 2006, thousands of uninsured and underinsured patients in Cincinnati, Ohio, and neighboring communities have been able to fill their critically needed medications at no charge through the St. Vincent de Paul Charitable Pharmacy.
//www.hda.org/news/hda-blog/2020/07/15/11/48/2020-07-16-covid19-reinforces-keysource-commitment
Since 2006, thousands of uninsured and underinsured patients in Cincinnati, Ohio, and neighboring communities have been able to fill their critically needed medications at no charge through the St. Vincent de Paul Charitable Pharmacy.
Dispensary of Hope Provides an Innovative Model for Helping Those In Need
//www.hda.org/news/hda-blog/2020/09/15/15/00/2020-09-15-dispensary-of-hope-provides-an-innovative-model
//www.hda.org/news/hda-blog/2020/09/15/15/00/2020-09-15-dispensary-of-hope-provides-an-innovative-model
Pharmaceutical Distributors are at the Forefront of Cold Chain Logistics
//www.hda.org/news/hda-blog/2020/09/28/17/55/2020-09-18-rx-distributors-at-the-forefront-of-cold-chain-logistics
As the fight against the coronavirus pandemic continues, the successful development of effective COVID-19 vaccines will represent a pivotal moment in our country’s efforts to end this public health crisis. However, the discovery of a vaccine is just the first step of many to ensure these critical medicines are widely accessible to providers and their patients.
//www.hda.org/news/hda-blog/2020/09/28/17/55/2020-09-18-rx-distributors-at-the-forefront-of-cold-chain-logistics
As the fight against the coronavirus pandemic continues, the successful development of effective COVID-19 vaccines will represent a pivotal moment in our country’s efforts to end this public health crisis. However, the discovery of a vaccine is just the first step of many to ensure these critical medicines are widely accessible to providers and their patients.
Strengthening the Strategic National Stockpile for the Future
//www.hda.org/news/hda-blog/2020/09/28/18/13/2020-09-25-strengthening-the-sns
The Strategic National Stockpile (SNS) plays a critical role in supplementing state and local supplies during public health emergencies. The lifesaving medicines and healthcare products secured by the stockpile serve as a buffer when supplies may otherwise not be immediately available.
//www.hda.org/news/hda-blog/2020/09/28/18/13/2020-09-25-strengthening-the-sns
The Strategic National Stockpile (SNS) plays a critical role in supplementing state and local supplies during public health emergencies. The lifesaving medicines and healthcare products secured by the stockpile serve as a buffer when supplies may otherwise not be immediately available.
Verification Network Update: Less than 60 Days Remain
//www.hda.org/news/hda-blog/2020/10/08/16/11/2020-10-09-verification-network-update
Industry and service providers continue to work to implement the Drug Supply Chain Security Act’s (DSCSA) serialized saleable return milestone. With the end of FDA-granted enforcement discretion ending on November 27, 2020, and the industry simultaneously responding to COVID-19, it is all hands on deck to reach the compliance finish line.
//www.hda.org/news/hda-blog/2020/10/08/16/11/2020-10-09-verification-network-update
Industry and service providers continue to work to implement the Drug Supply Chain Security Act’s (DSCSA) serialized saleable return milestone. With the end of FDA-granted enforcement discretion ending on November 27, 2020, and the industry simultaneously responding to COVID-19, it is all hands on deck to reach the compliance finish line.
Five Things to Know: Pharmaceutical Distributors and Vaccine Distribution
//www.hda.org/news/hda-blog/2020/10/15/13/43/2020-10-15-five-things-to-know-about-distributors-and-vaccine-distribution
The successful development of COVID-19 vaccines will mark a groundbreaking step in our fight against the pandemic. However, the massive demand for approved vaccines and therapies as they come to market will require extensive coordination across the pharmaceutical supply chain and with the public sector.
//www.hda.org/news/hda-blog/2020/10/15/13/43/2020-10-15-five-things-to-know-about-distributors-and-vaccine-distribution
The successful development of COVID-19 vaccines will mark a groundbreaking step in our fight against the pandemic. However, the massive demand for approved vaccines and therapies as they come to market will require extensive coordination across the pharmaceutical supply chain and with the public sector.
The First 90 Days of COVID-19: Lessons Learned
//www.hda.org/news/hda-blog/2020/10/27/09/49/2020-10-26-covid19-lessons-learned
The emergence of COVID-19 marked the beginning of a public health crisis the scale of which we have never seen. Amid this unprecedented challenge, the pharmaceutical supply chain — powered by distributors — quickly adapted and adjusted to the global pandemic, protecting the steady supply of critical, lifesaving medicines to hospitals, pharmacies, providers and patients.
//www.hda.org/news/hda-blog/2020/10/27/09/49/2020-10-26-covid19-lessons-learned
The emergence of COVID-19 marked the beginning of a public health crisis the scale of which we have never seen. Amid this unprecedented challenge, the pharmaceutical supply chain — powered by distributors — quickly adapted and adjusted to the global pandemic, protecting the steady supply of critical, lifesaving medicines to hospitals, pharmacies, providers and patients.
DSCSA Saleable Returns
//www.hda.org/news/hda-blog/2019/11/20/13/10/2019-11-21-dscsa-saleable-returns
It has been clear for some time that the pharmaceutical supply chain has been concerned with meeting the November 27, 2019, saleable returns milestone.
//www.hda.org/news/hda-blog/2019/11/20/13/10/2019-11-21-dscsa-saleable-returns
It has been clear for some time that the pharmaceutical supply chain has been concerned with meeting the November 27, 2019, saleable returns milestone.
HDA Highlights Distributors' Value, 2020 Policy Outlook in Chain Drug Review
//www.hda.org/news/hda-blog/2020/01/08/09/53/2020-01-08-hda-featured-in-chain-drug-review-pharmacy-outlook
With 2020 underway, HDA’s John M. Gray provided perspective on the vital role of pharmaceutical distributors and the Alliance’s policy priorities as part of Chain Drug Review’s annual “Pharmacy Outlook” feature.
//www.hda.org/news/hda-blog/2020/01/08/09/53/2020-01-08-hda-featured-in-chain-drug-review-pharmacy-outlook
With 2020 underway, HDA’s John M. Gray provided perspective on the vital role of pharmaceutical distributors and the Alliance’s policy priorities as part of Chain Drug Review’s annual “Pharmacy Outlook” feature.
A Conversation About Pharmaceutical Supply Chain Resilience and COVID-19
//www.hda.org/news/hda-blog/2020/11/06/12/45/2020-11-06-conversation-about-supply-chain-resilience
On October 27, HDA and The Hill brought together policymakers, leaders in the pharmaceutical industry and public health experts to discuss the supply chain’s response during COVID-19. In conversation with Steve Clemons, Editor-in-Chief of The Hill, speakers provided key insights on ensuring the strength and resilience of the pharmaceutical supply chain during this unprecedented crisis. Below are five takeaways from the dialogue.
//www.hda.org/news/hda-blog/2020/11/06/12/45/2020-11-06-conversation-about-supply-chain-resilience
On October 27, HDA and The Hill brought together policymakers, leaders in the pharmaceutical industry and public health experts to discuss the supply chain’s response during COVID-19. In conversation with Steve Clemons, Editor-in-Chief of The Hill, speakers provided key insights on ensuring the strength and resilience of the pharmaceutical supply chain during this unprecedented crisis. Below are five takeaways from the dialogue.
DSCSA, the 2023 Requirements and EPCIS
//www.hda.org/news/hda-blog/2020/11/10/17/42/2020-11-11-dscsa-2023-requirements-and-epcis
Since the enactment of the Drug Supply Chain Security Act in 2013, members of the pharmaceutical supply chain have undertaken efforts to meet each of the major milestones contained within the statute’s 10-year timeline to further secure the safety of the products being distributed. The industry’s progress to 2023 interoperability was top of mind as supply chain and other stakeholders came together at HDA’s recent Traceability Online Seminar.
//www.hda.org/news/hda-blog/2020/11/10/17/42/2020-11-11-dscsa-2023-requirements-and-epcis
Since the enactment of the Drug Supply Chain Security Act in 2013, members of the pharmaceutical supply chain have undertaken efforts to meet each of the major milestones contained within the statute’s 10-year timeline to further secure the safety of the products being distributed. The industry’s progress to 2023 interoperability was top of mind as supply chain and other stakeholders came together at HDA’s recent Traceability Online Seminar.
Leveraging Public and Private Sector Collaboration to Respond to COVID-19
//www.hda.org/news/hda-blog/2020/05/27/13/52/2020-05-27-leveraging-public-and-private-sector-collaboration-during-covid19
While it has only been a few months since the first American was diagnosed with COVID-19, the scope of the pandemic is one which we have never experienced before. Throughout, it has become abundantly clear that our nation’s ability to effectively respond to this once-in-a-lifetime crisis depends on the public and private sectors joining forces, maintaining constant coordination, and working together to identify operational and regulatory barriers impeding access to medicines and medical supplies.
//www.hda.org/news/hda-blog/2020/05/27/13/52/2020-05-27-leveraging-public-and-private-sector-collaboration-during-covid19
While it has only been a few months since the first American was diagnosed with COVID-19, the scope of the pandemic is one which we have never experienced before. Throughout, it has become abundantly clear that our nation’s ability to effectively respond to this once-in-a-lifetime crisis depends on the public and private sectors joining forces, maintaining constant coordination, and working together to identify operational and regulatory barriers impeding access to medicines and medical supplies.
Distributors Rising to the Challenge During the Coronavirus Pandemic
//www.hda.org/news/hda-blog/2020/03/16/17/08/2020-03-17-distributors-rising-to-the-challenge
//www.hda.org/news/hda-blog/2020/03/16/17/08/2020-03-17-distributors-rising-to-the-challenge
Distributors Leading the Way in the Next Phase of COVID-19
//www.hda.org/news/hda-blog/2020/11/23/13/07/2020-11-23-distributors-leading-the-way
Since the emergence of COVID-19, HDA distributor members have worked tirelessly to navigate the exceptional and unprecedented demands of this public health emergency. From managing unique inventory demands of the first hotspots, to ensuring access to emerging treatment options and testing, HDA members draw upon their extensive supply and distribution networks, logistics expertise and experience navigating public health emergencies. Moreover, distributors are committed to the public- and private-sector partnerships that are critical in combating COVID-19, fueling our recovery and improving pandemic resiliency for the future.
//www.hda.org/news/hda-blog/2020/11/23/13/07/2020-11-23-distributors-leading-the-way
Since the emergence of COVID-19, HDA distributor members have worked tirelessly to navigate the exceptional and unprecedented demands of this public health emergency. From managing unique inventory demands of the first hotspots, to ensuring access to emerging treatment options and testing, HDA members draw upon their extensive supply and distribution networks, logistics expertise and experience navigating public health emergencies. Moreover, distributors are committed to the public- and private-sector partnerships that are critical in combating COVID-19, fueling our recovery and improving pandemic resiliency for the future.
Healthcare Distribution Centers
//www.hda.org/news/hda-blog/2019/01/25/13/58/2019-01-25-healthcare-distribution-centers
Pharmaceutical distributors have a long history of bringing the newest advancements and technologies to their warehouses. Back in 1947, the National Wholesale Druggists’ Association (an early iteration of HDA) tapped Ohio State University marketing experts to reimagine an entirely new type of layout for wholesaler warehouses, which included longer aisles, moving belts, “and roller skates for order pickers.” While the roller skates never caught on, healthcare distributors’ commitment to harnessing innovation to develop facilities that safely and securely get prescription medicines and medical products to the patients who need them has only grown.
//www.hda.org/news/hda-blog/2019/01/25/13/58/2019-01-25-healthcare-distribution-centers
Pharmaceutical distributors have a long history of bringing the newest advancements and technologies to their warehouses. Back in 1947, the National Wholesale Druggists’ Association (an early iteration of HDA) tapped Ohio State University marketing experts to reimagine an entirely new type of layout for wholesaler warehouses, which included longer aisles, moving belts, “and roller skates for order pickers.” While the roller skates never caught on, healthcare distributors’ commitment to harnessing innovation to develop facilities that safely and securely get prescription medicines and medical products to the patients who need them has only grown.
Davis Spotlights HDA's 2021 Strategic Priorities
//www.hda.org/news/hda-blog/2021/01/05/16/19/2021-01-05-davis-spotlights-hda-2021-strategic-priorities
HDA will be carrying forward the early lessons learned from COVID-19 pandemic and supporting response efforts in 2021, writes President and CEO Chip Davis in the January 4 issue of Chain Drug Review — particularly as distributors play a role in the largest public vaccination effort in recent memory. Davis provided his perspective on the year ahead, along with other healthcare trade association leaders, as part of the publication’s 2021 “Pharmacy Outlook” feature.
//www.hda.org/news/hda-blog/2021/01/05/16/19/2021-01-05-davis-spotlights-hda-2021-strategic-priorities
HDA will be carrying forward the early lessons learned from COVID-19 pandemic and supporting response efforts in 2021, writes President and CEO Chip Davis in the January 4 issue of Chain Drug Review — particularly as distributors play a role in the largest public vaccination effort in recent memory. Davis provided his perspective on the year ahead, along with other healthcare trade association leaders, as part of the publication’s 2021 “Pharmacy Outlook” feature.
US Biopharma Finished Goods Supply Chain Response to COVID19
/~/media/pdfs/center/us-biopharma-finished-goods-supply-chain-response-to-covid19.ashx
/~/media/pdfs/center/us-biopharma-finished-goods-supply-chain-response-to-covid19.ashx
Service Provider Membership Benefits
/~/media/pdfs/membership/service-provider-membership-benefits.ashx
/~/media/pdfs/membership/service-provider-membership-benefits.ashx
International Membership Application
/~/media/pdfs/membership/international-membership-application.ashx
/~/media/pdfs/membership/international-membership-application.ashx
Service Provider Membership Application
/~/media/pdfs/membership/service-provider-membership-application.ashx
/~/media/pdfs/membership/service-provider-membership-application.ashx
2020 DIANA Nomination Process Guide
/~/media/pdfs/membership/2020-diana-nomination-process-guide.ashx
/~/media/pdfs/membership/2020-diana-nomination-process-guide.ashx
HBW Consumer Membership Application
/~/media/pdfs/membership/hbw-consumer-membership-application.ashx
/~/media/pdfs/membership/hbw-consumer-membership-application.ashx
19DIANA Forms Single Entry FILLABLE
/~/media/pdfs/membership/19diana-forms--single-entry-fillable.ashx
/~/media/pdfs/membership/19diana-forms--single-entry-fillable.ashx
Manufacturer Membership Application
/~/media/pdfs/membership/manufacturer-membership-application.ashx
/~/media/pdfs/membership/manufacturer-membership-application.ashx
Manufacturer Readiness Survey Results Report
/~/media/pdfs/industry-relations/manufacturer-readiness-survey-results-report.ashx
/~/media/pdfs/industry-relations/manufacturer-readiness-survey-results-report.ashx
HDA New Product Form 2020 Instructions
/~/media/pdfs/industry-relations/hda-new-product-form-2020-instructions.ashx
/~/media/pdfs/industry-relations/hda-new-product-form-2020-instructions.ashx
Recommended COVID 19 Protocols v2
/~/media/pdfs/industry-relations/recommended-covid-19-protocols-v2.ashx
/~/media/pdfs/industry-relations/recommended-covid-19-protocols-v2.ashx
HDA Role of Distributors in the US Health Care Industry
/~/media/pdfs/publications/hda-role-of-distributors-in-the-us-health-care-industry.ashx
/~/media/pdfs/publications/hda-role-of-distributors-in-the-us-health-care-industry.ashx
Risk and Realities of Commercial Drug Importation
/~/media/pdfs/publications/risk-and-realities-of-commercial-drug-importation.ashx
/~/media/pdfs/publications/risk-and-realities-of-commercial-drug-importation.ashx
2020 01 06 HDA Chain Drug Review Outlook
/~/media/pdfs/communications/2020-01-06-hda-chain-drug-review-outlook.ashx
/~/media/pdfs/communications/2020-01-06-hda-chain-drug-review-outlook.ashx
Distributors Create Efficiencies in Healthcare
/~/media/pdfs/communications/distributors-create-efficiencies-in-healthcare.ashx
/~/media/pdfs/communications/distributors-create-efficiencies-in-healthcare.ashx
2019 01 24 Avalere Report Infographic FINAL
/~/media/pdfs/communications/2019-01-24-avalere-report-infographic-final.ashx
/~/media/pdfs/communications/2019-01-24-avalere-report-infographic-final.ashx
2019 01 25 The Vital Link in the Pharmaceutical Supply Chain
/~/media/pdfs/communications/2019-01-25-the-vital-link-in-the-pharmaceutical-supply-chain.ashx
/~/media/pdfs/communications/2019-01-25-the-vital-link-in-the-pharmaceutical-supply-chain.ashx
2019 05 22 HDA Suspicious Order Reporting Fact Sheet
/~/media/pdfs/communications/2019-05-22-hda-suspicious-order-reporting-fact-sheet.ashx
/~/media/pdfs/communications/2019-05-22-hda-suspicious-order-reporting-fact-sheet.ashx
2019 01 07 Gray Chain Drug Review Outlook
/~/media/pdfs/communications/2019-01-07-gray-chain-drug-review-outlook.ashx
/~/media/pdfs/communications/2019-01-07-gray-chain-drug-review-outlook.ashx
2019 01 25 How Do Medicines Get to Where They Need to Go
/~/media/pdfs/communications/2019-01-25-how-do-medicines-get-to-where-they-need-to-go.ashx
/~/media/pdfs/communications/2019-01-25-how-do-medicines-get-to-where-they-need-to-go.ashx
2020 03 18 Final Joint Association COVID19 letter
/~/media/pdfs/communications/2020-03-18-final-joint-association-covid19-letter.ashx
/~/media/pdfs/communications/2020-03-18-final-joint-association-covid19-letter.ashx
2020 03 19 Joint Association COVID 19 Shelter in Place Governors Letter
/~/media/pdfs/communications/2020-03-19-joint-association-covid-19-shelter-in-place-governors-letter.ashx
/~/media/pdfs/communications/2020-03-19-joint-association-covid-19-shelter-in-place-governors-letter.ashx
2020 03 19 CISA Guidance on Essential Critical Infrastructure Workers
/~/media/pdfs/communications/2020-03-19-cisa-guidance-on-essential-critical-infrastructure-workers.ashx
/~/media/pdfs/communications/2020-03-19-cisa-guidance-on-essential-critical-infrastructure-workers.ashx
2020 03 25 Coalition BuyAmericanEO Treasury USTR Commerce NEC FINAL
/~/media/pdfs/communications/2020-03-25-coalition-buyamericaneo-treasury-ustr-commerce-nec-final.ashx
/~/media/pdfs/communications/2020-03-25-coalition-buyamericaneo-treasury-ustr-commerce-nec-final.ashx
2020 03 30 HDA Congressional Committee Letter
/~/media/pdfs/communications/2020-03-30-hda-congressional-committee-letter.ashx
/~/media/pdfs/communications/2020-03-30-hda-congressional-committee-letter.ashx
FEMA Supply Chain Task Force Four Prong Approach Secure Supplies
/~/media/pdfs/communications/fema-supply-chain-task-force-four-prong-approach-secure-supplies.ashx
/~/media/pdfs/communications/fema-supply-chain-task-force-four-prong-approach-secure-supplies.ashx
2020 04 27 HDA Letter to Pharmacy Organizations
/~/media/pdfs/communications/2020-04-27-hda-letter-to-pharmacy-organizations.ashx
/~/media/pdfs/communications/2020-04-27-hda-letter-to-pharmacy-organizations.ashx
HDA Principles for Pandemic and Public Health Emergency Response
/~/media/pdfs/communications/hda-principles-for-pandemic-and-public-health-emergency-response.ashx
/~/media/pdfs/communications/hda-principles-for-pandemic-and-public-health-emergency-response.ashx
2020 06 10 HDA letter to HHS Assistant Secretary for Preparedness and Response
/~/media/pdfs/communications/2020-06-10-hda-letter-to-hhs-assistant-secretary-for-preparedness-and-response.ashx
/~/media/pdfs/communications/2020-06-10-hda-letter-to-hhs-assistant-secretary-for-preparedness-and-response.ashx
2020 07 24 HDA Statement on Presidents Drug Affordability EOs
/~/media/pdfs/communications/2020-07-24-hda-statement-on-presidents-drug-affordability-eos.ashx
/~/media/pdfs/communications/2020-07-24-hda-statement-on-presidents-drug-affordability-eos.ashx
2020 09 Pharmaceutical Cold Chain Logistics
/~/media/pdfs/communications/2020-09-pharmaceutical-cold-chain-logistics.ashx
/~/media/pdfs/communications/2020-09-pharmaceutical-cold-chain-logistics.ashx
HDA Fact Sheet on COVID19 Supply Chain Response
/~/media/pdfs/communications/hda-fact-sheet-on-covid19-supply-chain-response.ashx
/~/media/pdfs/communications/hda-fact-sheet-on-covid19-supply-chain-response.ashx
Delivering Value Across the Healthcare Ecosystem
/~/media/pdfs/communications/delivering-value-across-the-healthcare-ecosystem.ashx
/~/media/pdfs/communications/delivering-value-across-the-healthcare-ecosystem.ashx
Delivering Medicine and Value to the Health System
/~/media/pdfs/communications/delivering-medicine-and-value-to-the-health-system.ashx
/~/media/pdfs/communications/delivering-medicine-and-value-to-the-health-system.ashx
2021 01 04 Pharmacy Outlook Chip Davis HDA
/~/media/pdfs/communications/2021-01-04-pharmacy-outlook-chip-davis-hda.ashx
/~/media/pdfs/communications/2021-01-04-pharmacy-outlook-chip-davis-hda.ashx
2018 02 27 Why Origin Final
/~/media/pdfs/industry-relations/hda-origin-documents/2018-02-27-why-origin-final.ashx
/~/media/pdfs/industry-relations/hda-origin-documents/2018-02-27-why-origin-final.ashx
FINAL Origin Infographic
/~/media/pdfs/industry-relations/hda-origin-documents/final-origin-infographic.ashx
/~/media/pdfs/industry-relations/hda-origin-documents/final-origin-infographic.ashx
Origin Overview Revised FINAL
/~/media/pdfs/industry-relations/hda-origin-documents/origin-overview-revised-final.ashx
/~/media/pdfs/industry-relations/hda-origin-documents/origin-overview-revised-final.ashx
HDA Origin Fact Sheet FINAL
/~/media/pdfs/industry-relations/hda-origin-documents/hda-origin-fact-sheet-final.ashx
/~/media/pdfs/industry-relations/hda-origin-documents/hda-origin-fact-sheet-final.ashx
VRS Technical Specifications for Responder CI Upload to Look Up Directory and LD Synchronization
/~/media/pdfs/industry-relations/vrs-documents/2019/vrs-technical-specifications-for-responder-ci-upload-to-look-up-directory-and-ld-synchronization.ashx
/~/media/pdfs/industry-relations/vrs-documents/2019/vrs-technical-specifications-for-responder-ci-upload-to-look-up-directory-and-ld-synchronization.ashx
VRS Task Force Report to Industry
/~/media/pdfs/industry-relations/vrs-documents/2019/vrs-task-force-report-to-industry.ashx
/~/media/pdfs/industry-relations/vrs-documents/2019/vrs-task-force-report-to-industry.ashx
VRS Governance Body Charter
/~/media/pdfs/industry-relations/vrs-documents/2019/vrs-governance-body-charter.ashx
/~/media/pdfs/industry-relations/vrs-documents/2019/vrs-governance-body-charter.ashx
VRS Authorized Trading Partner Requirements
/~/media/pdfs/industry-relations/vrs-documents/2019/vrs-authorized-trading-partner-requirements.ashx
/~/media/pdfs/industry-relations/vrs-documents/2019/vrs-authorized-trading-partner-requirements.ashx
VRS Solution Architecture Reference Document
/~/media/pdfs/industry-relations/vrs-documents/2019/vrs-solution-architecture-reference-document.ashx
/~/media/pdfs/industry-relations/vrs-documents/2019/vrs-solution-architecture-reference-document.ashx
VRS Current Security Approach
/~/media/pdfs/industry-relations/vrs-documents/2019/vrs-current-security-approach.ashx
/~/media/pdfs/industry-relations/vrs-documents/2019/vrs-current-security-approach.ashx
VRS Business Requirements Document
/~/media/pdfs/industry-relations/vrs-documents/2019/vrs-business-requirements-document.ashx
/~/media/pdfs/industry-relations/vrs-documents/2019/vrs-business-requirements-document.ashx
2019 11 06 Prioritizing Hacks How to Maximize Your Day Webinar
/~/media/pdfs/publications/webinars/2019-11-06-prioritizing-hacks-how-to-maximize-your-day-webinar.ashx
/~/media/pdfs/publications/webinars/2019-11-06-prioritizing-hacks-how-to-maximize-your-day-webinar.ashx
2019 05 16 Art of the Ask Webinar
/~/media/pdfs/publications/webinars/2019-05-16-art-of-the-ask-webinar.ashx
/~/media/pdfs/publications/webinars/2019-05-16-art-of-the-ask-webinar.ashx
2018 12 10 HDA Membership Webinar
/~/media/pdfs/publications/webinars/2018-12-10-hda-membership-webinar.ashx
/~/media/pdfs/publications/webinars/2018-12-10-hda-membership-webinar.ashx
2018 11 28 Simplifying Your Master Data Workflow Webinar
/~/media/pdfs/publications/webinars/2018-11-28-simplifying-your-master-data-workflow-webinar.ashx
/~/media/pdfs/publications/webinars/2018-11-28-simplifying-your-master-data-workflow-webinar.ashx
HDMA New Product Form 2014 Instructions
/~/media/pdfs/publications/new-product-form-files/hdma-new-product-form-2014-instructions.ashx
/~/media/pdfs/publications/new-product-form-files/hdma-new-product-form-2014-instructions.ashx
2020 10 26 The US Pharmaceutical Market during Covid19 Webinar
/~/media/pdfs/publications/webinars/2020-10-26-the-us-pharmaceutical-market-during-covid19-webinar.ashx
/~/media/pdfs/publications/webinars/2020-10-26-the-us-pharmaceutical-market-during-covid19-webinar.ashx
2019 12 17 HDA Testimony Senate Judiciary Committee FINAL
/~/media/pdfs/government-affairs/2019-12-17-hda-testimony-senate-judiciary-committee-final.ashx
/~/media/pdfs/government-affairs/2019-12-17-hda-testimony-senate-judiciary-committee-final.ashx
2011 06 01 HDMA Questions to DEA Seeking Regulatory Clarity
/~/media/pdfs/government-affairs/2011-06-01-hdma-questions-to-dea-seeking-regulatory-clarity.ashx
/~/media/pdfs/government-affairs/2011-06-01-hdma-questions-to-dea-seeking-regulatory-clarity.ashx
2010 07 08 HDMA Letter to DEA ARCOS
/~/media/pdfs/government-affairs/2010-07-08-hdma-letter-to-dea-arcos.ashx
/~/media/pdfs/government-affairs/2010-07-08-hdma-letter-to-dea-arcos.ashx
2019 08 26 HDA Response to HHS RFI Abuse Prevention Final
/~/media/pdfs/government-affairs/2019-08-26-hda-response-to-hhs-rfi-abuse-prevention-final.ashx
/~/media/pdfs/government-affairs/2019-08-26-hda-response-to-hhs-rfi-abuse-prevention-final.ashx
Traceability Resource HDA Comments on Initiation of Voluntary Recalls Guidance
/~/media/pdfs/government-affairs/traceability-resource-hda-comments-on-initiation-of-voluntary-recalls-guidance.ashx
/~/media/pdfs/government-affairs/traceability-resource-hda-comments-on-initiation-of-voluntary-recalls-guidance.ashx
2019 01 30 HDA Minnesota House Health and Human Services Policy Committee Testimony
/~/media/pdfs/government-affairs/2019-01-30-hda-minnesota-house-health-and-human-services-policy-committee-testimony.ashx
/~/media/pdfs/government-affairs/2019-01-30-hda-minnesota-house-health-and-human-services-policy-committee-testimony.ashx
2017 10 17 HDA Senate HELP Testimony
/~/media/pdfs/government-affairs/2017-10-17-hda-senate-help-testimony.ashx
/~/media/pdfs/government-affairs/2017-10-17-hda-senate-help-testimony.ashx
Reimbursement Resource 04 08 19 HDA Comments to Rebate Rule NPRM Final
/~/media/pdfs/government-affairs/reimbursement-resource-04-08-19-hda-comments-to-rebate-rule-nprm-final.ashx
/~/media/pdfs/government-affairs/reimbursement-resource-04-08-19-hda-comments-to-rebate-rule-nprm-final.ashx
Traceability Resource HDA Comments FDA Draft Guidance Product Identifiers Under DSCSA QA
/~/media/pdfs/government-affairs/traceability-resource-hda-comments-fda-draft-guidance--product-identifiers-under-dscsa-qa.ashx
/~/media/pdfs/government-affairs/traceability-resource-hda-comments-fda-draft-guidance--product-identifiers-under-dscsa-qa.ashx
Traceability Resource HDA Comments on FDAs notice Future Format of the National Drug Code
/~/media/pdfs/government-affairs/traceability-resource-hda-comments-on-fdas-notice-future-format-of-the-national-drug-code.ashx
/~/media/pdfs/government-affairs/traceability-resource-hda-comments-on-fdas-notice-future-format-of-the-national-drug-code.ashx
2017 12 13 HDA Testimony House E C Subcommittee on Health
/~/media/pdfs/government-affairs/2017-12-13-hda-testimony-house-e-c-subcommittee-on-health.ashx
/~/media/pdfs/government-affairs/2017-12-13-hda-testimony-house-e-c-subcommittee-on-health.ashx
Rx Drug Abuse HDA Comments to DEA on Propose Rule RE New Single Sheet Format for DEA Form 222
/~/media/pdfs/government-affairs/rx-drug-abuse-hda-comments-to-dea-on-propose-rule-re-new-single-sheet-format-for-dea-form-222.ashx
/~/media/pdfs/government-affairs/rx-drug-abuse-hda-comments-to-dea-on-propose-rule-re-new-single-sheet-format-for-dea-form-222.ashx
2019 04 24 Letter to FDA Commissioner on State Licensure Final
/~/media/pdfs/government-affairs/2019-04-24-letter-to-fda-commissioner-on-state-licensure-final.ashx
/~/media/pdfs/government-affairs/2019-04-24-letter-to-fda-commissioner-on-state-licensure-final.ashx
2018 Midterm Election Outcome Final
/~/media/pdfs/government-affairs/2018-midterm-election-outcome-final.ashx
/~/media/pdfs/government-affairs/2018-midterm-election-outcome-final.ashx
02 20 2020 Final Importation Draft Guidance Comments by HDA
/~/media/pdfs/government-affairs/02-20-2020-final-importation-draft-guidance-comments-by-hda.ashx
/~/media/pdfs/government-affairs/02-20-2020-final-importation-draft-guidance-comments-by-hda.ashx
2020 03 05 HDA Final Comment on Importation Proposed Rule
/~/media/pdfs/government-affairs/2020-03-05-hda-final-comment-on-importation-proposed-rule.ashx
/~/media/pdfs/government-affairs/2020-03-05-hda-final-comment-on-importation-proposed-rule.ashx
2020 03 27 AAM Letter to President on Buy American EO
/~/media/pdfs/government-affairs/2020-03-27-aam-letter-to-president-on-buy-american-eo.ashx
/~/media/pdfs/government-affairs/2020-03-27-aam-letter-to-president-on-buy-american-eo.ashx
2020 04 08 HDA Letter to Defense Logistics Agency
/~/media/pdfs/government-affairs/2020-04-08-hda-letter-to-defense-logistics-agency.ashx
/~/media/pdfs/government-affairs/2020-04-08-hda-letter-to-defense-logistics-agency.ashx
2020 04 09 CDC CISA Flyer Essential Critical Workers Dos and Donts COVID19
/~/media/pdfs/government-affairs/2020-04-09-cdc-cisa-flyer-essential-critical-workers-dos-and-donts-covid19.ashx
/~/media/pdfs/government-affairs/2020-04-09-cdc-cisa-flyer-essential-critical-workers-dos-and-donts-covid19.ashx
2020 04 09 CDC CISA Interim Guidance Critical Workers Safety Practices COVID19
/~/media/pdfs/government-affairs/2020-04-09-cdc-cisa-interim-guidance-critical-workers-safety-practices-covid19.ashx
/~/media/pdfs/government-affairs/2020-04-09-cdc-cisa-interim-guidance-critical-workers-safety-practices-covid19.ashx
2020 05 14 HDA Final Comments on DEA Registration Fees Proposed Rule
/~/media/pdfs/government-affairs/2020-05-14-hda-final-comments-on-dea-registration-fees-proposed-rule.ashx
/~/media/pdfs/government-affairs/2020-05-14-hda-final-comments-on-dea-registration-fees-proposed-rule.ashx
2020 06 05 HDA Comments FEMA Voluntary Agreement
/~/media/pdfs/government-affairs/2020-06-05-hda-comments-fema-voluntary-agreement.ashx
/~/media/pdfs/government-affairs/2020-06-05-hda-comments-fema-voluntary-agreement.ashx
2020 04 24 Enforcement Discretion Request Final by HDA
/~/media/pdfs/government-affairs/2020-04-24-enforcement-discretion-request-final-by-hda.ashx
/~/media/pdfs/government-affairs/2020-04-24-enforcement-discretion-request-final-by-hda.ashx
2020 06 19 HDA KeyExcerpts from WVA AG Investigation
/~/media/pdfs/government-affairs/2020-06-19-hda-keyexcerpts-from-wva-ag-investigation.ashx
/~/media/pdfs/government-affairs/2020-06-19-hda-keyexcerpts-from-wva-ag-investigation.ashx
2020 06 25 FINAL Letter to Chairman Alexander
/~/media/pdfs/government-affairs/2020-06-25-final-letter-to-chairman-alexander.ashx
/~/media/pdfs/government-affairs/2020-06-25-final-letter-to-chairman-alexander.ashx
2018 12 31 HDA Letter to CMS on IPI Demo Final
/~/media/pdfs/government-affairs/2018-12-31-hda-letter-to-cms-on-ipi-demo-final.ashx
/~/media/pdfs/government-affairs/2018-12-31-hda-letter-to-cms-on-ipi-demo-final.ashx
2020 09 28 Final HDA Comments DEA Form 106 Elec Submission Proposal
/~/media/pdfs/government-affairs/2020-09-28-final-hda-comments-dea-form-106-elec-submission-proposal.ashx
/~/media/pdfs/government-affairs/2020-09-28-final-hda-comments-dea-form-106-elec-submission-proposal.ashx
Guiding Principles of COVID Vaccine Distribution
/~/media/pdfs/government-affairs/guiding-principles-of-covid-vaccine-distribution.ashx
/~/media/pdfs/government-affairs/guiding-principles-of-covid-vaccine-distribution.ashx
HDA Letter to Congressional Leadership on CDC Funding
/~/media/pdfs/government-affairs/hda-letter-to-congressional-leadership-on-cdc-funding.ashx
/~/media/pdfs/government-affairs/hda-letter-to-congressional-leadership-on-cdc-funding.ashx
2020 11 16 HDA Letter to Biden Harris Transition Team
/~/media/pdfs/government-affairs/2020-11-16-hda-letter-to-biden-harris-transition-team.ashx
/~/media/pdfs/government-affairs/2020-11-16-hda-letter-to-biden-harris-transition-team.ashx
2020 12 01 Coalition Support Letter on Liability Reform
/~/media/pdfs/government-affairs/2020-12-01-coalition-support-letter-on-liability-reform.ashx
/~/media/pdfs/government-affairs/2020-12-01-coalition-support-letter-on-liability-reform.ashx
2020 12 12 PSPC Coalition Letter to Congressional Leaders
/~/media/pdfs/government-affairs/2020-12-12-pspc-coalition-letter-to-congressional-leaders.ashx
/~/media/pdfs/government-affairs/2020-12-12-pspc-coalition-letter-to-congressional-leaders.ashx
2020 12 28 Dec 8 9 Meeting Follow Up Comments By HDA
/~/media/pdfs/government-affairs/2020-12-28-dec-8-9-meeting-follow-up-comments-by-hda.ashx
/~/media/pdfs/government-affairs/2020-12-28-dec-8-9-meeting-follow-up-comments-by-hda.ashx
2021 1 11 HDA letter to President Elect Biden
/~/media/pdfs/government-affairs/2021-1-11-hda--letter-to-president-elect-biden.ashx
/~/media/pdfs/government-affairs/2021-1-11-hda--letter-to-president-elect-biden.ashx
2021 01 04 HDA Final SO Proposed Rule Comments
/~/media/pdfs/government-affairs/2021-01-04-hda-final-so-proposed-rule-comments.ashx
/~/media/pdfs/government-affairs/2021-01-04-hda-final-so-proposed-rule-comments.ashx
PSPC Coalition Letter to President Elect Biden January 14 2021
/~/media/pdfs/government-affairs/pspc-coalition-letter-to-president-elect-biden-january-14-2021.ashx
/~/media/pdfs/government-affairs/pspc-coalition-letter-to-president-elect-biden-january-14-2021.ashx
HDA Opposes Gross Receipts Taxes Levied on Pharmaceutical Distributors
/~/media/pdfs/government-affairs/position-statements/hda-opposes-gross-receipts-taxes-levied-on-pharmaceutical-distributors.ashx
/~/media/pdfs/government-affairs/position-statements/hda-opposes-gross-receipts-taxes-levied-on-pharmaceutical-distributors.ashx
DEA Rules-Suspicious Orders Monitoring
/~/media/pdfs/government-affairs/position-statements/dea-rules-suspicious-orders-monitoring.ashx
/~/media/pdfs/government-affairs/position-statements/dea-rules-suspicious-orders-monitoring.ashx
State Prescription Drug Monitoring Programs
/~/media/pdfs/government-affairs/position-statements/state-prescription-drug-monitoring-programs.ashx
/~/media/pdfs/government-affairs/position-statements/state-prescription-drug-monitoring-programs.ashx
State Licensing of Pain Management Clinics
/~/media/pdfs/government-affairs/position-statements/state-licensing-of-pain-management-clinics.ashx
/~/media/pdfs/government-affairs/position-statements/state-licensing-of-pain-management-clinics.ashx
Importation of Prescription Medicines
/~/media/pdfs/government-affairs/position-statements/importation-of-prescription-medicines.ashx
/~/media/pdfs/government-affairs/position-statements/importation-of-prescription-medicines.ashx
Pharmaceutical Pedigree and Traceability
/~/media/pdfs/government-affairs/position-statements/pharmaceutical-pedigree-and-traceability.ashx
/~/media/pdfs/government-affairs/position-statements/pharmaceutical-pedigree-and-traceability.ashx
State Controlled Substance Sales Reporting
/~/media/pdfs/government-affairs/position-statements/state-controlled-substance-sales-reporting.ashx
/~/media/pdfs/government-affairs/position-statements/state-controlled-substance-sales-reporting.ashx
Licensing Healthcare Distributors
/~/media/pdfs/government-affairs/position-statements/licensing-healthcare-distributors.ashx
/~/media/pdfs/government-affairs/position-statements/licensing-healthcare-distributors.ashx
Medicare Average Sales Price
/~/media/pdfs/government-affairs/position-statements/medicare-average-sales-price.ashx
/~/media/pdfs/government-affairs/position-statements/medicare-average-sales-price.ashx
Marketing and Gift Restrictions
/~/media/pdfs/government-affairs/position-statements/marketing-and-gift-restrictions.ashx
/~/media/pdfs/government-affairs/position-statements/marketing-and-gift-restrictions.ashx
2020 09 29 Enhanced Rx Distribution Traceability in 2023 Position Statement
/~/media/pdfs/government-affairs/position-statements/2020-09-29-enhanced-rx-distribution-traceability-in-2023-position-statement.ashx
/~/media/pdfs/government-affairs/position-statements/2020-09-29-enhanced-rx-distribution-traceability-in-2023-position-statement.ashx
2020 09 29 Getting Ready for EPCIS
/~/media/pdfs/government-affairs/position-statements/2020-09-29-getting-ready-for-epcis.ashx
/~/media/pdfs/government-affairs/position-statements/2020-09-29-getting-ready-for-epcis.ashx
BLC19 Registration Form Service Provider Contract correct
/~/media/pdfs/meetings/2019/blc19-registration-form-service-provider-contract-correct.ashx
/~/media/pdfs/meetings/2019/blc19-registration-form-service-provider-contract-correct.ashx
PCSC19 Registration Form Standard
/~/media/pdfs/meetings/2019/pcsc19-registration-form-standard.ashx
/~/media/pdfs/meetings/2019/pcsc19-registration-form-standard.ashx
FINAL PCSC19 Registration Form Standard
/~/media/pdfs/meetings/2019/final-pcsc19-registration-form-standard.ashx
/~/media/pdfs/meetings/2019/final-pcsc19-registration-form-standard.ashx
2019 PartnerLinx User Guide Phase I MANUFACTURERS SERVICE PROVIDERS
/~/media/pdfs/meetings/2019/2019-partnerlinx-user-guide-phase-i--manufacturers--service-providers.ashx
/~/media/pdfs/meetings/2019/2019-partnerlinx-user-guide-phase-i--manufacturers--service-providers.ashx
PCSC19 Registration Form Complimentary
/~/media/pdfs/meetings/2019/pcsc19-registration-form-complimentary.ashx
/~/media/pdfs/meetings/2019/pcsc19-registration-form-complimentary.ashx
2019 PartnerLinx Phase II User Guide
/~/media/pdfs/meetings/2019/2019-partnerlinx-phase-ii-user-guide.ashx
/~/media/pdfs/meetings/2019/2019-partnerlinx-phase-ii-user-guide.ashx
TNT19 Registration Form Substitute
/~/media/pdfs/meetings/2019/tnt19-registration-form-substitute.ashx
/~/media/pdfs/meetings/2019/tnt19-registration-form-substitute.ashx
BLC19 Registration Form Distributor Individual
/~/media/pdfs/meetings/2019/blc19-registration-form-distributor-individual.ashx
/~/media/pdfs/meetings/2019/blc19-registration-form-distributor-individual.ashx
BLC19 Registration Form Manufacturer
/~/media/pdfs/meetings/2019/blc19-registration-form-manufacturer.ashx
/~/media/pdfs/meetings/2019/blc19-registration-form-manufacturer.ashx
BLC19 Registration Form Service Provider Contract
/~/media/pdfs/meetings/2019/blc19-registration-form-service-provider-contract.ashx
/~/media/pdfs/meetings/2019/blc19-registration-form-service-provider-contract.ashx
BLC19 Registration Form Spouse Guest
/~/media/pdfs/meetings/2019/blc19-registration-form-spouse-guest.ashx
/~/media/pdfs/meetings/2019/blc19-registration-form-spouse-guest.ashx
BLC19 Registration Form Substitute
/~/media/pdfs/meetings/2019/blc19-registration-form-substitute.ashx
/~/media/pdfs/meetings/2019/blc19-registration-form-substitute.ashx
BLC19 Registration Form Distributor Coordinator
/~/media/pdfs/meetings/2019/blc19-registration-form-distributor-coordinator.ashx
/~/media/pdfs/meetings/2019/blc19-registration-form-distributor-coordinator.ashx
BLC20 Registration Form Distributor
/~/media/pdfs/meetings/2020/blc20-registration-form-distributor.ashx
/~/media/pdfs/meetings/2020/blc20-registration-form-distributor.ashx
DMC20 Registration Form Spouse Guest
/~/media/pdfs/meetings/2020/dmc20-registration-form-spouse-guest.ashx
/~/media/pdfs/meetings/2020/dmc20-registration-form-spouse-guest.ashx
DMC20 Registration Form Exhibitor
/~/media/pdfs/meetings/2020/dmc20-registration-form-exhibitor.ashx
/~/media/pdfs/meetings/2020/dmc20-registration-form-exhibitor.ashx
BLC20 Registration Form Service Provider Contract
/~/media/pdfs/meetings/2020/blc20-registration-form-service-provider-contract.ashx
/~/media/pdfs/meetings/2020/blc20-registration-form-service-provider-contract.ashx
BLC20 Registration Form Spouse Guest
/~/media/pdfs/meetings/2020/blc20-registration-form-spouse-guest.ashx
/~/media/pdfs/meetings/2020/blc20-registration-form-spouse-guest.ashx
BLC20 Registration Form Substitute
/~/media/pdfs/meetings/2020/blc20-registration-form-substitute.ashx
/~/media/pdfs/meetings/2020/blc20-registration-form-substitute.ashx
BLC20 Registration Form Manufacturer
/~/media/pdfs/meetings/2020/blc20-registration-form-manufacturer.ashx
/~/media/pdfs/meetings/2020/blc20-registration-form-manufacturer.ashx
BLC20 Registration Form Distributor Individual
/~/media/pdfs/meetings/2020/blc20-registration-form-distributor-individual.ashx
/~/media/pdfs/meetings/2020/blc20-registration-form-distributor-individual.ashx
2020 BLC PartnerLinx User Guide Phase I
/~/media/pdfs/meetings/2020/2020-blc-partnerlinx-user-guide-phase-i.ashx
/~/media/pdfs/meetings/2020/2020-blc-partnerlinx-user-guide-phase-i.ashx
DMC 2020 Premier Exhibitor Contract
/~/media/pdfs/meetings/2020/dmc-2020-premier-exhibitor-contract.ashx
/~/media/pdfs/meetings/2020/dmc-2020-premier-exhibitor-contract.ashx
DMC20Premier 2021 Exhibitor Contract
/~/media/pdfs/meetings/2021/dmc20premier-2021-exhibitor-contract.ashx
/~/media/pdfs/meetings/2021/dmc20premier-2021-exhibitor-contract.ashx
2020 BLC PartnerLinx User Guide Phase 2
/~/media/pdfs/meetings/2020/2020-blc-partnerlinx-user-guide-phase-2.ashx
/~/media/pdfs/meetings/2020/2020-blc-partnerlinx-user-guide-phase-2.ashx
PCSC20 Registration Form Complimentary
/~/media/pdfs/meetings/2020/pcsc20-registration-form-complimentary.ashx
/~/media/pdfs/meetings/2020/pcsc20-registration-form-complimentary.ashx
PCSC20 Registration Form Standard
/~/media/pdfs/meetings/2020/pcsc20-registration-form-standard.ashx
/~/media/pdfs/meetings/2020/pcsc20-registration-form-standard.ashx
BLC Online PartnerLinx User Guide Phase I
/~/media/pdfs/meetings/2020/blc-online-partnerlinx-user-guide-phase-i.ashx
/~/media/pdfs/meetings/2020/blc-online-partnerlinx-user-guide-phase-i.ashx
BLC Online PartnerLinx User Guide Phase I
/~/media/pdfs/meetings/2020/blc-online-partnerlinx-user-guide-phase-i.ashx
/~/media/pdfs/meetings/2020/blc-online-partnerlinx-user-guide-phase-i.ashx
BLC Online PartnerLinx User Guide Phase II
/~/media/pdfs/meetings/2020/blc-online-partnerlinx-user-guide-phase-ii.ashx
/~/media/pdfs/meetings/2020/blc-online-partnerlinx-user-guide-phase-ii.ashx
BLC20 Virtual Meetings User Guide
/~/media/pdfs/meetings/2020/blc20-virtual-meetings-user-guide.ashx
/~/media/pdfs/meetings/2020/blc20-virtual-meetings-user-guide.ashx
PCSC20 Online Registration Form Standard
/~/media/pdfs/meetings/2020/pcsc20-online-registration-form-standard.ashx
/~/media/pdfs/meetings/2020/pcsc20-online-registration-form-standard.ashx
Number Of Results : 1001
